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BSA bovine serum albumin
CalB Candida antarctica lipase B
CLEA cross-linked enzyme aggregate
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Da Dalton = one unified atomic mass unit
DABCO 1,4-diazabicyclo[2.2.2]octane
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Multi-enzyme systems
Part of this chapter will be published:
Schoffelen, S.; van Hest, J. C. M., 2011, subm itted
Chapter 1
1.1 -  Metabolic channeling in nature
Enzymes are nature’s catalysts. They increase the rate of an immense and diverse set of 
chemical reactions taking place in living organisms. They are involved in all processes 
essential for life such as DNA replication and transcription, protein synthesis, primary 
and secondary metabolism, signal transduction and the cell’s defense mechanisms.
Often a number of enzymes work together in multi-step reactions or cascade 
processes. In these metabolic pathways, the product of one enzyme is the substrate of 
the other. Activity is commonly regulated by spatial organization, in which enzymes of 
competing metabolic pathways are localized in separate organelles. Not only are 
cooperating enzymes often localized in the same compartment, they can also be 
associated in macromolecular complexes.
The organisation of enzymes in these specific assemblies has a major advantage 
that is referred to as metabolic channeling1, 2 The active sites of the enzymes are 
brought in close proximity of each other. In this way the intermediate is transferred 
from one catalytic site to the other without or with less diffusion into the bulk phase of 
the cell. Furthermore, the complexes maintain high local concentrations of the 
metabolites, which is crucial for unstable compounds. As the concentration in the rest 
of the cell is low, toxic intermediates are less dangerous. Finally, assembly of 
cooperating enzymes facilitates metabolic control by coordinating the activities of 
competing pathways, which use the same enzymes or intermediates. This type of 
regulation is based on dynamic complexes, in which the enzyme components assemble 
and dissociate in response to the metabolic status of the cell.
Several reviews discuss examples of metabolic channeling.1, 3  4 One of the best- 
characterized examples is the tryptophan synthase channel, which catalyzes the last two 
reactions in tryptophan biosynthesis .5 The two steps are catalyzed by two separate 
subunits (a and P), which combine to form a stable multi-enzyme complex (a 2p2) (see 
Scheme 1). It has been shown that the intermediate indole is transferred through a 
physical tunnel from the active site of the a subunit to the active site of subunit p. The 
tunnel is 25 A long and its diameter matches that of indole .6 It prevents diffusion of this 
hydrophobic intermediate, which could otherwise escape from the cell by passive 
diffusion across the cell membrane.
Other well-studied metabolons are the enzyme complexes involved in fatty acid 
oxidation7, 8 and the Calvin cycle9, 10, the pyruvate dehydrogenase complex11 and the 
citric acid cycle12, 13. This last example is of special interest, as many other biosynthetic
12
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pathways use its intermediates as starting compounds. It has been shown that six of the 
eight sequential enzymes interact with each other. Furthermore, it was found that all 
enzymes are bound to the mitochondrial inner membrane.
H—j—OH
c h 2o p o 32-
Scheme 1. The last two reaction steps in tryptophan biosynthesis catalyzed by tryptophan 
synthase. Indole, formed by subunit a, is transferred through a physical tunnel to subunit p where it 
reacts with serine resulting in tryptophan.
Scheme 2. Metabolic channeling in the citric acid cycle. Five out of eight enzymes (in grey) have 
been isolated as one multi-enzyme cluster.14
13
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Barnes et al. succeeded in isolating the five sequential enzymes fumarase, malate 
dehydrogenase, citrate synthase, aconitase and isocitrate dehydrogenase as one multi­
enzyme cluster (see Scheme 2 ) . 14 They showed that the complex, which they found in 
extracts of several bacterial species as well as rat liver mitochondria, catalyzed the 
formation of oxoglutarate from fumarate.
Metabolic channels are present in secondary metabolic pathways as well. 
Secondary metabolism refers to the biosynthesis of small molecule products, which are 
not directly involved in growth, development or reproduction of the organism. 
Examples, including antibiotics and pigments, are the polyketides15, alkaloids and 
isoprenoids16, and non-ribosomal peptides (see Scheme 3) . 17
Tetracycline Morphine Theobromine
Scheme 3. Examples of secondary metabolites synthesized via biosynthetic pathways involving 
metabolic channeling. Tetracycline is a polyketide, morphine and theobromine are alkaloids, 
linalool and capsaicin are isoprenoids, and cyclosporin A  is a non-ribosomal peptide.
The advantages observed in metabolic channels have inspired researchers to 
mimic this approach by bringing enzymes together in an artificial way. Recently, two 
reviews have been published which describe both naturally occurring multi-enzyme 
complexes and engineering strategies to create such systems4, 18. While in vivo 
approaches such as metabolic engineering and the production of gene fusions are 
thoroughly presented, in vitro strategies based on controlled co-localization of multiple 
enzymes outside (micro)organisms are discussed in less detail.
14
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This chapter aims at providing a more elaborate description of the in vitro 
methods, which vary in the degree of control over the assembly process. This control is 
two-sided. Firstly, it involves the specificity in which enzymes are immobilized or 
cross-linked. In addition, it takes into account the spatial organisation of the individual 
biocatalysts within the multi-enzyme complex. Scaffold-mediated approaches and 
methods in which enzymes are directly linked together will be discussed.
1.2 -  In vitro multi-enzymatic synthesis in solution
Multi-step enzymatic synthesis can be carried out in vitro by adding multiple enzymes 
to the same reaction vessel.19, 20 In contrast to in vivo approaches in which metabolic 
pathways in microbial hosts are exploited, reaction conditions are easier to control in in 
vitro systems. Consequently, reactions are easily optimized. In addition, substrates can 
be freely chosen, as toxicity of the substrate or reaction intermediates is no issue. 
Furthermore, the final products are usually obtained in higher purity in cell-free 
systems, because of the absence of side reactions and cell metabolites .18
In its most straightforward way the enzymes are present in solution. This 
approach is for example applied in cofactor regeneration. About 30% of the 
biotransformations performed in industry are catalyzed by oxidoreductases, which are 
dependent on cofactors, such as NAD(P)H and FAD .21 Therefore, a second 
oxidoreductase is added to the reactor to regenerate the reduced or oxidized cofactor 
(see Scheme 4).
Scheme 4. An example o f cofactor regeneration: reductive amination of trimethylpyruvate to L-tert 
leucine by leucine dehydrogenase (LeuDH) in which formate dehydrogenase (FDH) is added to 
catalyze the regeneration of NADH via irreversible oxidation of formate to CO2.
These biocatalysts are used in industrial processes such as asymmetric reduction 
of ketones to enantiomerically pure secondary alcohols and reductive amination of keto 
acids to enantiomerically pure amino acids. A number of multi-step processes have
15
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been developed that use two or more oxidoreductases. Examples are the making of 
denim fabric, degradation of lignin in the pulp and paper industry, and removal of 
pollutants from industrial waste and contaminated soil and water .20
Other enzymes than oxidoreductases are applied in in vitro biocatalytic multi-step 
reactions as well. 19 Like redox enzymes they can be particularly useful in the synthesis 
of single enantiomers. Another application is the (selective) glycosylation of bioactive 
compounds by glucosidases and glycosyltransferases. A large number of enzymes is 
used in transferring sugar moieties to relatively complex molecules such as antibiotics
and antitumor drugs.22, 2 3
An additional field in which multiple enzymes are involved is biofuel production. 
Cellulases hydrolyze cellulose leading to the production of glucose, xylose and other 
sugars. A set of different cellulases is commonly used in that process .24 By 
fermentation, the sugars are converted into biofuels such as ethanol, longer chain 
alcohols and fatty acid-based biofuels.
Many of these processes will benefit from enzyme co-localization. For some, this 
has already been investigated. Those examples will be discussed in more detail in the 
following sections.
1.3 -  Non-specific, covalent co-immobilization of enzymes
In order to improve the stability of a biocatalyst, it is immobilized on a solid support. 
Besides of increasing stability, immobilization enables catalyst reusability, whereas at 
the same time substrate-specificity, enantioselectivity and reactivity can be modified. 
With respect to multi-enzymatic processes, different enzymes can be linked to the same 
support. By co-immobilization the biocatalysts are brought in physical proximity of 
each other, in this way mimicking multi-enzyme complexes that are present in cellular 
systems.
1.3.1 Enzyme immobilization
Hanefeld et al. provide a detailed overview of the different immobilization methods 
involving hydrophobic, hydrophilic, ionic or covalent interactions .25 Adsorption on 
lipophilic carriers is widely applied for lipases that are used in organic solvents for 
esterification and amidation reactions and dynamic kinetic resolution. Alternatively, 
lipases and other biocatalysts are deposited on hydrophilic carriers, of which Celite is
16
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one of the most popular examples. Using a carrier bearing either negative or positive 
charges enables immobilization via ionic interactions.
Biocatalysts can be covalently bound to an insoluble carrier as well. This is 
particularly useful when the biotransformation takes place in aqueous medium in which 
non-covalent interactions with the carrier are not strong enough to prevent leaching of 
the enzyme. Usually the amino groups of the biocatalyst are employed for tethering to a 
solid support. As generally many lysine residues are present on the surface of a protein, 
multipoint attachment often occurs. More control over the site of immobilization can be 
achieved by employing a functional group that is less abundant in the enzyme, for 
example a cysteine residue.
A disadvantage of the attachment of enzymes to insoluble supports is the large 
amount of non-catalytic mass. In addition, the carriers can be considerably expensive. 
These drawbacks have led to the development of carrier-free immobilization 
techniques.26, 27 Quiocho and coworkers introduced the cross-linking of enzyme crystals 
(CLECs) using glutaraldehyde. Insoluble enzyme particles were obtained while 
catalytic activity was retained .28 When crystallisation is not (easily) achieved, cross­
linked enzyme aggregates (CLEAs) can be formed by solvent- or salt-induced 
aggregation followed by chemical cross-linking .29 The cross-linker, most often 
gluteraldehyde, can cause loss in activity due to chemical modification of essential 
residues or general denaturation. The use of dextran polyaldehyde has shown to be 
beneficial in some cases .30 For proteins that are poor in lysine residues the addition of 
BSA or polyethylenimine during cross-linking improved the CLEA formation.31, 32
It is not only the enzyme which determines which immobilization technique is 
optimal. The reaction and the reactor in which the biocatalyst is used, play a role as 
well. This is illustrated by the fact that for the lipase CalB numerous methods have
proven to be useful.3 3 -3 8
1.3.2 Co-immobilization of multiple enzymes
Mosbach and coworkers reported one of the first examples of co-immobilization of two 
biocatalysts .39 Hexokinase and glucose-6 -phosphate dehydrogenase were covalently 
linked to a matrix, Sepharose or a cross-linked copolymer of acrylamide-acrylic acid 
(see Scheme 5).
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Scheme 5. Covalent immobilization of hexokinase (HK) and glucose-6-phosphate dehydrogenase 
(G-6-PDH). An increase in NADPH formation was observed using the co-immobilized enzymes 
when compared to the same enzymes in solution.39
After addition of glucose, ATP and NADP+, the enzymatic activity of the bound 
enzymes was followed by measuring the formation of NADPH. For both matrices an 
increase in NADPH formation was detected when compared to the activity of the same 
amount of enzymes in solution. This was attributed to the fact that diffusion of the 
intermediate glucose-6 -phosphate was reduced. It could immediately be converted due 
to close proximity of the coupled enzymes.
Furthermore, so-called combi-CLEAs have been produced by aggregation and 
cross-linking of two or three different enzymes. The combined aggregation of an (S)- 
selective oxynitrilase and a non-selective nitrilase enabled the production of 
enantiomerically pure (S)-mandelic acid from benzaldehyde (see Scheme 6 ) . 40 It was 
suggested that racemization of the nitrile intermediate was suppressed because of 
immediate hydrolysis by the nitrilase without diffusion into the water phase.
? H H20  NH3
Scheme 6. A cross-linked enzyme aggregate consisting of (S)-selective oxynitrilase ((S)-HNL) and 
a non-selective nitrilase (NLase) was used to produce enantiomerically pure (S)-mandelic acid from 
benzaldehyde. Racemization of the nitrile intermediate was suppressed as immediate hydrolysis by 
the nitrilase could take place.40
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Vafiadi et al. produced a combi-CLEA consisting of three commercial enzymes 
with feruloyl esterase activity .41 This CLEA was considered a multipurpose biocatalyst 
for the esterification of different ferulic acids, which are interesting compounds for 
synthetic purposes. A third combi-CLEA was prepared for the five-component cascade 
synthesis of nucleotide analogues .42 The multiple-enzyme system contains three 
enzymes of the purine nucleotide analogue pathway and an auxiliary ATP recycling 
system. The aggregate showed improved stability in comparison to the soluble enzyme 
pathway.
Recently, P-glucosidase (P-Glu), glucose oxidase (GOx) and horseradish 
peroxidase (HRP) were immobilized in multicompartment particles .43 In contrast to 
abovementioned examples, the location of the three enzymes in the cross-linked 
aggregates was controlled. They were sequentially co-precipitated in presence of 
calcium carbonate followed by cross-linking. Microparticles were obtained consisting 
of three concentric compartments. A cascade reaction was demonstrated to take place 
on microscopic scale. Two separating shells containing BSA were inserted to show the 
influence of spacing on the cascade reaction kinetics.
Logan et al. report spatially separated immobilization of three enzymes in a 
microfluidic channel.44 Different patches in a microchannel were subsequentially 
activated by photopatterning followed by covalent attachment of invertase (INV), GOx 
and HRP. The order of the enzymes was varied. The microchannel containing the 
enzymes in the correct sequential order showed the highest amount of final product 
being formed.
Scheme 7. Immobilization of three enzymes in a microfluidic channel. The cascade reaction 
involves hydrolysis of sucrose to glucose and fructose (not shown) by invertase (INV), formation of 
H2O2 by glucose oxidase (GOx), and oxidation of Amplex Red to fluorescent resorufin by 
horseradish peroxidase (HRP).44
19
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A last example in which multiple enzymes were co-immobilized is reported by 
Moehlenbrock and colleagues .45 Mitochondria from Saccharomyces cerevisea were 
extracted and cross-linked before disruption of the mitochondrial membranes. The 
lysates were immobilized in a biofuel cell. Bioelectrocatalytic activity of the covalently 
linked mitochondrial enzymes was higher than the activity of lysed native 
mitochondria. This indicated that preservation of the enzyme complexes before 
isolation had a positive effect as substrate channeling could take place on the bioanode.
1.4 -  Non-covalent encapsulation of enzymes
It has been shown that the specific activity of enzymes is often reduced upon 
immobilization on a solid support or after cross-linking. To avoid any negative 
influence on structure and/or function, the biocatalyst may be entrapped or 
encapsulated in nanostructures.
1.4.1 Enzyme encapsulation
A commonly used material for enzyme entrapment is silica sol-gel.46, 47 This inorganic 
gel made out of SiO 2 is formed around the enzyme molecules. The gelation process can 
be adapted to the specific enzyme, which is being encapsulated, for example by using a 
pH consistent with catalytic activity. Ideally, each individual enzyme molecule is 
captured inside a nano-cage with enough space to change its conformation during the 
catalytic cycle. It is not necessary to attach the enzyme via adsorption, ionic 
interactions or covalent bonds. However, these interactions may occur and might 
interfere with enzyme efficiency. Other drawbacks are mass transfer limitations and 
low enzyme loading.
Alternatively, reverse micelles, liposomes, polymersomes and virus particles have 
been employed as self-assembled nanoreactors. The use of reverse micelles is 
summarized by Klyachko et a l .48 Walde and Ichikawa provide a review on the 
encapsulation of enzymes in liposomes , 49 whereas the viral capsid as nanoreactor is 
highlighted by De la Escosura et al.50 Examples of the use of polymersomes for 
enzyme encapsulation are described by Nallani and De Hoog.51, 52
A special approach of enzyme entrapment was developed by Kim and 
colleagues.5 3 Single enzyme nanoparticles (SEN) were formed by extraction of 
individual enzyme molecules into a hydrophobic organic solvent. Polymer chains were
20
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subsequently formed from the enzyme surface. By cross-linking a polymer network 
was formed which stabilizes the biocatalyst.
1.4.2 Multi-enzyme reactions in nanostructures
So far, the encapsulation of multiple enzymes in nanostructured materials has found 
limited application. Betancor et al. describe the co-encapsulation of nitrobenzene 
nitroreductase and glucose-6 -phosphate dehydrogenase in silica particles .54 It enabled 
the continuous conversion of nitrobenzene to hydroxylaminobenzene with NADPH 
recycling. The enzymes were encapsulated simultaneously and were not localized in 
different compartments.
Kreft and co-workers report an encapsulation method, in which a semi-permeable 
membrane separates two enzymes .55 Shell-in-shell polyelectrolyte capsules were 
produced containing glucose oxidase in the outer surrounding compartment and 
peroxidase in the inner capsule. Oxidation of glucose led to formation of H 2O2 , which, 
in the presence of an electron donor, acted as a substrate for peroxidase.
Delaittre et al. report the synthesis of nanoreactors composed of horseradish 
peroxidase-polystyrene (HRP-PS) and HRP-poly(methyl methacrylated) giant 
amphiphiles. The HRP-polymer conjugates were obtained by cofactor reconstitution. 
The polymer was attached to the cofactor, which was subsequently added to the 
apoprotein. The HRP-containing nanoaggregates were shown to retain their enzymatic 
activity. Glucose oxidase was enclosed inside the self-assembled structure resulting in a 
nanocontainer in which a cascade reaction could take place .56
Alternatively, both enzymes (glucose oxidase and HRP) were encapsulated inside 
polymersomes.5 7 By adding the lipase CalB as an additional enzyme a three-enzyme 
cascade reaction was performed by Van Dongen et al.5  In this last example the three 
enzymes were targeted to different locations in the polymersomes. Whereas glucose 
oxidase was inserted in the lumen, CalB was localized in the bilayer membrane and 
HRP was coupled to the surface of the polymersome nanoreactor.
1.5 -  Scaffold-mediated co-localization of enzymes
The in vitro strategies discussed so far provide ways to bring multiple enzymes in close 
proximity of each other. However, there is limited control over the way the assemblies 
are constructed. As discussed in Section 1.3, immobilization and carrier-free cross­
linking proceed in a non-specific way, most often via interactions with the amino
21
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groups of the enzyme molecules. With respect to entrapment and encapsulation in 
nanostructures the distance between individual enzyme molecules may still be 
relatively large, even when the biocatalysts are in the same compartment.
To create multi-enzyme systems that mimic nature’s metabolons to a better 
extent, it is necessary to control the construction of the biocatalytic assemblies. First of 
all, one would like to define the position at which an enzyme interacts with a support or 
other enzyme to prevent interference with residues that are crucial for structure and 
activity. Furthermore, when more than two different enzymes of a biosynthetic 
pathway are assembled, the orientation of the catalysts relative to each other may be 
important. It is desirable to position the enzymes in the correct order to induce substrate 
channeling.
1.5.1 Selective immobilization on solid supports using affinity tags
Affinity tags have been used for selective immobilization of proteins .59 For example, 
via a genetically introduced histidine tag, enzymes have been attached to a Ni2+ 
chelating support. The histidine tag is specifically introduced at the N or C terminus of 
the enzyme and has little influence on the catalytic performance. Liu and coworkers 
have shown that this technique can be exploited for the biosynthesis of UDP- 
galactose .60 Seven different enzymes were involved in this pathway. Because of the 
stability of the immobilized biocatalysts a higher product yield was obtained compared 
to the solution reaction. Although the spatial organisation of the enzymes was not 
controlled, the site of immobilization was. All enzymes were tethered via their N- 
terminus, which prevented loss in activity due to non-specific immobilization.
Another affinity tag, which has been applied in site-specific immobilization, is the 
cellulose-binding domain (CBD). As originally shown by Ong et al., it can be fused to 
a protein of interest which is subsequently bound to an inexpensive cellulose support.61 
The linker between the CBD and the enzyme is susceptible to proteolytic cleavage. 
This is prohibited by using a shorter linker with only prolines and threonines as shown 
by Gustavsson et al. for a CBD-CalB fusion .62 In this example lipase activity was not 
affected by varying the linker length, whereas cellulose-binding slightly decreased 
upon shortening the linker. Several enzyme-CBD fusions are reported in literature. The 
most recent studies involve the immobilization of laccase, a lignin-degrading enzyme 
used for pulp bleaching, and mannanase, which is used for degradation of 
hemicellulose.63, 64 Rootman and co-workers reported the successful application of
22
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CBD-protein fusions in a multi-enzyme reactor system containing three CoA 
biosynthetic enzymes.65
Other proteins used for controlled enzyme immobilization are the S-layer protein, 
elastin-like polypeptide (ELP) and polyhydroxyalkanoate (PHA) synthase.26 S-layer 
proteins self-assemble in crystalline monolayers in suspension and at different 
interfaces among which liposomes,66 whereas ELPs precipitate reversibly upon heating 
above the transition temperature.67 PHA synthase remains covalently attached while 
producing the polyester PHA granule.68 Fusions of the enzyme of interest to these 
proteins provide means of immobilization.69-71 However, to our knowledge, these 
polypeptide modules have not been exploited yet for the co-immobilization of multiple 
enzymes.
1.5.2. Well-defined co-localization on a protein or DNA scaffold
Whereas most affinity tags or binding modules fused to enzymes have been used for 
immobilization on solid supports, some assemblies have been constructed on protein 
scaffolds. Many anaerobic cellulolytic bacteria, which degrade plant cell walls, produce 
extracellular macromolecular complexes called cellulosomes.72 They are composed of a 
multidomain scaffoldin unit containing multiple cohesin domains linked to a CBD. The 
cohesin domains interact with a dockerin module, which is naturally present in 
hydrolytic enzymes such as cellulases, hemicellulases, pectinases, chitinases, 
glycosidases, and esterases (see Scheme 8).
Scheme 8. In a cellulosome multiple cellulases are co-localized on a protein scaffold consisting of 
cohesin and scaffoldin units. The protein scaffold is bound to cellulose via the celluose-binding 
domain (CBD).
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Cellulosomes have been constructed in vitro.73 The cellulases associated in this 
way showed to be more active than the same cellulases free in solution. Mitsuzawa and 
coworkers created a synthetic cellulosome containing 4 different cellulases assembled 
on a 18-subunit protein complex called a rosettasome.74 A cohesin module was fused to 
each 60 kDa rosettasome subunit to induce binding of the cellulases. Especially when 
all four enzymes were present in the complex, enhanced cellulase activity was detected 
when compared to the free enzymes or the unassembled rosettasome.
The stress-responsive protein SP1 from aspen plant forms an extremely stable 
ring-shaped dodecamer resistant to high temperature, a broad pH range and organic 
solvents. A fusion of SP1 with glucose oxidase (GOx) resulted in multi-enzyme 
nanotube particles containing hundreds of active GOx molecules per tube.75 Morals et 
al. produced an SP1 scaffold with cohesin modules to which dockerin-bearing 
exogluconases were linked.76 Highly effective degradation of cellulosic substrates was 
achieved after addition of a free endogluconase. Alternatively, virus particles have been 
exploited as a scaffold for the controlled positioning of lipase molecules.77
Recenlty, an elegant assembly strategy was reported by Hirakawa and coworkers. 
Cytochrome P450 and two electron transfer-related proteins were assembled by fusion 
to the protein PCNA (see Scheme 9).78 PCNA (proliferating cell nuclear antigen) is a 
trimeric ring-shaped protein that binds DNA and acts as a scaffold for DNA-related 
enzymes. A heterotrimeric PCNA was used to bring the three enzymes in close 
proximity to each other, enabling efficient electron transfer within the complex.
Scheme 9. Controlled co-localization of cytochrome P450, a ferrodoxin (putidaredoxin, PdX) and a 
ferrodoxin reductase (putidaredoxin reductase, PdR) via formation of a heterotrimeric PCNA  
complex. Efficient electron transfer was observed as determined by measuring N A D H  
consumption.78
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Furthermore, Dueber et al. co-localized three mevalonate biosynthesis enzymes 
by engineering an artificial scaffold which contained three different protein-protein 
interaction domains (see Scheme 10).79 This strategy was applied in vivo. The number 
of repeats and order of the interaction domains was varied to control the pathway flux. 
A 77-fold increase in product titer was obtained compared to the non-scaffolded 
pathway.
Scheme 10. Controlled co-localization of three mevalonate pathway enzym es on a protein-based 
scaffold, in which variation of the number and order of interaction domains allowed for optimization 
of the metabolic flux.79
Müller and colleagues employed DNA as scaffold for enzyme assembly.80 Two 
enzymes, HRP and GOx, were linked to thiolated oligonucleotides using sulfo- 
succinimidyl-4-(N-maleimido-methyl)-cyclohexan-1-carboxylate (sSMCC) as cross­
linker. The biomolecules were brought together by hybridization on a carrier strand. 
The same enzymes were used by Wilner et a l8  Upon linkage of the oligonucleotides, 
the DNA-enzyme conjugates were added to a hexagon DNA scaffold containing free 
overhangs for hybridization of the biocatalysts. The distance between both enzymes on 
the same scaffold was varied. While hardly any activity was detected in absence of the 
DNA scaffold, ABTS oxidation took place in presence of the scaffold. The conversion 
was higher when both enzymes were closer in proximity.
DNA-mediated immobilization of multiple enzymes has been applied by Vong et 
al. as well.82 Two different oligonucleotides were linked to CalB and HRP. The 
enzymes were positioned in a microfluidic channel decorated with the complementary 
DNA strands. A three-enzyme cascade reaction was performed by applying a solution 
containing glucose oxidase and relevant substrates.
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1.6 -  Site-specific, covalent linkage of enzymes
In order to facilitate substrate channeling, the distance from one active site to the other 
should be minimal. Taking this into account, one can imagine that direct linkage of 
enzymes is preferred over encapsulation or coimmobilization on a solid support or 
protein or DNA scaffold. As already discussed in the previous section, control over the 
site of conjugation is important. It prevents loss in activity, which regularly occurs 
when enzymes are cross-linked in a non-specific way. This section describes two 
different approaches towards controlled, covalent linkage of enzymes. The first strategy 
relies on the preparation of gene fusions, while in the second method enzymes are 
linked post-translationally.
1.6.1 Multi-enzyme systems obtained by gene fusion
Genes encoding for two different enzymes can be joined in-frame resulting in a 
chimeric gene that encodes a polypeptide chain carrying two active centres. Bulow and 
Mosbach describe the concept and report some of the early examples.83 In general, the 
order in which the genes are fused is usually chosen arbitrarily. As the N- and C- 
termini are charged and therefore usually located on the surface of the protein, the 
tertiary structure remains often intact. The length of linker between both proteins is 
ideally 3 -  10 amino acids long. For longer linkers proteolytic degradation has been 
observed.
The genes of P-galactosidase and galactokinase were connected and the hybrid 
protein was purified from Escherichia coli. It was shown that the fusion protein 
catalyzed the hydrolysis of lactose followed by phosphorylation of galactose.84 The 
bifunctional enzyme appeared to have a tetrameric configuration, which was in 
agreement with the fact that native P-galactosidase forms complexes usually consisting 
of four subunits. A third enzyme, galactose dehydrogenase, was used in a competition 
experiment by which substrate channeling was detected.85 An additional hybrid 
biocatalyst was prepared by fusion of P-galacosidase with galactose dehydrogenase.86 
In this case, substrate channeling was observed especially at low substrate 
concentrations and when a pH was used in which galactose dehydrogenase was more 
active than P-galactosidase. The same group reported construction of a gene fusion 
containing all three enzymes.87
Other biocatalysts have been linked by gene fusion as well. Mitochondrial citrate 
synthase (CS) and malate dehydrogenase (MDH), two enzymes taking part in the citric
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acid cycle, were expressed as a fusion protein.88 The activity of the CS-MDH conjugate 
was studied in presence of the competing enzyme aspartate aminotransferase (AAT) 
(see Scheme 11). The intermediate oxalacetate appeared to be more sequestered by the 
fusion protein than in the system with free enzymes, in which AAT was a more 
effective competitor.
Scheme 11. Reaction scheme of an experiment in which the activity of a malate dehydrogenase 
(M DH) -  citrate synthase (C S) fusion protein was tested. Aspartate aminotransferase (AAT) was 
shown to be a less effective competing enzyme when compared to free CS and M D H .88
Brodelius and coworkers prepared a fusion of farnesyldiphosphate synthase 
(FPPS) and epi-aristolochene synthase (eAS).89 The formation of the intermediate FPP 
and the sesquiterpene epi-aristolochene was followed in time. The amount of epi- 
aristocholene produced was considerably higher for the fusion enzyme than for the 
mixture of single enzymes, whereas the amount of FPP was essentially the same for 
both systems.
Furthermore, Iturrate et al. constructed a bifunctional aldolase/kinase enzyme.90 
Dihydroxyacetone kinase (DHAK) and fructose-1,6-bisphosphate aldolase were 
coupled by gene fusion. A one-pot C-C bond-formation procedure could be performed 
using dihydroacetone (DHA) as the starting compound. The unstable dihydroxyacetone 
phosphate (DHAP) was formed in situ and used as a substrate in the aldol condensation 
catalyzed by a DHAP-dependent aldolase. Glycerol-3-phosphate dehydrogenase was 
added as competing enzyme to show that substrate channelling took place (see Scheme 
12).
As a last example, a three-enzyme fusion was produced by Fan and colleagues.91 
Three hemicellulases were fused using either flexible peptide linkers or linkers 
containing a cellulose-binding domain (CBD). The multimeric enzymes showed to be
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as active as the parental enzymes. As seen before, the CBD-containing enzymes 
displayed higher hydrolytic activity towards substrates with a high-cellulose content.
Scheme 12. The activity of a kinase -  aldolase fusion protein investigated using glycerol-3- 
phosphate dehydrogenase (G P D H ) as competing enzyme. In presence of the fusion protein, 
activity of G PD H was almost twice as low when compared to G PD H activity in the free enzyme
1.6.2. Post-translational, selective enzyme modification
One of the limitations of the production of multi-enzymatic gene fusions is the fact that 
bacteria are often not efficient in the correct folding of large multidomain proteins. So, 
especially when more than two enzymes are to be linked to each other, gene fusion is 
not an ideal solution.
As an alternative, enzymes can be linked after being translated and folded. 
However, to retain the control over the coupling procedure, specific sites in the enzyme 
should be targeted. In Section 1.3 methods were discussed which make use of the 
reactive side-chain of lysine residues. As lysine is an abundant amino acid in most 
proteins, enzyme molecules are cross-linked at multiple positions, which readily leads 
to enzyme inactivation.
To overcome this limitation, numerous methods have been developed for site- 
specific protein modification. Reactive side-chains of natural amino acids can be 
exploited as summarized by Basle et a l92 Especially, residues which are only located at 
the protein surface to a limited extent, such as cysteines, tyrosines and tryptophans, are 
useful targets when modification of a small number of positions is desired. The 
introduction of non-natural amino acids has expanded the toolbox for protein 
modification. The unique functionalities in non-proteinogenic amino acids can be 
addressed in highly selective, bio-orthogonal conjugation reactions.93-95 In addition, 
several enzymatic strategies have been developed which allow for selective
NAD+ -* '1  
OH
H 0 ^ ^ 0 P 0 32-
system.90
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modification of proteins.96 For example, transglutaminase (TGase) has been used to 
transfer polymer chains or fluorescent probes to glutamine residues.97, 98 In addition to 
these approaches in which amino acid side chains are modified, the N- and C- terminus 
of proteins have specifically been functionalized.99, 100
All these site-specific modification strategies have mainly been exploited for the 
linkage of relatively small molecules, such as fluorescent probes, to proteins. 
Additionally, they have been employed in the production of protein-polymer 
conjugates.101 For the linkage of proteins to each other, however, these approaches have 
hardly been applied. Among the few examples reported in literature are the conjugation
102 103of bovine serum albumin (BSA) to a lipase , the cross-linking of avidin to BSA , the 
coupling of two immunoglobulin-binding protein G domains104 and direct linkage of 
two GFP molecules105.
To our knowledge, Hirakawa and colleagues describe the only example, in which 
proteins involved in a biocatalytic process are site-specifically coupled. A branched 
fusion protein was produced consisting of the monooxygenase cytochrome P450 and 
the electron transfer proteins putidaredoxin (Pdx) and Pdx reductase.106 The three 
proteins were coupled via an enzymatic procedure using TGase. Similar to the protein- 
scaffold mediated co-localization of these three proteins, which is described by the 
same authors78, efficient electron transfer took place.
1.7 -  Outline of this thesis
As presented in this chapter, enzymes have been co-localized in different ways. 
Surprisingly, the use of site-specific modification strategies to link enzymes to each 
other has hardly been investigated. The research described in this thesis aimed at 
exploring this approach, i. e. to construct well-defined enzyme architectures via 
selective bioconjugation methods.
Chapter 2 describes the introduction of the non-natural amino acid 
azidohomoalanine in the model enzyme Candida antarctica lipase B (CalB). 
Expression of CalB in Escherichia coli is reported as well as its purification. In 
addition it is shown how some aspects of the protocol were studied in more detail in 
order to optimize the yield and purity of the azide-functionalized biocatalyst.
Application of the introduced azide moiety as a handle for bioconjugation is 
presented in Chapter 3. Studies with respect to selectivity of the conjugation reaction 
are described. It is demonstrated that residue-specific incorporation of
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azidohomoalanine enables site-specific immobilization of the enzyme to different 
polymer-like materials.
Chapter 4 reports production of well-defined CalB oligomers. Four strategies are 
highlighted which all exploit the method described in the previous chapters. Studies 
investigating the activity of two different kinds of CalB dimers are presented as well.
In Chapter 5, an alternative way of introducing azide functionalities in proteins is 
described. A mild, metal-free and pH-controlled diazotransfer reaction is presented, 
which allows for selective conversion of amines into azides in a post-translational 
manner. This straightforward modification method is tested on CalB and two other 
model proteins.
Chapter 6 reports steps towards the production of a biohybrid catalyst. Two 
different transition-metal ligands are coupled near the active site of CalB. As soon as 
introduction of the metal is achieved, a unique system will be created containing both 
enzymatic and transition-metal activity. This will allow for performance of a two-step 
reaction in one pot.
In Chapter 7, the construction of a multi-enzyme complex is described. Three 
enzymes involved in the biosynthesis of resveratrol are coupled to each other. 
Heterotelechelic linkers are used to control the complex formation. It is demonstrated 
that the multi-enzyme complex successfully catalyzes the production of glycosylated 
resveratrol.
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azidohomoalanine in Candida Antarctica lipase B
Chapter 2
2.1 -  Introduction
2.1.1 Candida antarctica lipase B
One of the most popular biocatalysts used in industry is Candida antarctica lipase B 
(CalB). It is an enzyme composed of 317 amino acid residues with a mass of 33 kDa.1 
Its natural function is hydrolysis of triglycerides in order to break down fats and oils. 
Like other lipases, CalB is highly effective towards a broad range of small esters and 
amides.2 Furthermore, the lipase is resistant to quite harsh conditions. In aqueous media 
the enzyme is active from pH 3.5 to pH 9.5 and is thermostable up to 50 till 60 °C. 
Moreover, the enzyme remains active in non-aqueous solvents (organic solvents and 
ionic liquids). The biocatalyst is therefore widely applied in organic synthesis3, 4 With 
its broad substrate specificity it is used for various applications such as amidation 
reactions, dynamic kinetic resolution, esterification and ring-opening polymerization5- 
11.
The activity and physical properties of CalB have extensively been studied. For 
example, its substrate specificity towards alcohols with different chain lengths and 
towards arylaliphatic glycolipids has been investigated.12, 13 Other studies have focused 
on the influence of acyl chain length on the enantioselectivity in kinetic resolution, and 
the dependence of its amidase activity on length of the acyl residue and substituents 
groups in the aromatic ring of amides.14, 15
Immobilization of enzymes is usually favourable as it allows for application in 
industrial continuous processes and recycling of the biocatalyst.16 CalB and other 
lipases have been immobilized in different ways, resulting in increased stability and 
activity.17 The most popular commercial form of CalB is Novozym 435 in which the 
lipase is adsorbed on a hydrophobic macroporous polymer. Koops et al. describe the 
adsorption of modified CalB on both hydrophobic and hydrophilic supports.18 The 
increase in activity was especially high when the hydrophobic support was used. CalB 
was protected from structural alterations during adsorption onto the hydrophilic support 
by modifying it with polyethylene glycol (PEG) 2000 monomethyl ether, PEG 300 
monooctyl ether or n-octanol. Besides of that, the enzyme was attached to a ceramic 
membrane which enabled its use in an enzyme membrane reactor.19 Furthermore, the 
stability of immobilized CalB at elevated temperatures was studied,20 as well as the 
production of cross-linked enzyme aggregates (CLEAs)21.
Several studies have aimed at changing the catalytic and physical properties of 
CalB by protein engineering.22, 23 Patkar et al. describe the effect of replacing threonine
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103, a residue close to the active site, by glycine. Thermostability was substantially 
increased while activity was not affected.24 A second interesting example involves 
circular permutation, an approach in which the N and C termini of a protein are 
relocated. Several variants of the lipase were generated with increased catalytic 
activity.25 Additionally, by rational design CalB’s enantioselectivity was improved and 
its substrate specificity was expanded.26-28 Both Zhang et al. and Chodorge and 
coworkers employed directed evolution resulting in CalB variants with enhanced 
thermostability29, 30 Furthermore, chimeras have been produced in which one of the 
flexible regions in CalB, helix a5, was substituted with the lid regions from related 
lipases. Lipase variants were created with increased enantioselectivity towards 2- 
arylpropanoic acid, a common core structure of the profen drug family31.
In industry and in most of the genetic engineering studies, the lipase is produced 
in fungal hosts such as Pichia pastoris, Saccharomyces cerevisiae or Aspergillus 
oryzae26’ 29, 32 The fact that the prokaryotic system Escherichia coli is much easier to 
handle has resulted in several attempts to enable functional CalB expression in this 
microorganism.33, 34 Different groups have aimed at improving the expression yield in 
E. coli by mutagenesis, by using different temperatures and expression systems and 
through the production of fusion mutants.35-37
2.1.2 Incorporation of non-natural amino acids
Genetic engineering facilitates not only the creation of mutants, in which specific 
amino acids are substituted by one of the other twenty natural residues. It also enables 
the introduction of novel functionalites via the incorporation of non-canonical amino 
acids. These analogues contain unique reactivities, which are different from the 
proteinogenic amino acid side chains. They add new biological functions to the protein 
or enable site-specific protein conjugation. They have been introduced into 
recombinant proteins in both prokaryotic and eukaryotic cells.38, 39
Nowadays, two strategies are widely applied. The first method, which was 
developed by Schultz and coworkers, allows the introduction of an additional 21st 
amino acid via ribosomal protein production. In order to achieve this extension of the 
genetic code, an orthogonal tRNA and aminoacyl tRNA-synthetase (aaRS) couple is 
introduced into the host cell. The tRNA, which is aminoacylated with the non- 
canonical amino acid, specifically recognizes the amber (UAG) stop codon. This stop 
codon can be inserted at any position of choice in the gene of the recombinant protein. 
By selecting an orthogonal aaRS/tRNA pair from another microorganism than the host
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it is prevented that the introduced aaRS aminoacylates any of the endogenous tRNAs or 
that the suppressor tRNA functions as a substrate for any of the host aminoacyl tRNA- 
synthetases.40
The second strategy involves the residue-specific replacement of a particular 
natural amino acid with a non-canonical analogue. It is added to the growth medium of 
an auxotrophic bacterial host, which is unable to synthesize the natural residue.41 The 
supplied amino acid is incorporated at every position where normally the natural 
analogue would be present. In its most straightforward way, this method relies on 
structural similarity of the analogue to the natural amino acid.42 However, Tirrell and 
others have expanded the set of amino acids that can be incorporated in this way by 
overexpression of the aaRS and by development of a mutant aaRS with more space in 
the amino acid binding site.43 Attenuation of the editing activity of specific aminoacyl 
tRNA-synthetases has allowed for introduction of additional novel amino acids.44, 45
Among the functionalities that have been incorporated using these two approaches 
are alkynes46, azides47, 48, ketones49 and aryl halides50, 51. These unique reactivities have 
shown to be very useful for in vivo fluorescent labeling of newly synthesized proteins52 
and for site-specific biotinylation, glycosylation and PEGylation48, 53, 54 The 
introduction of fluorinated analogues of leucine has been used for the stabilization of 
hydrophobic folded structures55, while photoactive side chains have been employed to 
study protein-protein interactions56, 57. More recently, a metal-ion chelating amino acid 
has been incorporated to function as a biophysical probe.58 As a last example, Budisa 
and coworkers have succeeded in labeling a protein with three non-canonical
analogues.59
With regard to CalB the introduction of an unnatural amino acid will facilitate site- 
specific conjugation to solid supports. Furthermore, the introduction of a unique 
functional handle will enable the controlled linkage of other (bio)catalysts to the 
enzyme. For bioconjugation the biocompatible and orthogonal reactions between azides 
and (strained) alkynes, phosphines or oxanorbornadienes have proven to be highly 
suitable.60, 61 For that reason the introduction of an azide moiety in the protein is 
required. This chapter describes the production and purification of azido-functionalized 
CalB by residue-specific incorporation of the non-natural amino acid 
azidohomoalanine. The expression protocol was studied in more detail to improve yield 
and purity of the modified enzyme.
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2.2 -  Results and discussion
2.2.1 Cloning, expression and purification of CalB
The mature calB gene was cloned in the pET22b expression plasmid. This plasmid 
contains an N-terminal periplasmic localization signal for correct disulfide bond 
formation of this extracellular protein, and a C-terminal histidine tag. Signal and 
propeptide sequences of CalB were omitted as reported previously by Blank et al.34 As 
a consequence of the cloning strategy that was used, an additional methionine residue 
was introduced, which was the first amino acid after cleavage of the periplasmic 
localization peptide (see Scheme 1).
S chem e 1. Sequence of the N- and C-terminus of CalB when produced in the pET22b expression 
plasmid. The site at which an endogenous peptidase cleaves off the localization signal is indicated 
by the arrow.
After introduction of the plasmid in BL21(DE3)pLysS or B834(DE3)pLysS E. 
coli cells (Novagen), a culture was grown in 2xYT medium. When an OD600 of 0.8-1 
was reached, protein expression was induced by adding IPTG (isopropyl-P-D- 
thiogalacto-pyranoside). Cells were incubated overnight at 25 °C before being 
harvested by centrifugation. Purification via Ni2+ NTA affinity chromatography was 
performed according to the manufacturer’s protocol (Qiagen). An additional 
purification step was carried out by size-exclusion chromatography. The protein was 
obtained pure as shown by gel electrophoresis (see Figure 1). The yield as determined 
by measuring absorbance at 280 nm was approximately 5 mg per litre bacterial culture.
The protein was further analysed by ESI-TOF mass spectrometry. Following 
ultrafiltration for salt removal, a mass spectrum was obtained which, upon 
deconvolution, resulted in a detected protein mass of 34269 Da. Taking into account 
the three sulfur bridges present in CalB this mass corresponded exactly with the 
calculated mass. This indicated that no mutations or any post-translational 
modifications had occurred and that the periplasmic localization signal was cleaved off 
as expected.
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Figure 1. Purification of CalB from E. coli cells. A) Eluate from a Ni2+ NTA affinity column analyzed 
by SD S-PA G E. B) Typical FPLC chromatogram obtained when the eluate was loaded on a size- 
exclusion column. C) SDS-PAG E analysis of the FPLC fractions that were expected to contain 
CalB (see grey box in FPLC chromatogram).
2.2.2 Introduction of azidohomoalanine
In order to incorporate azidohomoalanine 1 in CalB, protein synthesis was 
performed in methionine auxotrophic B834(DE3)pLysS E. coli bacteria (Novagen). 
The procedure that was followed is depicted in Scheme 2. Cells were grown in minimal 
medium containing all twenty natural amino acids till the desired optical density was 
reached. To ensure incorporation of 1, methionine had to be removed. However, as the 
pET system was used, in which protein expression is under control of the T7 
promoter62, it was necessary to induce for a short period of time while the cells were 
still in methionine containing medium. This allows synthesis of T7 RNA polymerase 
under normal conditions, which is required for efficient transcription of the gene of 
interest. After incubation at 37 °C for 15 minutes the medium was removed. Cells were 
washed and resuspended in medium containing all natural amino acids except for 
methionine. The bacteria were left at 37 °C for 10 minutes before adding the non­
natural amino acid together with a fresh amount of the inducer IPTG. After 18 hours at 
18 °C centrifugation of the culture was followed by purification as described in the 
previous section. This resulted in approximately 1-2 mg protein from a 1 L bacteria 
culture.
The mass of CalB containing azidohomoalanine (AHA-CalB) was expected to be 
25 dalton less than the mass of CalB harboring methionine residues (Met-CalB), i.e. 5 
dalton for each methionine - azidohomoalanine replacement. This mass difference was
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detected by ESI-TOF mass spectrometry (see Figure 2). More insight in the degree of 
AHA incorporation was obtained by trypsin digestion followed by MALDI-TOF MS. 
This is described in chapter 3.
S chem e 2. Procedure for the residue-specific incorporation of azidohomoalanine in a protein 
expressed in methionine auxotrophic E. coli cells. (1) Cells are grown till the desired density in 
minimal medium containing methionine (Met). (2) Protein expression in presence of Met is shortly 
induced to allow synthesis of T7 RNA polymerase. (3) A medium shift is performed by 
centrifugation and washing the cells twice with 0.9%  NaCl. (4) Cells are kept in minimal medium  
containing all natural amino acids except for Met (19AA) allowing the cells to use any Met that was  
left. (5) Azidohomoalanine (AHA) and IPTG are added for protein synthesis in presence of the non­
natural amino acid.
34100 34200 34300 34400 34500 34600 34700 34100 34200 34300 34400 34500 34600 34700 
Mass / Da Mass / Da
Figure 2. Deconvoluted ESI-TO F spectra of A) Met-CalB and B) AHA-CalB. Calculated masses for 
Met-CalB and AHA-CalB are 34269.7 Da and 34244.7 Da, respectively.
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2.2.3 Optimization of the yield and purity of CalB containing 
azidohomoalanine
Due to the fact that protein production is induced for a short period of time before the 
medium is changed (step 2 in scheme 2), some CalB will contain methionine instead of 
azidohomoalanine. In order to reduce the amount of Met-CalB, it was investigated 
whether this step could be shortened. Induction periods of 0, 5, 10 and 15 minutes were 
tested. The influence on the final amount of protein was determined by Western blot 
analysis.
As shown in Figure 3, the duration of step 2 had a significant influence on the 
amount of protein that was produced. Even though the Western blot film did not allow 
quantification of protein amounts, it was clear that CalB production increased when 
synthesis of T7 RNA polymerase in presence of methionine had been allowed to take 
place for a longer period of time. Lanes 2-5 show that shortening this stage indeed led 
to less production of MetCalB. However, lanes 6-9 show that considerably less AHA- 
CalB was synthesized as well. It was therefore decided not to decrease the duration of 
step 2.
Figure 3. W estern blot of crude cell lysates collected before induction (lane 1), before addition of 
azidohomoalanine (lanes 2-5) and after overnight incubation (lanes 6-9). Initial induction while cells 
were still in methionine containing medium was allowed to take place for 0 (lane 2, 6), 5 (lane 3, 7), 
10 (lane 4, 8) and 15 (lane 5, 9) minutes. Anti-CalB antibody was used to visualize the amount of 
CalB.
When CalB was expressed in minimal medium, a protein of approximately 25 
kDa was co-purified. As estimated from electrophoresis gels, the amount of this 
contaminant varied per expression experiment from hardly any to up to 50% of the total 
amount of purified protein. According to ESI-TOF mass spectrometry the exact mass 
of the contaminating protein was 22340 Da. This corresponded to the mass of one of
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the native E. coli proteins, which was known to be co-purified by Ni2+ NTA affinity 
chromatography.63
The contaminant, YodA, is a stress-responsive protein that is over-expressed in 
response to oxidative and acid stress. It could be separated from CalB by eluting the 
proteins with two different concentrations of imidazole. While YodA eluted at 80 mM 
imidazole, most CalB eluted only at 250 mM imidazole. However, as shown in Figure 
4, a small amount of CalB was lost by washing with 80 mM imidazole, and not all 
YodA could be removed.
kDa 1 2  3 4 5
Residue-specific incorporation of azidohom oalanine in Candida antarctica lipase B
Figure 4. Separation of YodA (22.3 kDa) and CalB (34.3 kDa) via Ni2+ NTA affinity chromatography 
analyzed by SDS-PAG E analysis. Lanes 1-3 are from elution with 80 mM imidazole. Lanes 4 and 5 
contain CalB eluting at 250 mM imidazole. The most left lane contains the mix of both proteins 
before the additional Ni2+ NTA purification step.
We therefore investigated whether production of YodA could be prohibited. One 
of the tryptic fragments of YodA containing methionine - and not azidohomoalanine - 
was detected by MALDI-TOF. This indicated that the protein was produced before the 
medium shift. Thus, the bacteria appeared to experience some stress during the growth 
in M9 minimal medium (step 1 in scheme 2).
It was tested whether minimal medium containing methionine could be replaced 
by 2xYT medium. As an alternative to azidohomoalanine, the non-natural amino acid 
homopropargyl glycine (HPG) 2, which is also recognized as an analogue of 
methionine, was used in this experiment.42 Even though the cells were expected to 
experience less stress because of the nutritionally rich medium, the efficiency of HPG 
incorporation was reduced significantly. As detected by mass spectrometry, protein was 
obtained in which the number of non-natural residues varied from 0 to 5 (see Figure 5). 
Clearly, 2xYT medium is too rich in methionine. It cannot be removed completely by 
washing the cells twice with 0.9 % NaCl solution.
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Figure 5. Deconvoluted E SI-TO F spectra of CalB upon introduction of the methionine analogue 
homopropargyl glycine (HPG, 2) using different culturing conditions. Calculated masses for this 
CalB mutant (149CalB, see Chapter 4) containing five methionines or five HPGs are 34227.4  Da 
and 34117.4  Da, respectively. A -22 Da mass shift is expected per M et-HPG replacement. Both 
cultures contained the same amount of HPG during protein induction. A) Structure of 
homopropargyl glycine. B) Mass spectrum of 149CalB obtained from cells grown in rich 2xYT  
medium. C) Mass spectrum of 149CalB  obtained from cells grown in minimal medium.
Finally, it turned out that growing the cells to an OD600 of 0.8 or lower before 
induction had a positive effect on the purity of AHA-CalB. In that case, hardly any 
YodA was co-purified with the protein (data not shown). Larger culturing volumes 
might be desirable using this procedure, as less protein will be produced by a smaller 
amount of cells.
2.3 -  Conclusions
In this chapter we have described the production of CalB in E. coli via periplasmic 
expression of the protein. Purification by Ni2+ NTA affinity chromatography followed 
by size-exclusion chromoatography resulted in 5 mg pure protein per litre bacterial 
culture.
Using methionine-auxotrophic bacteria, azidohomoalanine was successfully 
introduced in CalB. Approximately 1-2 mg azide-functionalized protein was obtained 
per litre bacterial culture. Mass analysis confirmed replacement of methionine by its 
non-natural analogue.
Changes in the procedure for azidohomoalanine incorporation resulted in less 
protein or less efficient incorporation of the non-natural amino acid. Shortening step 2 
(induction in presence of methionine) led to lower amounts of Met-CalB, but also much 
less AHA-CalB was produced. Using rich medium in step 1 while growing the cells to
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the desired OD600 resulted in protein containing a varying number of non-natural 
residues as not all methionine could be removed.
When AHA-CalB was produced, a protein was co-purified that was identified as 
the stress-responsive protein YodA. The contaminant could be removed by eluting the 
proteins separately from Ni2+ NTA beads using 80 mM and 250 mM imidazole, 
respectively. A better solution was to grow cells not further than an OD600 of 0.8. This 
reduced production of YodA.
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2.5 -  Experimental section
Materials and general remarks
Primers were purchased from Biolegio (Malden, the Netherlands) and dNTP mix from 
Invitrogen. Restriction enzymes were from N ew  England Biolabs and Promega. Natural amino 
acids, chloroamphenicol, lysozyme, PMSF, Triton X-100 and imidazole were obtained from 
Sigma Aldrich. Ampicillin and IPTG were purchased from MP Biomedicals, and thiamine and 
glucose from Merck. Triflic anhydride and sodium azide were obtained from Acros. 2xYT 
medium was provided by the Nijmegen Centre for Molecular Life Sciences (NCMLS, the 
Netherlands). Solutions used for protein expression were sterilized by autoclave or by filtration 
over a 0.2 ^m membrane (Corning Life Sciences, or Whatman GmbH).
Centrifugation was performed on a Biofuge Pico microcentrifuge (Heraeus Instruments), a 
Multifuge 3 S-R (Heraeus Instruments) using a Sorvall Heraeus 75006445 rotor, a RC-5 
Superspeed Refrigerated centrifuge (Sorvall, Dupont Instruments) using a GS-3 or SM-24 rotor 
and a Sepatech Minifuge RF (Heraeus Instruments) with a #3360 rotor. Cell cultures were shaken 
at 200 rpm in an Infors HT Multitron shaker. Cell densities were measured on an Ultrospec 10 
Cell density meter (Amersham Biosciences). NMR spectra were recorded on a Varian Inova 400 
(400 MHz for 1H) and a Bruker DMX 300 (75 MHz for 13C), while infrared spectroscopy was 
performed on a Thermo Mattson Nicolet 300 FTIR.
Construction of CalB plasmids
The gene encoding CalB was isolated from the yeast Pseudozyma aphidis, strain 70725 
(Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Germany) by colony PCR.
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Forward (CATATGAAGCTACTCTCTC TGACCG) and reverse (AGATCTTAGGGGGTGA 
CGATGC) primers were derived from the beginning and the end o f the lipase B gene from 
Candida antarctica respectively as determined by Uppenberg et al.1 Restriction enzyme 
recognition sites, NdeI in the forward primer and BglII in the reverse primer are shown in italics. 
For colony PCR, cells o f an overnight culture (50 pl) were pelleted and treated with a zymolase 
solution (1 mg/ml) containing 1 M  sorbitol, 10 mM Tris pH 8.0 for 1 hr at 37 °C. Cells were 
again pelleted by centrifugation at 5000 rpm. PCR was conducted on a PE Applied Biosystem 
9700 thermal cycler under the following conditions: 95 °C for 1 min followed by 25 cycles o f (95 
°C for 30 s, 55 °C for 30s, 68 °C for 120s) and finally 68 °C for 3 min. The reaction mixture (50 
pl) contained 200 pmol o f each primer, Advantage cDNA polymerase mix (1 pi, Clontech), 
dNTP mix (0.2 mM), the cell lysis pellet and 10x reaction buffer (5 pl). The PCR amplified 
fragment was purified using QIAQuick PCR purification kit (Qiagen) and was cloned into the 
NdeI/BamHI o f the pET15b expression vector (Novagen).
The mature calb gene (lacking signal and propeptide coding sequences) was cloned into pET22b 
vector (Novagen) for periplasmic expression. pET22b contains a pelB signal sequence and a 
His6-tag. The calb gene was amplified from the plasmid containing the complete calb gene in 
pET15b described above by PCR using the primers, 
AGTACC4rGGGACTACCTTCCGGTTCGGACC and AGTACTCG4GGGGGGT 
GACGATGCCG. Restriction sites, NcoI and XhoI are shown in italics. After purification the 
PCR fragment was cloned into the NcoI and XhoI sites o f pET22b, thus creating pET22b-calb. 
The DNA sequence encoding for this lipase contains 8 nucleotides different to the original calb 
gene as reported by Uppenberg et al} Only two o f these mutations lead to amino acid changes 
which are Thr(57)Ala and Ala(89)Thr, respectively (numbers refer to the amino acid position in 
the mature lipase which starts with the three amino acids LPS). After cleavage o f  the periplasmic 
localization signal, the amino acid sequence is as follows:
MGLPSGSDPAFSQPKSVLDAGLTCQGASPSSVSKPILLVPGTGTTGPQSFDSNWIPLSAQL
GYTPCWISPPPFMLNDTQVNTEYMVNAITTLYAGSGNNKLPVLTWSQGGLVAQWGLTF
FPSIRSKVDRLMAFAPDYKGTVLAGPLDALAVSAPSVWQQTTGSALTTALRNAGGLTQI
VPTTNLYSATDEIVQPQVSNSPLDSSYLFNGKNVQAQAVCGPLFVIDHAGSLTSQFSYVV
GRSALRSTTGQARSADYGITDCNPLPANDLTPEQKVAAAALLAPAAAAIVAGPKQNCEP
DLMPYARPFAVGKRTCSGIVTPLEHHHHHH
Production and purification of MetCalB
E. coli BL21(DE3)pLysS or B834(DE3)pLysS cells (Novagen) were transformed with pET22b- 
calb plasmid. 2x YT medium supplemented with ampicillin (100 mg/L) and chloroamphenicol 
(50 mg/L) was inoculated with a single colony and incubated overnight at 37 °C. The culture was 
diluted in 1 L 2x YT medium to an OD60 0 o f 0.1 and grown at 37 °C. W hen an OD 60 0 o f 0.8 was 
reached, isopropyl-P-D-thiogalactopyranoside (IPTG) was added to a final concentration o f 1 
mM. Protein production was allowed to take place for 20 hours at 25 °C.
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The His6-tagged protein was purified by Ni2+ NTA affinity chromatography under native 
conditions (Qiagen, Hilden, Germany). The bacteria pellet was lysed in lysis buffer (30 mL o f 50 
mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH8.0) containing Triton X-100 (0.1%), PMSF 
(1 mM) and lysozyme (1 mg/mL). After sonication on a Branson Sonifier the lysate was cleared 
by centrifugation at 4 °C (13000 g, 30 minutes). The protein was allowed to bind to Ni2+ NTA 
beads (1.5 mL, Qiagen) for 2 hours at 4 °C. Upon loading, the column was washed once with 
lysis buffer and twice with wash buffer (20 volumes o f 50 mM NaH2PO4, 300 mM NaCl, 20 mM 
imidazole, pH 8.0). The protein was eluted in elution buffer (10 mL o f 50 mM NaH2PO4, 300 
mM NaCl, 250 mM imidazole, pH 8.0).
Elution fractions containing CalB were concentrated (Amicon® Ultra-15 Centrifugal Filter 
Device 10,000 NMWL). Further purification was performed by size exclusion chromatography 
using a Superdex 75 PC 10/300 column on an AKTA FPLCtm (GE Healthcare Life Sciences). A 
buffer solution containing 50 mM NaH2PO4 and 150 mM NaCl (pH 7.0) was used as eluent 
while applying a flow rate o f 0.5 mL/min and collecting 0.5 mL fractions. Protein concentration 
was determined by measuring the absorption at 280 nm on a Nanodrop ND-1000 spectrometer.
Synthesis of azidohomoalanine
TfN3 was prepared by dropwise adding triflic anhydride (8.8 ml, 52 mmol) to NaN3 (6.8 g, 104 
mmol) in a mixture o f H2O (20 mL) and CH2Cl2 (20 mL), pre-cooled at 0 °C. The reaction 
mixture was stirred at 0 °C for 2-3 hours. Saturated NaHCO3 was added at room temperature 
until no more CO2 was liberated. The aqueous phase was extracted twice with CH2Cl2 (25 mL). 
CH2Cl2 fractions were combined and washed with saturated NaHCO3.
tert-butyloxycarbonyl (Boc)-protected L-diaminobutyric acid (10 mmol, Bachem) was dissolved 
in H2O (37.5 mL) followed by addition o f  MeOH (125 mL), Et3N  (4.18 mL) and ZnCl2 (10 mg, 1 
mol%). A freshly prepared solution o f TfN3 (37.5 mL) was added at once. The reaction mixture 
was stirred overnight at room temperature. Methanol was evaporated under vacuum and H2O (50 
mL) was added. The pH was lowered till 6 by adding HCl (1 M). The aqueous solution was 
extracted with EtOAc (2 times 50 mL), keeping the pH at 6. Subsequently, pH was adjusted to 2 
by adding KHSO4 (1 M) and the product was extracted with EtOAc (3 times 70 mL). The extract 
was dried by adding MgSO4. EtOAc was evaporated under vacuum giving Boc-protected 
azidohomoalanine as an oil. HCl (2 M) in EtOAc was added to remove the Boc group. The 
precipitate was filtered and dried in a desiccator giving a white powder in quantitative yield. 1H- 
NM R (400 MHz, DMSO): S=8.39 (s, 2H), 3.89 (t, J=6.4 Hz, 1H), 3.52 (m, 2H), 1.99 (m, 2H). 
13C-NMR (75 MHz, D2O): 5=171.3, 50.6, 46.6, 28.5. FTIR-ATR: v=2982, 2088 (N3), 1735, 
1449, 1245, 1160 cm-1.
Production of azido-functionalized CalB
E. coli B834(DE3)pLysS cells (Novagen) were transformed with pET22b-calb plasmid. 2x YT 
medium (25 mL) was inoculated with a single colony and incubated overnight at 37 °C. An
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aliquot o f the overnight culture, being sufficient to obtain an OD600 o f 0.1 when diluted in 1 L 
medium, was centrifuged for 10 minutes (6500 g) at 4 °C. The pellet was resuspended in M9 
minimal medium (1 L) supplemented with all 20 natural amino acids (40 mg/L each), glucose 
(0.4%), MgSO4 (1 mM), thiamine (0.0005%), ampicillin (200 mg/L) and chloramphenicol (50 
mg/L). The bacteria culture was incubated at 37 °C. Upon reaching an OD600 o f 0.7-0.8, 
isopropyl-P-D-thiogalactopyranoside (IPTG) was added to a final concentration o f 1 mM. Protein 
expression was induced for 15 minutes at 37 °C. The culture was sedimented by centrifugation 
for 10 minutes (6500 g) at 4 °C and washed twice in cold NaCl (0.9%). Cells were resuspended 
in M9 minimal medium (900 mL) containing 19 amino acids (40 mg/L, no methionine), glucose, 
MgSO4, thiamine, ampicillin and chloramphenicol. After incubation for 10 minutes at 37 °C, 100 
mL azidohomoalanine (400 mg/L) was added. Then, protein expression was induced by adding 
IPTG (1 mM) followed by incubation overnight at 25 °C. The overnight culture (with typically 
an OD60 0 o f 1.4-1.8) was centrifuged for 10 minutes (6500 g) at 4 °C. The purification procedure 
was the same as for MetCalB.
Mass analysis
Approximately 15 pg protein in phosphate buffer was desalted by ultrafiltration with MQ (3 
times 0.5 mL) using 10 kDa MWCO centrifugal filter units (Millipore) and analysed by 
electrospray ionization time-of-flight (ESI-TOF) on a JEOL AccuTOF. 5-10 pM protein in 
formic acid (0.1-1 %) was injected. Deconvoluted spectra were obtained using MagTran 1.03b2. 
Isotopically averaged molecular weights were calculated using the “Protein Calculator v3.3” at 
http://www.scripps.edu/~cdputnam/protcalc.html.
Western blot analysis
1 mL aliquots from 50 mL cultures were centrifuged for 2 minutes at 13000 g. Pellets were 
resuspended in SDS-PAGE sample buffer. The volume added was adjusted to the OD600 o f the 
culture at the time the 1 mL aliquot was collected. 4 pL o f each sample was loaded on a 12% 
(w/v) polyacrylamide gel. Proteins were separated (100-130 V) and transferred to a nitrocellulose 
membrane (1 hour at 100 V, room temperature). The membrane was blocked in 5% milk/TBST. 
The membrane was incubated with anti-CalB antibody (1000x dilution in 0.5% milk/TBST, 
provided by T. Michon, INRA, Villenave d ’Ornon, France) for 1.5 hr at room temperature. 
Washing (3 times 10 minutes) was followed by incubation with HRP-conjugated rabbit-anti- 
mouse antibody (2000x dilution in 0.5% milk/TBST) for 1 hour at room temperature. Finally, the 
blot was washed (4 times 10 minutes) and incubated with ECL solution (Amersham, GE 
Healthcare) for 2 minutes. An X-ray film (Kodak, Carestream Health, Inc.) was developed after 
exposure to the blot for 30 seconds in the dark.
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Separation of CalB and YodA
A N i2+ NTA spin column (Qiagen) was equilibrated with lysis buffer (0.6 mL o f 50 mM 
NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH8.0). A protein sample containing approximately 
20 pg o f both CalB and YodA (20 pL) was mixed with lysis buffer (0.5 mL) and added to the 
column. Upon binding o f the protein by centrifugation at 2000 rpm for 5 min, 0.1 mL buffer was 
added containing 80 mM imidazole in 50 mM NaH2PO4, 300 mM NaCl, pH 8.0. The eluate was 
collected by centrifugation at 2900 rpm for 2 min. This step was repeated twice. Subsequently, 
CalB was eluted by adding two times 0.1 mL buffer containing 250 mM imidazole in 50 mM 
NaH2PO4, 300 mM NaCl, pH 8.0. 8 pL o f each elution fraction was mixed with 5X SDS-PAGE 
sample buffer and loaded on a 12% SDS-PAGE gel. Eletrophoresis was followed by silver 
staining for visualization o f the proteins.
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Chapter 3
The introduction of novel functionalities into proteins has been extensively studied in 
recent decades. Chromophores, polymers and polypeptides have been coupled to 
proteins to study or manipulate their function.1, 2 In most of these cases, the side chain 
functionalities of the amino acids cysteine and lysine were targeted for conjugation 
reactions, because of the reactivity of the free thiol and amine moieties, respectively.3-5 
However, cysteines are often involved in disulfide bonds that occur inside proteins. 
Breakage of these bonds can easily lead to loss of structural integrity and, hence, 
function. Lysine residues are positively charged, predominantly located at the protein 
surface and relatively abundant. As a consequence, it is very likely that multiple 
functional handles are introduced when this residue is targeted for modification.6 Since 
the properties of the bioconjugates thus generated are influenced by the degree and site 
of modification, it is highly desirable to introduce new functional groups in a more 
defined manner.7, 8
One approach to achieve this involves the modification of proteinogenic amino 
acids of which only some residues are exposed to the solvent. As an example, Francis 
et al. have shown that tyrosine can be functionalized using n-allylpalladium 
complexes.9 Only four tyrosines are present in their model protein chymotrypsinogen 
(245 amino acids in total). Two residues are surface-accessible and were therefore 
selectively modified. This strategy is somewhat limited, since most hydrophobic amino 
acids have no suitable reactivity in the side chain. One way to overcome this limitation, 
is by replacing natural amino acids by non-canonical analogues with similar structure. 
This replacement can be performed in a residue-specific manner using auxotrophic 
bacterial strains. The bacteria, being unable to produce one of the natural amino acids, 
incorporate the supplied non-canonical analogue at each position in the protein where 
normally the natural amino acid would be present.10 In this way, there are still multiple 
reactive handles introduced. Non-natural amino acids can also be introduced in a site- 
directed way via in vivo techniques such as the amber suppressor method.11-13 One of 
the drawbacks of the latter method is that it involves complicated and time-consuming 
molecular biology procedures.
We hypothesized that, as an alternative to tyrosine, methionine would be a good 
candidate for mono-functionalization of proteins. It is one of the least abundant amino 
acids in proteins and is among the most hydrophobic residues. Except for the N- 
terminal residue, it is expected to be predominantly buried inside proteins.14, 15 The
3.1 -  Introduction
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methyl thioether is not very reactive under conditions which are commonly used for 
bioconjugation. However, it has been shown that the non-natural amino acid 
azidohomoalanine can efficiently replace methionine when a methionine auxotrophic 
E. coli strain is used for protein production.16 Upon introduction of the azide moiety, it 
is possible to apply the bioorthogonal Cu:-catalyzed [3+2] cycloaddition17, which has 
been shown before to work very well for protein modification18-21.
Although the replacement of methionine by reactive analogues has been well 
established, it has not been investigated whether the limited availability of this residue 
can be used to control the number of conjugation sites. Previously, recombinant 
proteins were chemoselectively modified by replacing methionine with 
azidohomoalanine, followed by the Staudinger ligation under denaturing conditions.22 
The presence of eight azides led to the formation of at least five different ligation 
products in a reduced environment. The use of native conditions during the ligation 
reaction is expected to limit the labeling to solvent-exposed azide residues only.
In order to study whether this relatively simple method can be used to site- 
specifically functionalize proteins, we have investigated the model enzyme Candida  
antarctica lipase B (CalB). The protein variant that was used contains five methionine 
residues, four of which are buried inside the protein. In chapter 2 we showed that all 
methionines could be replaced via residue-specific incorporation of azidohomoalanine. 
Here we show that this strategy leads to introduction of only one accessible azide for 
reaction with alkynes via the CuI-catalyzed [3+2] cycloaddition, also known as the 
click reaction. Thus, a residue-specific substitution leads effectively to an enzyme, 
which can be functionalized at a single defined position. Importantly, we found that the 
enzyme remains active after non-natural amino acid incorporation and click chemistry. 
Furthermore, covalent linkage to polymer-like materials was shown to be possible as 
described by coworkers.
3.2 -  Results and discussion
3.2.1 Modification of azide-CalB at a single position
To investigate whether the azide moieties in CalB were reactive towards alkynes, 
AHA-CalB was incubated with alkyne-functionalized dansyl 1 (20 equivalents) in the 
presence of 1 mM CuSO4, sodium ascorbate and bathophenanthroline ligand 2 (all 30 
equivalents, fig. 1). The reaction was allowed to proceed overnight at room temperature 
in phosphate buffer (pH 7.0). Met-CalB was used as a negative control. Unreacted
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dansyl and click reagents were removed by ultrafiltration. Proteins were separated by 
electrophoresis and labeling was verified by visualizing the fluorescent bioconjugate by 
UV (see Figure 1). Only AHA-CalB treated with Cu(I)-catalyst and 1 turned out to be 
specifically labelled.
F ig u re  1. Labeling of A H A -C a lB  with alkynyl-dansyl 1 in the presence of C u S O 4, ascorbate, and 
bathophenanthroline ligand 2. Reactions were analyzed by S D S -P A G E , with gel stained with 
Coom assie after visualization of fluorescence by U V  light.
To identify which of the azides were reactive towards the alkyne-functionalized 
dansyl, reacted and non-reacted AHA-CalB and Met-CalB samples were treated with 
trypsin, and digests were analysed by MALDI-TOF mass spectrometry. As expected, 
fragments containing methionine in Met-CalB proved to be five units lower in mass in 
the corresponding AHA-CalB sample, due to the presence of azidohomoalanine (see 
Figure 2). For example, the peptide fragment of residues 130-138 containing 
methionine at residue number 131 (1055 Da) was detected as a fragment of 1050 Da in 
the tryptic digest of unreacted AHA-CalB.
The same fragment was present in the digest of dansyl-reacted AHA-CalB, 
indicating that no dansyl had been attached to this azide moiety. By contrast, a mass 
shift of 288 Da (corresponding to the weight of dansyl) was detected for the peptide 
fragment of residues 1-15 containing an azide at residue position 1. It was therefore 
concluded that this azide, being located at the N-terminus of the processed protein, was 
accessible for ligation reactions. It was observed that the labeling with dansyl was 
quantitative as no residual signal at 1513 Da was detected. Finally, these data showed 
that, as expected, there was a small fraction of methionine present in AHA-CalB (see 
small peaks at 1055 and 1518 Da in figure 2A and 2C). The degree of 
azidohomoalanine incorporation was shown to be 90%.
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mfin
Mass / Da
F ig u re  2. M A L D I-T O F  spectra of two tryptic fragments derived from A ) M et-CalB  incubated with 
dansyl, B) A H A -C a lB , and C ) A H A -C a lB  reacted with dansyl. The  peak at 1055/1050 dalton com es 
from the peptide fragment with residue num bers 130-138. The peak at 1518/1513 dalton originates 
from the N-terminal peptide fragment (residue num bers 1-15) to which alkynyl dansyl can be linked. 
Attachment o f dansyl causes a mass shift of 288 dalton, leading to a peak at 1801 dalton.
The addition of dansyl to AHA-CalB was further analysed by ESI-TOF mass 
spectrometry. Only one dansyl molecule was found to be attached to the protein, giving 
the expected mass of 34533 Da (Figure 3). The fraction of CalB which contained 
methionine instead of azidohomoalanine was detected as a residual peak at 34269 Da.
34533
34000 34200 34400 34600 34800 35000 
Mass / Da
F ig u re  3. E S I-T O F  mass spectrum of A H A -C a lB  reacted with dansyl. O ne dansyl w as attached to 
A H A -C a lB  resulting in addition of 288 Da to the A H A -C a lB  mass of 34245 Da. A s  expected, the 
non-reactive fraction of M et-CalB  w as detected at 34269 Da.
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Subsequently, alkyne-functionalized PEG(5000) was coupled to AHA-CalB. 
After removal of the excess PEG(5000) by clicking to azide-functionalized resin,23 
attachment of the polymer to CalB was analysed by gel electrophoresis (see Figure 
4A). A single band shift was detected between 37 and 48 kDa. Non-functionalized 
CalB was separated from the PEGylated fraction by size-exclusion chromatography 
(see Figure 4B). The chromatogram showed two peaks indicating that only one 
derivative had been produced.
The N-terminal methionine codon was replaced by glycine, indicated as AHA- 
CalB(M>G). Upon reaction with alkynyl-PEG(5000), no pegylation was observed by 
gel electrophoresis. Moreover, labeling of AHA-CalB(M>G) with alkynyl-dansyl did 
not result in a fluorescent band on SDS-PAGE gel (see Figure 4C). This confirms that 
of all five azides introduced in non-mutated AHA-CalB, only the N-terminal one was 
accessible for clicking.
A B
1 2  3 kDa <  0.15
0 20 40 60 
Tim e / min
C
1 2 1 2 kDa
—  50
—  —
— 37
—  25
F ig u re  4. Labeling of A H A -C a lB  and A H A -C a lB (M > G ) with PEG5000 and alkynyl dansyl 1. A) 
PEG ylation reactions, analysed by S D S -P A G E  using Coom assie staining; 1. M et-CalB , 2. A H A - 
CalB, 3. A H A -C a lB (M > G ). B) Separation of P EG yla ted A H A -C a lB  from non-reacted CalB  by s ize - 
exclusion chrom atography. C ) Click reactions with alkynyl dansyl, analysed by S D S -P A G E  and 
visualized by U V  prior to Coom assie staining; 1. A H A -C a lB , 2. A H A -C a lB (M > G ).
The enzymatic activity of different CalB variants was analysed by hydrolysis of 
para-nitrophenyl butyrate. Formation of para-nitrophenol by Met-CalB and AHA- 
CalB was monitored by measuring absorbance at 405 nm. Upon introduction of 
azidohomoalanine, hydrolytic activity was retained for 75% (see Figure 5A).
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Additionally, we investigated the effect of the click reaction on enzymatic activity. 
Met-CalB and AHA-CalB were incubated in the presence of click reagents, with or 
without alkynyl dansyl. Subsequent measurements showed that the reagents had some 
negative effect on the activities of both Met-CalB and AHA-CalB. As shown in figure 
5A, the activity of Met-CalB was decreased to 70%. The activity of AHA-CalB was 
reduced to 52% after incubation with dansyl and click reagents, which is 69% of the 
activity of non-treated AHA-CalB.
Furthermore, the enzymatic activities of both the PEG-CalB conjugate and the 
non-PEGylated CalB fraction were monitored after size-exclusion chromatography. 
Comparing the fractions, which were derived from the same click reaction mixture, 
measurements revealed that there was hardly any loss of activity due to attachment of 
the polymer itself (Figure 5B).
A B
Time / sec
F ig u re  5. A ) Hydrolytic activity of M et-CalB  and A H A -C a lB , and the influence of click reagents. 
Formation of para-nitrophenol w as monitored by detecting absorbance at 405 nm. (-) = after 
incubation in phosphate buffer, (+) = after incubation with C u S O 4, ascorbate and ligand 2, (++) = 
after incubation with C u S O 4, ascorbate, ligand 2 and a lkynyl-dansyl 1. B) Com parison of the 
hydrolytic activity of P E G yla ted  CalB  and the non-functionalized fraction. Th e  latter sam ple consists 
of a small fraction of M et-CalB  together with non-labelled A H A -C a lB .
3.2.2 Conjugation to polymer-like materials
The properties of lipases depend on their orientation on a surface.24 Therefore, it would 
be preferable to immobilize the enzyme in a site-specific way. For CalB, this has been 
achieved previously by the introduction of a cysteine at a defined position via genetic 
engineering. Via this free cysteine the enzyme was attached to a maleimide-activated 
surface in an oriented way4. However, the free cysteine reduced the yield of the 
functionally expressed lipase by a factor of 10.
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In Section 3.2.1 we showed that azide-functionalized CalB enabled site-specific 
linkage to a fluorescent dye and PEG. The same methodology was applied to anchor 
the biocatalyst in a site-selective manner to a variety of substrates. These studies are 
described elsewhere (see Table 1).
In summary, azide CalB was tethered to the alkyne-functional surface of PS-PIAT 
polymersomes, which were used as nanoreactors for multistep synthesis.25 
Furthermore, the enzyme was attached via click chemistry to the temperature­
responsive biopolymer ELP, which enabled enzyme immobilization in a microchannel 
in a temperature-controlled fashion.26 In both cases it was shown that the enzyme 
remained active while the function of the polymer-like materials was retained as well. 
Additionally, azide-CalB was linked to a 20 base-pair DNA oligonucleotide.27 The 
DNA-CalB conjugate was immobilized in a DNA patterned microchannel via 
hybridization to its complementary oligonucleotide. It was shown that the enzyme 
could easily be removed by dehybridization after which the microchannel could be 
reloaded with a fresh DNA-enzyme batch. Immobilization of a second enzyme (HRP) 
and addition of a third enzyme in solution (GOx) allowed for a cascade reaction to take 
place.
Ta b le  1. Site-specific linkage of azide-functionalized CalB  to polymer-like materials.
M a te ria l A p p lic a t io n R ef.
A PS-PEG block- 
co-polymer
Linkage onto the surface of 
polymersomes used as 
nanoreactors
25
B
^ [V P G X G ]9o +
N:)
Elastin-like
polypeptide
Temperature-controlled 
positioning in a microreactor
26
C
1 ^ -
DNA
oligonucleotide
Dynamic positional 
immobilization in a 
microchannel
27
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3.3 -  Conclusions
To conclude, we have developed a convenient method to modify CalB protein in a site- 
directed way. An azide-bearing methionine analogue was introduced to act as 
functional handle. Subsequently, other molecules were covalently linked via the highly 
selective Cu(I)-catalyzed click reaction. Although multiple azides were introduced, 
only one moiety appeared to be reactive under native conditions, as the other residues 
were buried inside the protein. The method seems to be a good substitute for the less 
straightforward amber suppressor strategy.
Our method can be considered a versatile tool to modify proteins in a site-specific 
way, as long as one solvent-accessible methionine residue is present. In many cases, it 
will be the N-terminal methionine that is available. It should be noted, however, that 
the N-terminal methionine or its analogue can be cleaved off during post-translational 
processing28. If no other methionine is accessible, a novel residue can be introduced via 
a single mutagenesis step. Therefore, the method is not restricted to N-terminal 
labeling. It can also be used to modify other regions of the protein surface with absolute 
control over the site of modification.
Azide-CalB has been immobilized to (bio)polymers and polymeric architectures 
in a site-specific way. Upon incorporation of the non-natural amino acid the enzyme 
could covalently be attached via the Cu(I) catalyzed azide-alkyne cycloaddition. The 
enzyme was still active while the functionality of the polymer-like materials was 
retained as well.
A part of the hydrolytic activity was lost due to the incorporation of the non- 
proteinogenic amino acid and the use of CuSO4, ascorbate and ligand. Application of a 
copper-free click reaction such as the Staudinger ligation, the strain-promoted [3+2] 
azide-alkyne cycloaddition, or the reaction between azides and oxanorbornadienes will
22 29 30lead to less loss in activity. , , Our group has shown that fast and efficient 
PEGylation of azide-functionalized CalB is possible using a newly developed aza- 
dibenzocyclooctyne.31 This moiety will be used for the formation of CalB oligomers, as 
described in the next chapter.
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3.5 -  Experimental section
Materials and general remarks
mPEG was purchased from Sigma Aldrich, while sodium hydride and propargyl bromide were 
obtained from Acros. CuSO4 was from Merck, sodium ascorbate from Fluka, and 
bathophenanthroline ligand from GFS Chemicals. Alkynyl dansyl and azide functionalized 
Merrifield resin were kindly provided by René Brinkhuis and Joost Opsteen respectively. 
Polymersomes decorated with CalB as well as CalB-ELP and CalB-DNA conjugates were 
obtained and analysed as described elsewhere.25-27
Synthesis of alkynynl-PEG(5000)
a-m ethoxy poly(ethylene glycol) (mPEG, Mn = 5000 g/mol; 2.5 g,
under reduced pressure for three times, in order to remove possibly
present water by means o f co-evaporation. mPEG was then dissolved in anhydrous THF (80 mL) 
under an argon atmosphere and cooled to 0 °C. NaH (60 mg o f a 60% dispersion in mineral oil, 
1.5 mmol) was added and the mixture was stirred at 0 °C for 15 min. Subsequently, the mixture 
was warmed to room temperature and propargyl bromide (140 pL o f an 80% solution in toluene,
1.26 mmol) was added. The mixture was allowed to stir at room temperature for 18 hours, after 
which water (10 mL) was added to quench the remaining NaH. Next, the solvent was largely 
removed by evaporation under reduced pressure and the residue was taken up in CH2Cl2 (100 
mL). After washing the mixture with water (100 mL), the organic phase was dried over 
anhydrous Na2SO4 and concentrated under reduced pressure until approximately 10 mL o f liquid 
remained. Upon precipitation in Et2O (500 mL) the desired product was obtained as a white solid
(2.15 g, 85%). ‘H-NMR (300 MHz, CDCl3): 8=4.21 (d, J  = 2.3 Hz, 2H), 3.64 (br s, 452H), 3.38 
(s, 3H), 2.44 (t, J  = 2.3 Hz, 1H).
Click reaction between AHA-CalB and alkynyl-dansyl or alkynyl-PEG(5000)
mM phosphate buffer (pH 7-8). A stock solution o f CuSO4 and sodium ascorbate in water (10 
mM each) was prepared and pre-mixed with bathophenanthroline sulfonated sodium salt (10 
mM, GFS Chemicals), which acts as Cu' ligand. Alkyne-functionalized dansyl was dissolved in 
THF to a final concentration o f 9 mM. AHA-CalB (1.875 nmol) was reacted overnight at room 
temperature in the dark with alkynyl-dansyl (20 equivalents) and CuSO4/ascorbate/ligand (30 
equivalents) in 50 pL reaction volume. Next day, reactions were washed with buffer (five times 8
0.50 mmol) was dissolved in toluene (30 mL) and concentrated
Cu'-catalyzed cycloaddition between AHA-CalB and alkynyl-dansyl was performed in 25 or 50
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volumes o f 50 mM NaH2PO4, 150 mM NaCl, pH 7.0) to remove click reagents and unreacted 
dansyl using Microcon® Centrifugal Filter Units (10,000 kDa, Millipore). As a negative control 
Met-CalB was added to the reaction mixture instead o f  AHA-CalB.
Similar conditions were used for the click reaction between AHA-CalB and alkyne-PEG(5000). 
PEG(5000) (20 equivalents) was added to AHA-CalB (1.875 nmol) or Met-CalB together with 
CuSO4, ascorbate and ligand (30 equivalents each). Reaction samples were incubated at room 
temperature for 1-3 days and analysed by SDS-PAGE. Before measuring enzyme activity o f 
PEGylated CalB, azide-functionalized M em field resin (1.5 mg) was added to enable the removal 
o f non-reacted PEG(5000) as much as possible. An additional amount o f CuSO4, ascorbate and 
ligand was added as well. Overnight incubation and ultrafiltration using buffer was followed by 
size-exclusion chromatography on a Superdex 75 PC 2.3/30 column.
Enzyme activity assay
Lipase activity was analysed by the hydrolysis o f para-nitrophenol butyrate (p-NPB, Sigma). 
The reaction mixture (50 pL, pH 7) was composed o f 50 mM NaH2PO4, 150 mM NaCl, enzyme 
(100 nM), isopropanol (5%), Triton X-100 (0.1%) and p-NPB (1 mM). The production o fpara- 
nitrophenol was monitored for 5-6 minutes at 25 °C by measuring absorbance at 405 nm in a 
UV-Visible spectrometer (Varian). The slope o f the curve was taken as a measure o f hydrolytic 
activity.
SDS-page analysis
Protein samples were analysed by electrophoresis on 12 % (w/v) polyacrylamide gels followed 
by Coomassie staining. To detect coupling o f fluorescent alkynyl-dansyl to AHA-CalB, the gel 
was placed onto a UV light box prior to staining.
Mass characterization
Incorporation o f azidohomoalanine into CalB and coupling o f the alkyne-functionalized dansyl to 
AHA-CalB was detected by matrix-assisted laser desorption/ionization time-of-flight (MALDI- 
TOF) mass spectrometry. The protein was treated with trypsin in advance. Sequencing-grade 
modified trypsin (0.5 pg, Promega) was added to AHA-CalB or Met-CalB (approximately 6 pg) 
in 50 mM NH4HCO3, pH 8.0. After incubation overnight at 37 °C, the tryptic digest was 
analysed on a Bruker Biflex III spectrometer with a-cyanohydroxycinnamic acid (Sigma) as 
matrix.
The whole protein was analysed by electrospray ionization time-of-flight (ESI-TOF) on a JEOL 
AccuTOF. CalB (~4-10 pM) in formic acid (0.1-1 %) was injected. Deconvoluted spectra could 
be obtained using Magtran software.
63
Chapter 3
3.6 -  References
1. G. Pasut and F. M. Veronese, Polymer Therapeutics I: Polymers as Drugs, Conjugates and  
Gene Delivery Systems, 2006, 192, 95-134.
2. R. Federico, A. Cona, P. Caliceti and F. M. Veronese, Journal o f  Controlled Release, 2006, 
115, 168-174.
3. A. J. T. Dirks, S. S. van Berkel, N. S. Hatzakis, J. A. Opsteen, F. L. van Delft, J. J. L. M. 
Cornelissen, A. E. Rowan, J. C. M. van Hest, F. P. J. T. Rutjes and R. J. M. Nolte, 
Chemical Communications, 2005, 4172-4174.
4. K. Blank, J. Morfill and H. E. Gaub, Chembiochem, 2006, 7, 1349-1351.
5. F. M. Veronese, B. Sacca, P. P. de Laureto, M. Sergi, P. Caliceti, O. Schiavon and P. 
Orsolini, Bioconjugate Chemistry, 2001, 12, 62-70.
6. Y. S. Wang, S. Youngster, M. Grace, J. Bausch, R. Bordens and D. F. Wyss, Advanced  
D rug Delivery Reviews, 2002, 54, 547-570.
7. P. Thordarson, B. Le Droumaguet and K. Velonia, Applied Microbiology and  
Biotechnology, 2006, 73, 243-254.
8. K. L. Heredia, D. Bontempo, T. Ly, J. T. Byers, S. Halstenberg and H. D. Maynard, 
Journal o f  the American Chemical Society, 2005, 127, 16955-16960.
9. S. D. Tilley and M. B. Francis, Journal o f  the American Chemical Society, 2006, 128, 
1080-1081.
10. J. C. M. van Hest, K. L. Kiick and D. A. Tirrell, Journal o f  the American Chemical Society, 
2000, 122, 1282-1288.
11. A. Deiters, T. A. Cropp, D. Summerer, M. Mukherji and P. G. Schultz, Bioorganic & 
M edicinal Chemistry Letters, 2004, 14, 5743-5745.
12. K. Kodama, S. Fukuzawa, H. Nakayama, T. Kigawa, K. Sakamoto, T. Yabuki, N. Matsuda, 
M. Shirouzu, K. Takio, K. Tachibana and S. Yokoyama, Chembiochem, 2006, 7, 134-139.
13. L. Wang and P. G. Schultz, Angewandte Chemie-International Edition, 2005, 44, 34-66.
14. J. L. Cornette, K. B. Cease, H. Margalit, J. L. Spouge, J. A. Berzofsky and C. Delisi, 
Journal o f  M olecular Biology, 1987, 195, 659-685.
15. J. Janin, S. Wodak, M. Levitt and B. Maigret, Journal o f  M olecular Biology, 1978, 125, 
357-386.
16. A. J. Link and D. A. Tirrell,M ethods, 2005, 36, 291-298.
17. V. V. Rostovtsev, L. G. Green, V. V. Fokin and K. B. Sharpless, Angewandte Chemie­
International Edition, 2002, 41, 2596-+.
18. K. E. Beatty, F. Xie, Q. Wang and D. A. Tirrell, Journal o f  the American Chemical 
Society, 2005, 127, 14150-14151.
19. S. Iida, N. Asakura, K. Tabata, I. Okura and T. Kamachi, Chembiochem, 2006, 7, 1853­
1855.
20. S. Sen Gupta, J. Kuzelka, P. Singh, W. G. Lewis, M. Manchester and M. G. Finn, 
Bioconjugate Chemistry, 2005, 16, 1572-1579.
21. S. I. van Kasteren, H. B. Kramer, H. H. Jensen, S. J. Campbell, J. Kirkpatrick, N. J. 
Oldham, D. C. Anthony and B. G. Davis, Nature, 2007, 446, 1105-1109.
22. K. L. Kiick, E. Saxon, D. A. Tirrell and C. R. Bertozzi, Proceedings o f  the National 
Academy o f  Sciences o f  the United States o f  America, 2002, 99, 19-24.
23. J. A. Opsteen and J. C. M. van Hest, Chemical Communications, 2005, 57-59.
24. B. Chen, N. Pernodet, M. H. Rafailovich, A. Bakhtina and R. A. Gross, Langmuir, 2008,
24, 13457-13464.
25. S. F. M. van Dongen, M. Nallani, S. Schoffelen, J. J. L. M. Cornelissen, R. J. M. Nolte and 
J. C. M. van Hest, Macromolecular R apid Communications, 2008, 29, 321-325.
64
Site-specific m odification of azide-functionalized Candida antarctica lipase B
26. R. L. M. Teeuwen, S. S. van Berkel, T. H. H. van Dulmen, S. Schoffelen, S. A. 
Meeuwissen, H. Zuilhof, F. A. de W olf and J. C. M. van Hest, Chemical Communications,
2009, 27, 4022-4024.
27. T. H. Vong, S. Schoffelen, S. F. M. van Dongen, T. A. van Beek, H. Zuilhof, J. C. M. van 
Hest, Chemical Science, 2011, 2, 1278-1285.
28. A. Wang, N. W. Nairn, R. S. Johnson, D. A. Tirrell and K. Grabstein, Chembiochem, 2008,
9, 324-330.
29. N. J. Agard, J. A. Prescher and C. R. Bertozzi, Journal o f  the American Chemical Society,
2004, 126, 15046-15047.
30. S. S. van Berkel, A. T. J. Dirks, M. F. Debets, F. L. van Delft, J. J. L. M. Cornelissen, R. J. 
M. Nolte and F. P. J. T. Rutjes, Chembiochem, 2007, 8, 1504-1508.
31. M. F. Debets, S. S. van Berkel, S. Schoffelen, F. P. J. T. Rutjes, J. C. M. van Hest and F. L. 
van Delft, Chemical Communications, 2010, 46, 97-99.
65
Chapter 3
66
4
Synthesis of covalently linked CalB oligomers
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Chapter 4
The organization of proteins into complexes is of great importance for their function.1 
Several classes of protein receptors, such as growth factor receptors and ion channels, 
need to form dimers or even larger oligomeric structures to effectuate transfer of a 
biochemical signal across the cell membrane. Specific families of eukaryotic 
transcription factors bind to DNA as dimers through recognition of palindromic DNA 
sequences.2 Additionally, many enzymes are organized into macromolecular 
complexes. They cooperate in the biosynthesis of a wide range of molecules. Their 
spatial organization establishes that the (unstable) intermediates are transferred between 
the catalytic sites without diffusion into the bulk phase of the cellular environment.3
The amount of examples in literature describing well-defined syntheses of 
artificial protein oligomers is limited. Native chemical ligation (NCL) has been used to 
form dimers of expressed polypeptides, and to attach multiple fluorescent protein 
molecules to a dendrimer.4, 5 Furthermore, the NCL method has been exploited to 
introduce an azide or alkyne moiety at the N-terminus of a protein for dimerization via 
the Cu(I) catalyzed azide-alkyne cycloaddition.6
An alternative approach has been followed for the production of a heterodimer of 
bovine serum albumin (BSA) and Thermomyces Lanuginosa lipase (TLL). The proteins 
were linked via the free, solvent-accessible cysteine of BSA and the only free lysine of 
a TLL mutant using 3-azidopropyl-1-maleimide and 4-pentynoic acid as additional 
reagents. In this case, BSA functioned as an anchor to immobilize the lipase on a 
surface for single enzyme activity studies.7 In a more recent study a heterodimer of 
BSA and streptavidin was formed using a biotin-maleimide heterotelechelic polymer.8
Only one example has been reported sofar which describes the covalent linkage of 
enzymes that collaborate in a metabolic process.9 As stated earlier, the co-localization 
of multiple enzymes can have a beneficial effect on substrate conversion. In that case it 
would be desirable to have control over the relative orientation of the active sites. Thus, 
a site-specific bioconjugation strategy is required that allows variation in the site of 
conjugation. Here, we describe a method that meets this requirement, resulting in the 
preparation of well-defined enzyme architectures. Scheme 1 gives an overview of the 
different kinds of oligomers that were prepared using Candida antarctica lipase B 
(CalB) as model enzyme.
4.1 -  Introduction
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S chem e 1. The different strategies described in this chapter for the preparation of CalB oligomers. 
A ) Direct linkage of azide-functionalized CalB to CalB containing an alkyne moiety by addition of 
Cu(I). B) Formation of CalB dimers using a short cross-linker and different variants of CalB  
resulting in dimers that have either their N-termini or their active sites in proximity of each other. C) 
CalB oligomerization by introduction of an alkyne group in azide-CalB via N-terminal specific 
labeling followed by incubation with Cu(I). D ) Oligomerization of CalB containing two azide moieties 
by addition of a dibenzoazacyclooctyne cross-linker.
The first strategy relies on the direct linkage of two CalB molecules containing an 
azide or alkyne moiety, respectively (see Scheme 1A). Both unique functionalities can 
be site-specifically introduced in proteins via residue-specific replacement of 
methionine 1 by azidohomoalanine 2 and homopropargylglycine 3 (see Scheme 2).10, 11 
In chapter 3 we have shown that only one out of five methionine residues in CalB is 
solvent-accessible. It is the N-terminal residue which is available for conjugation via 
the Cu(I)-catalyzed azide-alkyne cycloaddition.12
S'" n3
1 2 3
S chem e 2. Structures of methionine 1 and its analogues azidohomoalanine 2 and 
homopropargylglycine 3.
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Alternatively, short dialkynyl spacers will be used to link two CalB molecules that 
both contain an azide moiety (see Scheme 1B). Site-directed mutagenesis enables the 
introduction of a methionine residue at any location of choice provided that the side- 
chain is solvent-accessible and the amino acid replacement does not lead to structural 
changes. Thus, by using this method, conjugation is not limited to a specific site in the 
protein as is for example the case for expressed protein ligation13 or the N-terminal 
labeling approach, which has been developed by Francis et a!14. Here, it will enable the 
formation of different kinds of dimers, which have either their N-termini or their active 
sites in proximity of each other.
An additional bioconjugation technique is required to enable site-specific linkage 
of three or more biocatalysts. It has been shown before that the N-terminus of a protein 
can selectively be targeted for modification.15 Treatment of the protein with glyoxylic 
acid in presence of Cu(II) as chelator results in imine formation. Hydrolysis leads to 
formation of a ketone, which selectively reacts with a hydroxylamine moiety (Scheme 
3). We envisioned that this method could be combined with the incorporation of a non­
natural amino acid to obtain two functional handles in one protein. An enzyme variant 
will be produced with an alkyne functionality at the N-terminus and a single accessible 
azide near the active site of the protein. The addition of Cu(I) will lead to oligomer 
formation (see Scheme 1C).
As a final strategy, a protein variant will be produced with two accessible azides 
(see Scheme 1D). A cross-linker containing two moieties of the highly reactive 
dibenzoazacyclooctyne16 will facilitate the formation of enzyme chains. As no copper 
is needed, reaction conditions are much milder, which makes it applicable for the 
oligomerization of less stable biocatalysts.
S chem e 3. Specific modification of the N-terminus of a protein using glyoxylic acid, Cu(II) and a 
substrate containing a hydroxylamine. R is the side-chain of the N-terminal amino acid.
+
B-H
O protein
glycine
^protein
protein O
protein
O
70
Synthesis of covalently linked CalB dimers
4.2.1 Preparation of CalB dimers linked via the N-termini
The most straightforward approach towards the formation of CalB dimers was to 
directly link an azide-functionalized enzyme molecule to one with an alkyne moiety. 
The azide moiety was introduced into CalB using the methionine analogue 
azidohomoalanine 2 (AHA). According to the same protocol, the alkyne handle was 
introduced via the incorporation of homopropargylglycine 3 (HPG).
4.2 -  Results and discussion
S chem e 4. Direct linkage of two CalB molecules with an azide or alkyne moiety.
We tested whether the azide and alkyne variants of the wildtype protein 
(wt(AHA)CalB and wt(HPG)CalB) could be covalently linked. In a 1:1 ratio 
wt(AHA)CalB and wt(HPG)CalB were reacted overnight at room temperature in 
presence of 50 equivalents Cu(I). The reaction product was purified by size-exclusion 
chromatography (see Figure 1A). The separation of dimer from unreacted CalB was 
verified by SDS-PAGE (see Figure 1B).
Figure 1. Dimerization of wt(AHA)CalB and wt(HPG)CalB. A) Size-exclusion chromatogram of the 
reaction mixture. The shoulder in the second peak is caused by the presence of a native E. coli 
protein which co-elutes with CalB. B) SDS-PAG E gel on which a fraction of both peak 1 (lane 1) 
and peak 2 (lane 2) was loaded.
71
Chapter 4
As expected, the first peak showed to be CalB dimer. The second peak contained 
both unreacted CalB and an impurity in the protein sample, which was known to be 
YodA, a native protein from E. c o li11 The relative amount of formed dimer compared 
to unreacted CalB was quantified by measuring the fluorescence of the corresponding 
protein bands, which were stained by Coomassie Brilliant Blue. 40% of the total 
amount of CalB had formed dimers.
The activity of the wtCalB dimer was compared to the activity of the unreacted 
wt(AHA)CalB and wt(HPG)CalB. p-Nitrophenyl butyrate (pNPB) was used as a 
substrate. Different concentrations of pNPB were added to a dilution of the protein in 
phosphate buffer containing 0.1% Triton X-100. As shown in Figure 2 the activity of 
the dimer was not significantly different from the monomer. Apparently, the linkage of 
the two molecules to each other did not affect their structure and/or activity.
a>
0.125 0.250 0.500 1.000 
Substrate concentration / mM
Figure 2. Hydrolytic activity of CalB dimer linked via the N-termini. Its activity was compared to the 
activity of CalB that had remained unreacted. Different concentrations of p-nitrophenyl butyrate 
were used. The slope in the curves obtained by measuring absorbance at 405 nm for 20 minutes 
were plotted in this chart. The assay was performed in duplo.
4.2.2 CalB mutants with a functional handle near the active site
In order to produce a so-called ‘kissing’ dimer, i.e. a dimer in which the active sites of 
the enzyme molecules are facing each other, an additional methionine codon had to be 
introduced. The 3D structure of the protein was examined in silico to select amino acids 
near the active site that could be replaced by methionine. Four different amino acids 
were chosen being located in the two loops surrounding the catalytic cleft, which were 
leucine(147), valine(149), leucine(219) and valine(221) (see Figure 3). Like methionine 
these residues are hydrophobic. Furthermore they seemed to be accessible to the
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solvent. A multiple sequence alignment among the lipase family was performed to 
check for conservation of these residues. Since they appeared to be hardly conserved, 
we expected that replacement by methionine or its non-natural analogue would not 
harm the enzyme’s structure and function.
Figure 3. Picture of CalB indicating with dashed circles the amino acids that were changed into 
methionine. The entrance of the channel leading to the active site is indicated by the arrow and the 
N-terminus is indicated with a solid-line circle.
To prevent functionalization at two positions, the solvent-accessible methionine 
codon located near the N-terminus was replaced by glycine. In this way only the newly 
introduced azide moiety would be available for conjugation. Upon expression and 
purification the different mutants were analyzed by mass spectrometry. The detected 
masses corresponded with the calculated ones indicating that the correct mutations had 
been introduced (see Table 1). In the first column of Table 1, wt stands for wildtype. 
MG refers to the Met(1)Gly mutation and 147, 149, 219 and 221 refer to the additional 
sites that were mutated in these protein variants.
Table 1. Overview of the different CalB mutants that were produced.
Name M utation Calculated (Da) Detected (Da)
wt(AHA)CalB - 34244.5 34245.3
MG(AHA)CalB Met(1)Gly 34175.4 34175.5
147(AHA)CalB Met(1)Gly + Leu(147)Met 34188.4 34189.9
149(AHA)CalB Met(1)Gly + Val(149)Met 34202.4 34203.9
219(AHA)CalB Met(1)Gly + Leu(219)Met 34188.4 34191.7
221(AHA)CalB Met(1)Gly + Val(221)Met 34202.4 34203.7
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Conjugation of alkyne-functionalized poly(ethylene glycol) (Mw 5000) or dansyl 
to the protein mutants proved that the newly introduced azides were indeed solvent- 
accessible (data not shown). No conjugation product was detected using the variant 
containing only the Met(1)Gly mutation. This indicated that the four other azide 
moieties that are buried inside the protein had remained unaccessible, meaning that the 
overall structure of CalB had not significantly changed.
4.2.3 Preparation of CalB dimers using a dialkynyl linker
Dimers of the CalB mutants were formed in two steps. This appeared to be necessary as 
no dimer formation was observed when a mutant functionalized with HPG was reacted 
with a mutant containing AHA. Probably the newly introduced functional handles were 
less accessible than the ones near the N-terminus. Dialkynyl linkers 4 and 5 were used 
to circumvent the problem of steric hindrance (see Scheme 5A).
First, azide-functionalized protein was incubated with 50 equivalents of 4 or 5 in 
presence of Cu(I). After removing the excess of linker, fresh azide-protein was added to 
allow the reaction with the alkyne-functionalized protein to take place. Using this 
approach, which is shown in Scheme 5B, 147(AHA)CalB dimers were prepared (147- 
dimer). As a control, dimers of wt(AHA)CalB were produced in a similar way (wt- 
dimer).
S chem e 5. Dimer formation using a dialkynyl spacer. A) The structures of ‘clickable' spacers 4  en 5 
which will be used for dimerization of azide-functionalized CalB. B) Schematic representation of the 
two different kind of dimers that were obtained using one of the CalB mutants or wildtype CalB.
Dimers that were produced using 4 were separated from the unreacted monomer 
by size-exclusion chromatography (see Figure 4A). The peak areas in the
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chromatogram were calculated to determine the relative amount of protein in the 
different fractions. Using 4, 27% of the total 147(AHA)CalB protein amount had been 
converted into dimers. In the case of wt(AHA)CalB this was 33%. As shown in Figure 
4B, the 147-dimer runs higher on a (denaturing) SDS-PAGE gel than the wt-dimer. 
This may be explained by taking into account the position at which the two protein 
chains are coupled. For the wt-dimer, this is at the N-terminus of the chains, which 
results in a totally linear construct upon unfolding. Unfolding of the 147-dimer results 
in a branched structure because the two chains are linked in the middle. Apparently, 
such a branched structure results in a lower electrophoretic mobility.
25
35 45 55 20
Time / min
Figure 4. Dimerization of wt(AHA)CalB and 147(AHA)CalB mediated by dialkynyl linker 4. A) Size- 
exclusion chromatograms obtained upon injection of the reaction products on a column without any 
pre-purification. The numbers above the peaks correspond to the lanes in figure B. B) SD S-PA G E  
gel containing aliquots of the crude reaction mix (lane 1) and of the purified fractions (lane 2 and 3). 
The arrows indicate the dimers.
Dimers were also formed using spacer 5. According to the size-exclusion 
chromatograms, 34% of the total amount of 147(AHA)CalB and 41% of wt(AHA)CalB 
had formed dimers (see Figure 5A). The SDS-PAGE gel showed that dimer and 
monomer were well-separated. Again, the 147-dimer had a lower electrophoretic 
mobility than the wt-dimer (see arrows in Figure 5B).
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Figure 5. Dimerization of wt(AHA)CalB and 147(AHA)CalB mediated by dialkynyl linker 5. A) Size- 
exclusion chromatograms obtained from both reactions after injection onto a Superdex 75 column. 
The numbers above the peaks correspond to the lanes in figure B. B) SDS-PA G E gel containing 
aliquots of the crude reaction mix (lane 1) and of the purified fractions with the dimer in lane 2 and 
monomer in lane 3.
4.2.4 Effect of dimerization on the activity of the ‘kissing’ dimer
We investigated the effect of dimerization on the activity of the ‘kissing’ 147-dimer. As 
a model reaction the esterification of 1-octanol using vinyl acetate was studied (see 
Scheme 6). This reaction, which proceeds in dry organic solvents, has been employed 
before to study the activity of different CalB formulations.18
S chem e 6. The reaction between 1-octanol and vinyl acetate catalyzed by CalB. Due to 
rearrangement of vinyl alcohol to acetaldehyde the reaction is irreversible.
We compared the activity of 147-dimers with the activity of their corresponding 
monomers. These monomers had undergone the same reaction procedures, such as the 
click reaction with dialkynyl linker 4 or 5 in presence of Cu(I), followed by 
ultrafiltration to remove the excess of linker, incubation with freshly added Cu(I) and 
purification via size-exclusion chromatography. As the click reaction during the first 
step did not result in 100% conjugation, a part of these monomers was functionalized 
with the linker whereas the remaining portion was not changed.
Based on the absorbance signal in the size-exclusion chromatograms, equal 
amounts of protein were taken from the first (dimer) and second (monomer) peak
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fractions. These aliquots were lyophilized followed by the addition of a mixture of 1- 
octanol and vinyl acetate in dried THF. Conversion into octyl acetate was followed in 
time by GC-MS. Both the decrease in the amount of 1-octanol and the increase in the 
amount of octyl acetate were detected and plotted against time (Figure 6).
Figure 6. Esterification of 1-octanol catalyzed by 147-dimer and its unreacted monomers. A) The 
conversion of 1-octanol into octyl acetate catalyzed by the 147-dimer coupled by 4. B) The initial 
reaction rates of the esterification of 1-octanol by (1) 147-dimer linked by 4 and (2) its monomer, 
and (3) 147-dimer linked by 5 and (4) its monomer.
Figure 6A shows the plot that was obtained from the 147-dimer linked by spacer 
4. The slope of the curves in the first three hours was taken as a measure for the 
activity. In Figure 6B these initial reaction rates of all four analysed samples are shown. 
Hardly any difference between dimer and monomer was detected. Bar 1 and 2 represent 
the activities of the 147-dimer linked by 4 and its unreacted monomer. Bar 3 and 4 
correspond to the activities of the 147-dimer linked by 5 and its monomer. The activity 
of 147(AHA)CalB reacted with 5 is higher. One could postulate that conjugation of 
linker 4 to the enzyme results in a greater loss of activity. However, even though 
protein concentrations were determined as accurately as possible, the deviation in 
activity may be due to differences in the amounts of protein added to the reactions as 
well.
4.2.5 Activity of ‘kissing’ dimers towards alkyl diols
We hypothesized that the activity of the so-called ‘kissing’ dimers towards substrates 
containing two hydroxyl or carboxyl moieties could be higher than the activity of CalB 
monomer or N-terminally linked CalB dimers, due to the close proximity and right
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orientation of the active sites. In the esterification of alkyl diols with vinyl acetate we 
therefore expected to see a faster conversion of the monoacetylated intermediate into 
the diacetylated product.
This hypothesis was tested in an assay using 1,8-octanediol and vinyl acetate. The 
activity of the 147-dimer was compared with the activity of its corresponding monomer 
and the activity of the wt-dimer. Both dimers were formed using 4 as linker. Figure 7 
shows the plots that were obtained by following the conversion of 1,8-octanediol in 
time. The starting compound, the monoacetylated intermediate and the diacetylated 
product were detected by GC-MS. By comparing Figure 7A with Figure 7B it looks 
like the 147-dimer is more active than the 147-monomer. On the other hand, the wt- 
monomer seems to be more active than the wt-dimer (Figure 7C, D). Furthermore, the 
curves of the 147-dimer look quite similar to those of the wt-dimer. Apparently, the 
formation of diacetylated product (3) does not proceed significantly faster for the 147- 
dimer compared to the wt-dimer.
Figure 7. Esterification of 1,8-octanediol catalyzed by (A) 147-dimer, (B) the respective monomer, 
(C) wt-dimer and (D) its corresponding monomer. Dimers were prepared with 4 as linker. The 
relative amounts of (1) 1,8-octanediol, (2) octyl acetate and (3) the diacetylated product as 
determined by G C -M S are plotted against time.
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Since it could be that the effect we expected could not be detected with 1,8- 
octanediol, because this substrate was relatively short compared to the distance 
between the two active sites, some test reactions were performed with longer 
substrates, i.e. 1,10-decanediol and 1,12-dodecanediol. Unfortunately, using the 
reaction and analysis set-up that was optimized for 1,8-octanediol the results that were 
obtained with these substrates were not reliable. This was due to solubility problems 
and the fact that the compounds could not be well-separated on the GC column that 
was available.
4.2.6 Activity of ‘kissing’ dimers towards poly(ethylene glycol) 
diols
The distance between the two active sites of a ‘kissing’ dimer was difficult to predict as 
it not only depends on the depth of the catalytic clefts and the length of the cross-linker, 
but also on the flexibility of the dimer and the substrates. Therefore, it was hard to 
estimate the particular length of a difunctional substrate that would fit in between the 
active sites of the dimer in such a way that conversion would proceed faster.
We therefore decided to investigate the esterification of dihydroxy-poly(ethylene 
glycol) (HO-PEG-OH). The polydispersity of commercially available PEG would 
allow us to test multiple lengths at the same time. If one of the lengths would fit better 
between the active sites of a ‘kissing’ CalB dimer than the other lengths, then 
esterification of that specific length would proceed faster. We expected that this effect 
would be visible in mass spectra of the crude reaction mixture.
We performed an assay using HO-PEG300-OH and vinyl 2-chloroacetate. Vinyl 
2-chloroacetate was chosen instead of vinyl acetate to simplify the assignment of the 
different peaks in the mass spectra. The amount of ethylene glycol units in PEG300 
varies from approximately 5 to 11 units. The lengths of the molecules will therefore 
vary between 17.5 and 38.5 Á. The catalytic cleft of CalB is 12 Á. Taking this into 
account, we hypothesized that PEG300 would be well suited to determine if there was 
an optimal substrate length with respect to rate of conversion by the ‘kissing’ dimer.
The shortest of the two available spacers (5) was used to prepare the 147-dimer 
and wt-dimer. Acetylation of PEG by these dimers and their respective monomers was 
investigated. As in earlier assays, equal amounts of dimer and monomer were taken 
based on the peak areas in the size-exclusion chromatograms. Lyophilization of these 
fractions was followed by addition of a mixture containing PEG300 and vinyl 2-
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chloroacetate in dry THF. At different time points aliquots of the reaction mixtures 
were analysed by mass spectrometry.
Figure 8 shows some typical mass spectra that were obtained. The signals could 
be assigned to the different PEG lengths and their corresponding acetylated products. 
However, no clear preference for one of the lengths was visible in the reaction 
performed by the 147-dimer. The fact that both NH4+ and Na+ adducts were present in 
varying degree resulted in peaks being split up. Furthermore, as mass spectrometry on 
its own is not quantitative, minor effects could not be detected.
Another analytic technique is required to verify whether the ‘kissing’ dimer 
exhibits some special activity towards molecules with two substrate moieties. RP- 
HPLC analysis may enable the separation of the individual PEG oligomers to quantify 
their relative abundance.19
Figure S. Esterification of poly(ethylene glycol) diol catalyzed by 147-dimer. The acetylation of HO- 
PEG 300-O H  was followed in time. Mass spectra of three different time points (in hours) are shown. 
The peaks surrounded by the dark grey bars belong to the starting compound, white bars indicate 
the monoacetylated intermediates and light grey bars correspond to the diacetylated products. The 
numbers indicate the amount of ethylene glycol units.
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Furthermore, it could be that the orientation of the two active sites with respect to 
each other is not optimal. Even though the enzyme molecules are linked near the 
catalytic clefts, these domains may point in another direction and not face each other. 
Therefore, it may be interesting to study the activity of the dimers in aqueous solution 
instead of organic solvent. It is known that the conformational dynamics of enzymes is 
higher in an aqueous environment.20 It could be that such a higher degree of flexibility 
is required for the ‘kissing’ dimer to enable the active sites to cooperate.
4.2.7 Oligomerization of CalB containing an azide and alkyne 
moiety
The first approach towards the formation of CalB oligomers was the introduction of an 
alkyne functionality into azide-CalB (see Scheme 7). The N-terminus was selectively 
targeted for conjugation with cross-linker 6, a tetra(ethylene glycol) molecule 
containing an alkyne moiety at one side and a hydroxylamine at the other side.
^  O ^  / N H 2
6
o
S chem e 7. Formation of CalB oligomers by introduction of both an azide and alkyne moiety in one 
enzyme molecule. A) Compound 6 will be used to introduce an alkyne moiety at the N-terminus of 
azide-functionalized CalB. B) Schematic representation of the oligomerization strategy.
N-terminal specific labeling was first tested using poly(ethylene glycol) 
functionalized with a hydroxylamine (Mw 5000, PEG5000-ONH2) and wildtype CalB 
(wtCalB) containing methionine instead of azidohomoalanine. The protein was treated 
with CuSO4 and glyoxylic acid in 2.5 M NaOAc buffer (pH 5.5) followed by 
ultrafiltration using 0.1 M NaOAc (pH 4.6). Different amounts of PEG5000-0NH2 
were added together with 0.1 M NaOAc (pH 3.6). The reaction was allowed to proceed 
overnight at room temperature and was analysed by SDS-PAGE. Whereas little 
PEGylation had occurred in presence of 10 or 50 equivalents of PEG5000-ONH2, the 
addition of 250 equivalents resulted in more than 50% conversion (see Figure 9A).
81
Chapter 4
The influence of the reaction conditions on the activity of CalB was analysed by 
measuring the hydrolysis of p-nitrophenyl butyrate at 405 nm. The activities of CalB 
being incubated overnight in 0.1 M NaOAc (pH 3.6) only, and CalB being treated with 
glyoxylic acid and CuSO4 followed by incubation in 0.1 M NaOAc (pH 3.6), were 
determined. The derived curves are plotted in Figure 9B together with the curve 
obtained from CalB being treated with those reagents and PEG5000-ONH2. Although 
the reaction conditions are known to be rather harsh, the enzyme was still active.
Figure 9. N-terminal specific labeling of wtMetCalB using P EG 5000-O N H 2. A) SDS-PAG E gel of 
wtMetCalB after treatment with C uSO4 and glyoxylic acid for one hour followed by overnight 
incubation in presence of 0 (lane 1), 10 (lane 2), 50 (lane 3) and 250 (lane 4) equivalents of 
PEG5000-ONH2. B) Hydrolytic activity of several wtM etCalB samples to study the influence of the 
conjugation reactions conditions. (b) incubation in 0.1 M NaOAc, pH 3.6, (c) treatment with CuSO4 
and glyoxylic acid followed by incubation in 0.1 M NaOAc, pH 3.6, and (d) incubation in presence of 
these reagents and the addition of P E G 5000-O N H 2. As a positive control untreated wtMetCalB was 
used (a).
After establishing the viability of the N-terminal labeling approach, 
147(AHA)CalB was labeled with 6. As 6 is too small to lead to a mass shift on a SDS- 
PAGE gel, the labeling was analysed by mass spectrometry (see Figure 10A). It turned 
out that N-terminal specific labeling was less efficient for 147(AHA)CalB than for 
wt(Met)CalB. While more than 50 % of wt(Met)CalB could be labeled with 6, at 
maximum 25 % of 147(AHA)CalB was conjugated under the same reaction conditions. 
Peaks with lower mass values correspond to the glyoxylic acid adducts of both protein 
variants. As for wt(Met)CalB, oxidation had taken place as indicated by a partial +16 
kDa mass shift for both peaks.
82
Synthesis of covalently linked CalB dimers
It is not clear what caused the difference in labeling efficiency. Both the presence 
of a glycine residue instead of a methionine residue at the N-terminus and the 
incorporation of azidohomoalanine instead of methionine seemed to have some 
negative effect. This was deduced from the observed decrease in labeling efficiency of 
both wildtype and mutant CalB (in this case 149CalB instead of 147CalB) containing 
either methionine or azidohomoalanine (see Figure 10B). Besides of that it was noted 
that higher conversions were obtained when a freshly prepared protein batch was used 
(data not shown).
A  CalB-6 « wt(Met)CalB B
M \  1 2  3 4
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Figure 10. N-terminal specific labeling of wildtype and CalB mutants using 6 or P E G 5000-O N H 2. A) 
Mass spectra of wt(Met)CalB (upper graph) and 147(AHA)CalB (lower graph) modified with 6. 
Calculated masses of functionalized proteins are 34497 Da and 34417 Da for w t(Met)CalB and 
147(AHA)CalB , respectively. B) Labeling of w t(Met)CalB (lane 1), wt(AHA)CalB (lane 2), 
149(Met)CalB (lane 3) and 149(AHA)CalB (lane 4) with PEG5000-ONH2, analysed by gel 
electrophoresis.
Although it was in low yield, CalB was obtained which contained both an azide 
and alkyne functionality. Cu(I) was added to the crude product obtained from the 
reaction of 147(AHA)CalB labeled with 6. Overnight incubation at room temperature 
or at 40 °C resulted in oligomer formation. The reactions were analysed by SDS-PAGE 
(see Figure 11A). It was clear that not only dimers but also trimers and probably even 
some larger oligomers had been formed. The reaction at 40 °C showed a higher amount 
of these larger aggregates. Injection of the reaction mixtures onto a Superdex 75 
column resulted in the chromatograms shown in Figure 11B. It confirmed that
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oligomerization had occurred. The different fractions showed to contain hydrolytic 
activity towards p-nitrophenylbutyrate (data not shown).
1 2
“  •*- CalB trimer
75 —
CalB dimer
50 —
37 —
*■ CalB monomer
25 —
Figure 11. Oligomerization of CalB via N-terminal labeling of 147(AHA)CalB with cross-linker 6. A) 
SD S-PA G E gel of 147(AHA)CalB labeled with 6 after overnight incubation in presence of Cu(I) at 
room temperature (lane 1) or 40 C (lane 2). B) Size-exclusion chromatogram of the crude reaction 
mixtures showing that oligomers of several sizes were formed.
4.2.8 Oligomerization of CalB containing two accessible azides
In order to improve the oligomerization strategy, two changes were made in the 
synthetic procedure (see Scheme 8). First, the highly reactive dibenzoazacyclooctyne 
was used16, as it was expected that conjugation would be more efficient using this 
moiety instead of the alkyne. Second, a protein variant was prepared that was fully 
functionalized with two handles, in contrast to the small fraction of azide-alkyne CalB 
that could be obtained via the strategy described above.
S chem e 8. Formation of CalB oligomers by introduction of two azides in one enzym e molecule. A) 
Compound 7 will be used as linker. B) Schematic representation of the oligomerization strategy.
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10 0 %  d i- fu n c tio n a liz a tio n  w a s  a c h ie v e d  b y  c lo n in g  a  C a lB  v a r ia n t  th a t  c o n ta in e d  
b o th  a  m e th io n in e  re s id u e  a t th e  N - te rm in u s  a n d  o n e  n e a r  th e  a c tiv e  s ite , th a t  is , a t 
p o s i t io n  147. In c o rp o ra t io n  o f  a z id o h o m o a la n in e  re su l te d  in  a  C a lB  v a r ia n t  w ith  tw o  
a c c e s s ib le  az id es . A s  sh o w n  in  S c h e m e  8, a  c ro s s - l in k e r  w a s  a d d e d  th a t  c o n s is te d  o f  
tw o  d ib e n z o a z a c y c lo o c ty n e  m o ie t ie s  l in k e d  v ia  a  l in e a r  sp a c e r  (7). T h e  re a c tio n  w a s  
p e rfo rm e d  o v e rn ig h t  a t ro o m  te m p e ra tu re  b y  m ix in g  th e  c ro s s - l in k e r  a n d  C a lB  in  a  1:1 
ra tio . T h e  re a c tio n  w a s  p e r fo rm e d  w ith  w t(A H A )C a lB  as w e ll.
F ig u re  12 sh o w s  th e  S D S -P A G E  a n a ly s is  o f  th e  re a c tio n  m ix tu re s . A s  e x p e c te d , 
w t(A H A )C a lB  ( la n e  1) fo rm e d  d im e rs . D im e r iz a t io n  w a s  n o t  as e f f ic ie n t  a s  b e fo re  
w h e n  a  tw o -s te p  a p p ro a c h  h a d  b e e n  fo l lo w e d  u s in g  4  o r  5. T h is  m ay  b e  d u e  to  th e  fa c t  
th a t  a  la rg e  a m o u n t o f  C a lB  h a d  re a c te d  w ith  th e  l in k e r  w h ile  n o  n e w  p ro te in  w a s  ad d ed  
in  an  a d d itio n a l step . T h e re fo re , th e  a m o u n t o f  u n re a c te d  C a lB  w a s  re la tiv e ly  lo w  su c h  
th a t  d im e r iz a tio n  d id  le s s  e as ily  o c cu r. A d d it io n  o f  e x tra  p ro te in  a n d  in c u b a tio n  fo r  
m u lt ip le  d a y s  in c re a s e d  th e  d e g re e  o f  d im e riz a tio n .
T h e  w t(A H A )C a lB  a p p e a re d  to  fo rm  so m e  tr im e rs  as w e ll. T h is  is  p ro b a b ly  a 
r e su lt  o f  th e  in c re a s e d  e f fic ie n c y  o f  th e  c lic k  re a c tio n  w h e n  th e  d ib e n z o a z a c y c lo o c ty n e  
is  u se d  in s te a d  o f  an  a lk y n e  to g e th e r  w ith  C u (I). In  th is  c a se , o n e  o f  th e  o th e r  fo u r  
a z id es , w h ic h  a re  le s s  a c c e s s ib le , re a c te d  to  so m e  d e g re e  too .
T h e  m u ta n t  w i th  tw o  re a d ily  a c c e s s ib le  a z id e s  (F ig u re  12A , lan e  2 ) fo rm e d  
o lig o m e rs  o f  v a ry in g  size. T h e  b a n d s  in  th e  re g io n  w h e re  C a lB  o lig o m e rs  w e re  to  b e  
e x p e c te d  w e re  ra th e r  b ro a d . T h is  m a y  b e  e x p la in e d  b y  th e  fa c t  th e  e n z y m e s  c a n  b e  
c ro s s - l in k e d  a t tw o  d if fe re n t  p o s i t io n s  p e r  p ro te in  c h a in . F o r  e x a m p le , t r im e rs  m a y  b e  
fo rm e d  in  th re e  d if fe re n t  w a y s . T h is  w il l  r e s u l t  in  d if fe re n t  b ra n c h e d  s tru c tu re s  u p o n  
u n fo ld in g  o f  th e  o lig o m e rs  a n d  th e s e  w ill  h a v e  d if fe re n t  e le tro p h o re t ic  m o b ili tie s . T h is  
e f fe c t w a s  a lso  o b se rv e d  w h e n  d im e rs  w e re  fo rm e d  u s in g  a  d ia lk y n y l l in k e r  an d  
d if fe re n t m u ta n ts  o f  C a lB  (se e  S e c tio n  4 .2 .3 ) .
F ig u re  12B  sh o w s  th e  s iz e -e x c lu s io n  c h ro m a to g ra m s  th a t w e re  o b ta in e d . 
A lth o u g h  se p a ra tio n  w a s  n o t  o p tim a l, i t  w a s  c le a r  th a t  o l ig o m e r iz a t io n  w a s  m o re  
e f f ic ie n t  th a n  in  th e  p re v io u s  a p p ro ac h . T h e  p e a k  o f  C a lB  th a t  h a d  n o t  fo rm e d  
o lig o m e rs  w a s  re la tiv e ly  sm a ll  c o m p a re d  to  th e  c u rv e s  sh o w n  in  F ig u re  11B.
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Figure 12. Oligomerization of wt(AHA)CalB and (AHA)CalB with two readily accessib le azides. A) 
SDS-PAGE gel: (lane 1) wt(AHA)CalB and (lane 2) (AHA)CalB with two accessib le azides. As 
confirmed by adding more equivalents of 7, the band underneath the one corresponding to CalB is 
the CalB-7 conjugate. B) Size-exclusion chrom atogram s obtained from the reaction mixtures. The 
num bers correspond to the lanes in A).
4.3 -  Conclusions
A series of CalB dimers have been produced. Via the incorporation of non-natural 
amino acid analogues of methionine, CalB was produced with either an azide or alkyne 
at the N-terminus. They were directly linked by the addition of Cu(I). Dimerization did 
not affect hydrolytic activity.
Mutants of CalB were produced with an accessible azide near the active site. 
Using a dialkynyl linker, dimers were prepared in which both active sites were brought 
in proximity of each other. Remarkably, these dimers behaved differently on a SDS- 
PAGE gel compared to dimers that were linked at their N-termini.
A model substrate with one alcohol moiety was converted as efficiently by the 
dimers as by the CalB monomers. Also in case of molecules containing two substrate 
moieties no difference in rate was detected. A more quantitative assay may give more 
insight in the question whether in particular the ‘kissing’ dimer can convert the latter 
kind of substrates faster. Testing hydrolytic activity in aqueous environment will be the 
assay of choice as some degree of flexibility may be necessary for the ‘kissing’ dimer 
to function in a cooperative way.
Finally, oligomers of CalB have been prepared. An alkyne functionality was 
introduced at the N-terminus of a CalB variant containing a single accessible azide. 
Cu(I) was added to induce oligomerization. Alternatively, a dibenzoazacyclooctyne
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linker was used in combination with a CalB variant containing two accessible azides. 
Oligomerization proceeded in a more efficient way without the need of adding Cu(I).
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4.5 -  Experimental section
Materials
A m picillin  and chloroam phenicol w ere purchased from  M P Biom edicals. IPT G , 1,8-octanediol, 
glyoxylic acid and ED TA  were obtained from  A cros. Prim ers w ere ordered at B iolegio (M alden, 
the N etherlands). _para-Nitrophenyl butyrate, vinyl acetate and polyethylene glycol (average M n 
300) w ere purchased from  Sigm a Aldrich. C uSO 4-5H2O w as from  M erck, vinyl chloroacetate 
from  A B C R  (K arlsruhe, G erm any) and 1-octanol from  Janssen Chimica. 1-Octanol, 1,8- 
octanediol, polyethylene glycol and vinylchloroacetate w ere dried w ith m olecular sieves (0.3 
nM ) before use.
D ialkynyl linkers 4 and 5 and the dibenzoazacyclooctyne linker 7 w ere kindly provided by Luiz 
Canalle and M arjoke D ebets, respectively. H ydroxylam ine functionalized PE G 5000 was 
synthesized by Sander van Berkel.
Protein production and purification
The m ethionine auxotrophic strain B 834(D E3)pLysS E. coli (N ovagen) w as used for protein 
production. C om petent cells w ere transform ed w ith pET22 plasm id containing the CalB gene o f  
interest. Protein expression w as induced in presence o f  azidohom oalanine or hom opropargyl 
glycine (Chiralix) follow ed by purification v ia affinity and size-exclusion chrom atography (as 
described in chapter 2). The protein concentration o f  the purified sam ples w as determ ined by 
m easuring absorbance at 280 nm  using a N anoD rop 2000 (Therm o Scientific). The w hole protein 
was analysed by electro-spray ionization tim e-of-flight (ESI-TO F) on a JEOL A ccuTO F. CalB 
(10 pM ) in form ic acid (0.1 % ) w as injected. D econvoluted spectra w ere obtained using M agtran 
software.
Site-directed mutagenesis
The structure o f  the protein w as available from  PD B file 1tca.21 The Yasara & W H A T IF 
Twinset w as used for v isualization and analysis o f  the protein to select am ino acids that could be 
changed into m ethionine residues.22
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The Q uikchange®  site-directed m utagenesis protocol (Stratagene) was follow ed to produce the 
d ifferent CalB m utants. The follow ing prim ers w ere used: M et(1)G ly forward: G CC G  GCG 
A T G  GCC GG G  GGA CTA CCT TCC GG. M et(1)G ly reverse: CC GGA A G G  TA G  TCC CCC 
GGC CAT CGC CG G  C. L eu(147)M et forward: CCT CTC GAT TCA A T G  G CG  GTT A G T 
GC. L eu(147)M et reverse: GC A C T A A C  CGC CAT TGC A T C  GA G  A G G . V al(149)M et 
forward: GAT GCA CTC G CG  A T G  A G T GCA CCC TCC. L eu(149)M et reverse: GGA GGG 
TGC A C T CAT CGC GA G  TGC. L eu(219)M et forward: G TG  TGT GG G  CC G  A T G  TTC GTC 
A TC  GAC. L eu(219)M et reverse: GTC GAT G A C  GAA CA T C G G  CCC A C A  CAC. 
V al(221)M et forward: GG G  CC G  CTG  TTC A T G  A TC  GAC CAT GC. V al(221)M et reverse: 
GC A T G  GTC GAT CAT GAA C A G  CG G  CCC.
Cu(I)-catalyzed click reactions
Each tim e a fresh stock solution o f  C uSO 4 (20 m M ) and sodium  ascorbate (25 m M ) in M Q  w as 
prepared and prem ixed in a 1:1 ratio w ith a 40 m M  stock solution o f  tristriazole ligand23 in 
M eCN. This m ixture will be referred to as ‘click m ix ’.
For the direct linkage o f  w t(A H A )C alB  and w t(H PG C alB ), 44 nm ol Cu(I) (4.4 pL click m ix) was 
added to 0.88 nm ol o f  each protein variant in buffer containing 50 m M  N aH 2PO 4, 150 m M  N aCl 
(pH  7.0). The final reaction volum e w as 45 pL. The reaction w as incubated overnight at room  
tem perature w hile gently shaken.
For the dim erization o f  (A H A )C alB  using a dialkynyl linker, 10 m M  stock solutions w ere 
prepared o f  4 (in M Q ) and 5 (in D M SO). 25 nm ol o f  linker 4 or 5 and 25 nm ol Cu(I) (2.5 pL 
click m ix) w ere m ixed w ith 0.44 nm ol w t(A H A )C alB  or 147(AH A)CalB  resulting in a final 
reaction volum e o f  12.5-20 pL. A fter overnight incubation at room  tem perature click m ix and 
excess o f  linker w ere rem oved by ultrafiltration w ith 0.5 mL buffer containing 50 m M  N aH 2PO 4, 
150 m M  NaCl (pH  7.0) using a 10 kD a M W C O  centrifugal filter unit (M illipore). Subsequently,
0.44 nm ol fresh w t(A H A )C alB  or 147(AH A)CalB w as added together w ith 25 nm ol Cu(I) 
resulting in a final volum e o f  25-33 pL. The reaction w as left at room  tem perature for an 
additional night.
Preparation of the hetero telechelic TEG spacer
Hetero telechelic tetraethylene glycol 6 was synthesized as depicted in Scheme 9 follow ing 
m odified literature procedures.24, 25
8 0 °C  - ►  r.t., 18h u  9
(93%)
S ch em e  9. Synthesis of hetero telechelic tetraethylene glycol 6
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3,6,9,12-Tetraoxapentadec- 14-yn-1-ol 8
, > To a cooled solution (0 °C) o f  tetraethylene glycol (1.50 g, 10
m m ol) in dry THF (10 m L) w as added N aH  (260 m g, 6.5 m m ol, 
60%  on mineral oil). The resulting suspension was stirred at 0 °C 
during 30 min. during w hich the H 2-gas form ation ceased. N ext, proparyl brom ide (0.54 m L, 5.0 
m m ol, 80 wt%  in toluene) w as added drop wise. A fter full addition the resulting m ixture was 
stirred for 2 hours at 0 °C and a subsequent 20 hours at room  tem perature. The reaction was 
quenched w ith H 2O (50 m L) and extracted w ith C H 2Cl2 (3 x 50 mL). The com bined organic 
phases w ere dried over N a2SO4 and purified by colum n chrom atography (100%  EtO Ac). Two 
products w ere obtained being the m ono- and di-substituted tetraethylene glycol (RF = 0.7 (100%  
EtOAc)). The desired product w as obtained as light yellow  oil (700 m g, 69% ), R F = 0.2 (100%  
EtO Ac). ‘H-N M R  (400 M H z, C D C l3): 5 = 4.20 (d, J  = 2.4 Hz, 2H), 3.73-3.64 (m, 14H), 3 .62­
6.60 (m, 2H ), 2 .47 (br s, 1H), 2.42 (t, J  = 2.4 H z, 1H) ppm. 13C-N M R  (75 M H z, C D C l3): 5 = 
79.55, 74.52, 72.52, 70.57, 70.51, 70.49, 70.33, 70.26, 69.05, 61.69, 58.34 ppm. FT-IR: v  = 
3237, 2867, 2113, 1350, 1099 cm-1. HRM S: calcd. for C 11H 20N aO 5 = 255,1208; found: 255.1202.
2-(3,6,9,12-Tetraoxapentadec-14-yn-1-yloxy)isoindoline-1,3-dione 9
/ = \  o  A  flam e-dried, N 2-purged, Schlenk tube w as charged
\  w ith alkyne-TEG  8 (232 m g, 1.0 m m ol),
hydroxyphthalim ide (179 m g, 1.1 m m ol, 1.1 eq.) and
O triphenylphosphine (275 m g, 1.05 m m ol, 1.05 eq.). The
m ixture was three tim es evacuated and back-filled w ith N 2-gas before adding dry C H 2Cl2 (10 
mL). A fter the drop w ise addition o f  diisopropyl azodicarboxylate (214 |iL , 1.1 m m ol, 1.1 eq.) 
the reaction m ixture w as stirred for 20 hours at room  tem perature. A fter com pletion o f  the 
reaction, the m ixture w as acidified w ith 2M  H C l (aq.) to pH  = 5 (approx.). A dditional H 2O (10 
m L) w as added and the layers separated. The w ater phase w as extracted w ith C H 2Cl2 (3 x 10 
m L) after w hich the com bined organic phases w ere dried over N a2SO 4 and purified by colum n 
chrom atography (C H 2Cl2/M eO H  9:1) to yield com pound 9 as m ilky oil (349 m g, 93% ). *H-NMR 
(400 M H z, C D C l3): 5 = 7.85-7.83 (m, 2H ), 7.76-7.74 (m , 2H ), 4 .39-4.37 (m , 2H ), 4.20 (d, J  = 2.4 
Hz, 2H ), 3.88-3.86 (m , 2H ), 3 .71-3.64 (m , 6H ), 3.63-3.56 (m, 6H), 2.43 (t, J  = 2 .4  H z, 1H) ppm. 
13C -N M R  (75 M H z, C D C l3): 5 = 163.42 (2C), 134.39 (2C), 128.89 (2C), 123.45 (2C), 74.48, 
70.72 (2C), 70.45 (4C), 69.25, 69.03, 58.34 ppm. LRM S: calcd. for C 19H 23N N aO 7 (MNa+) = 
400,1372; found: 400.2.
0-(3,6 ,9 ,12-tetraoxapentadec-14-yn-1-yl)hydroxylam ine 6
ATTEN TIO N : w ork com pletely acetone free! R inse 
^  glassw are, filters and stirring bar w ith C H 2Cl2 prior to use. 
A lkyne-hydroxyphthalim ide TEG 9 was dissolved in dry C H 2C H 2 (10 m L) and N 2H 4-H2O (2 x 
70 |iL) w as added. The reaction w as stirred for 3 hours at room  tem perature (a w hite precipitate
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is form ed). The w hite solid w as filtered-off and rinsed w ith C H 2C l2 (10 mL). The organic phase 
was w ashed w ith 2M  N aH C O 3 (15 m L) and subsequently dried over M gSO 4. N o further 
purification o f  the product w as required. H ydroxylam ine 6 w as obtained as colorless oil (120 mg, 
92% ). ‘H-N M R  (400 M H z, C D C l3): 5 = 5.45 (br s, 2H ), 4.20 (d, J  = 2.4 H z, 2H ), 3.84-3.82 (m, 
2H ), 3.71-3.59 (m , 14H), 2.42 (t, J  = 2.4 H z, 1H) ppm. 13C -N M R  (75 M H z, C D C l3): 79.63, 
74.75, 74.47, 70.57, 70.53 (2C), 70.48, 70.36, 69.56, 69.07, 58.35 ppm. LRM S: calcd. for 
C „ H 22N O 5 (MH+) = 248,1498; found: 248,1502.
N-terminal specific labeling and Cu(I)-catalyzed oligomerization
2.9 nm ol w t(M et)C alB  w as m ixed w ith 500 nm ol C uSO 4 and 25 pm ol glyoxylic acid in 1.25 M  
N aO A c (pH  5.5). Incubation for 60 m inutes at room  tem perature w as follow ed by addition o f  one 
volum e (250 pL) 0.1 M  EDTA. The m ixture w as concentrated over a centrifugal filter unit 
(M illipore, 10 kD a M W C O ) and w ashed tw ice w ith 0.5 mL 0.1 M  N aO A c (pH  4.6). To the 
residual volum e (25 pL) 55 pL 0.1 M  N aO A c (pH  3.6) w as added. The sam ple w as divided in 4 
aliquots o f  20 pL follow ed by addition o f  0, 10, 50 or 250 equivalents o f  PE G 5000-O N H 2 (10 
m M  stock solution in M Q). The reaction w as shaken overnight at room  tem perature. 
147(AH A)CalB was m odified in a sim ilar way using 6 instead o f  PE G 5000-O N H 2. The excess o f  
6 was rem oved by dialysis over a centrifugal filter unit by adding three tim es 0.5 mL buffer 
containing 50 m M  N aH 2PO 4 and 150 m M  N aC l (pH  7.0).
To 0.62 nm ol o f  the functionalized 147(A H A )CalB  3.5 pL ‘click m ix ’ (see above) w as added 
follow ed by overnight incubation at room  tem perature o r 40 °C. O ld ‘c lick’ m ix w as rem oved by 
ultrafiltration before a fresh aliquot o f  0.62 nm ol functionalized 147(AHA)CalB and 6 pL freshly 
prepared click m ix w ere added. The reaction m ixtures w ere shaken overnight at room  
tem perature o r 40 °C.
Copper-free oligomerization
0.88 nm ol (AH A)CalB  w ith two accessible azides or w t(A H A )C alB  was m ixed w ith 0.88 nmol 
o f  cross-linker 7 (dissolved in D M SO , 0.25 m M ) in buffer containing 50 m M  N aH 2P O 4, 150 m M  
N aCl (pH  7.0). The final reaction volum e w as 15-20 pL. R eactions w ere shaken overnight at 
room  tem perature.
Size-exclusion chromatography
D im erization and oligom erization reactions w ere analyzed on a Pharmacia SM ART  fast 
perform ance liquid chrom atography (FPLC) system  equipped w ith a Superdex 75 PC 3.2/30 
colum n (GE H ealthcare L ife Sciences) using buffer containing 50 m M  N aH 2PO 4, 150 m M  NaCl 
(pH  7.0) as an eluent. The flow  rate w as typically 25 pL/m in and fractions o f  25 pL were 
collected. Only for the analysis o f  the directly linked w t(A H A )C alB  and w t(H PG )C alB  a flow  
rate o f  20 pL /m in w as used.
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SDS-PAGE analysis
Protein sam ples w ere analysed by electrophoresis on 12% (w/v) polyacrylam ide gels follow ed by 
Coom assie B rilliant B lue or silver staining. The Odyssey Infrared Im aging System  (LI-C OR 
B iosciences) w as used to quantify the intensity o f  the C oom assie stained protein bands.
Activity assay with p-nitrophenyl butyrate
H ydrolysis o f  ^ -n itrophenyl butyrate (pN PB ) w as detected by m onitoring the absorbance at 405 
nm  using a M ulticounter W allac V ictor2 (PerkinElm er L ife Sciences). A  96-w ells plate well was 
filled w ith 45 pL buffer containing 50 m M  N aH 2PO 4, 150 m M  N aC l (pH  7.0) containing 0.1%  
Triton-X100. 2.5 pL o f  enzym e solution in 50 m M  N aH 2PO 4, 150 m M  N aCl (pH  7.0) w as added. 
D irectly before the m easurem ent w as started 2.5 pL substrate (concentrations varying from  2.5,
5, 10 and 20 m M  in isopropanol) w as added. A utohydrolysis o f  the substrate w as m onitored by 
adding 2.5 pL 50 m M  N aH 2PO 4, 150 m M  N aC l (pH  7.0) w ithout enzym e. A bsorbance was 
m easured every two m inutes for at least 60 m inutes w hile the tem perature w as kept at 25 °C. The 
slope o f  the curve in the first 20  m inutes w as taken as a m easure o f  hydrolytic activity.
Esterification assay with vinyl acetate and 1-octanol, 1,8-octanediol and PEG.
Esterification o f  1-octanol or 1,8-octanediol using vinyl acetate w as perform ed in dry THF. A  2x 
stock solution w as prepared containing 2.2 M  vinyl acetate and 0.38 M  1-octanol or 1,8- 
octanediol in THF. The com pounds w ere dried in advance using m olecular sieves (3 A). 500 pL 
stock solution and 500 pL THF w ere added to an eppendorf tube containing the lyophilized 
enzym e. L yophilization w as perform ed using a solution o f  the enzym e in 50 m M  N aH 2P O 4, 150 
m M  N aC l (pH  7.0) w ithout addition o f  any cryoprotectant such as PEG-6000.
The reaction m ix w as incubated at room  tem perature w hile gently shaken. 20pL -aliquots w ere 
w ithdraw n from  the reaction m ixture at specific tim e points. They w ere analysed after 10x 
dilution in acetone by GC-M S on a Therm o Finnigan PolarisQ  using a capillary colum n (Varian 
FactorFour™ , 30m  x 0.25 m m  i.d.). The tem perature o f  the GC oven was increased by 30 °C 
m in-1 from  100 to 190 °C. The retention tim es for 1-octanol and the corresponding ester were 
3.00 and 3.53, respectively. For 1,8-octanediol, a G C -gradient w as used in w hich the oven was 
heated by 30 °C m in-1 from  160 to 270 °C. This resulted in retention tim es o f  2 .82, 3.22 and 3.60 
m in, for diol, m onoester and diester, respectively.
The acetylation assay o f  PEG 300 was perform ed in a sim ilar w ay using a stock solution o f  2.2 M  
vinyl 1-chloroacetate and 0.38 M  PEG 300. 5-pL aliquots w ere w ithdraw n from  the reaction 
m ixture and analyzed upon 10,000x dilution in M eO H  by ESI-TO F on a Therm o Finnigan LCQ  
A dvantage M ax. For PEG -6 the follow ing m asses w ere detected: B efore incubation w ith CalB: 
M S (ESI+) m /z calcd. for C 12H 26O7 [M +NH4]+ 300.2, found: 300.1; [M+Na]+ 305.2, found: 
305.3. A fter incubation w ith CalB: M S (ESI+) m /z calcd. for C 16H 28Cl2O 9 [M +NH4]+ 452.3, 
found: 452.1; [M+Na]+ 457.3, found: 457.1.
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Chapter 5
Proteins are modified to study or manipulate their function, for conjugation to surfaces 
or other molecules, and to increase their stability or uptake in single cells or organisms. 
For many applications, a chemoselective ligation strategy is desired to control the 
degree and site of modification. A well-known reaction that has proven to be highly 
suitable for these purposes is the Cu(I)-catalyzed cycloaddition between azides and 
alkynes.1, 2 Recently, great interest in the copper-free variant of this click reaction has 
emerged, as it is known that copper is toxic to cells and difficult to remove from 
proteins.3, 4
Azide moieties are introduced in enzymes, antibodies or other proteins in various 
ways. Via genetic engineering non-natural amino acids such as para- 
azidophenylalanine and azidohomoalanine have successfully been incorporated at a 
single site or in a residue-specific manner.5-7 Alternatively, azides have been installed 
in glycoproteins via metabolism of a synthetic azidosugar.8 Using an engineered lipoic 
acid ligase, an alkyl azide can specifically be attached to proteins containing a short 
peptide tag.9 Furthermore, native chemical ligation has facilitated functionalization of a 
protein’s N-terminus with an azide moiety.10
Our group recently reported a more straightforward method that does not require 
any genetic or metabolic manipulation. Free amines were converted into azides via an 
aqueous diazotransfer (Scheme 1).11 The hydrochloric salt of imidazole-1-sulfonyl
azide 1 is used as a shelf-stable, non-explosive and water-soluble diazotransfer
12reagent.
5.1 -  Introduction
Scheme 1. Introduction of azides in proteins using 1 as diazotransfer reagent.
Whereas this approach is much easier to apply, it is less selective. Four and five 
azides were introduced in the fluorescent protein DsRed and horseradish peroxidase 
(HRP), respectively. Moreover, a close to equimolar amount of Cu(II) relative to amine 
was added as a catalyst and by adding potassium carbonate a pH of 11 was created to
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ensure that all amines were deprotonated. However, not all proteins are stable at high
pH13 and Cu(II) may affect the structure or function of the protein or the biological
system in which it will subsequently be used14.
Traditionally, amines have been diazotized in solvent mixtures such as
water/CH2Cl2 or water/CH2Cl2/MeOH using trifly l azide as transfer reagent.15, 16 The
use of Cu(II), Ni(II) or Zn(II) as a catalyst was initially reported by Alper et a!.17 Since
then several procedures have been described in which Cu(II) is used as a catalyst in a 1­
12 18 2010 mol% quantity relative to the amine. , " Nyffeler and coworkers investigated the 
diazotransfer reaction in more detail.21 They showed that both copper sulfate and zinc 
chloride are effective catalysts, but also when no catalyst was present 80% conversion 
was detected for some of the aminoglycoside substrates after 18 hours of reaction.
Here, we demonstrate that in a similar way azides can be introduced in proteins 
without adding Cu(II). Moreover, lowering the pH to 8.5 leads to selective conversion 
of the amine with the lowest pKa, the a-amine at the N-terminus of the model proteins.
5.2 -  Results and discussion
5.2.1 Diazotransfer at pH 11 in presence and absence of Cu(II)
Hen egg-white lysozyme C and a recombinant variant of Candida antarctica lipase B 
(CalB) were used as model enzymes. These proteins contain six and nine lysines, 
respectively. They were incubated overnight at room temperature in presence of 
diazotransfer reagent 1 (1.75 equivalents relative to the amines) and sodium carbonate 
as a base, leading to a pH of 11 in the reaction medium. The conversion of amines into 
azides was analyzed by mass spectrometry.
As shown in Figure 1 and Table 1, amines were indeed converted into azides 
when no Cu(II) was added. As for lysozyme, on average five azides were introduced, 
whereas CalB contained mainly two to three azides. In comparison, six azides were 
present in lysozyme when 1 was added together with Cu(II). Under these conditions up 
to seven azides were introduced in CalB.
Elastin-like polypeptide (ELP), a structural protein that has previously been 
engineered in our lab22, was used as a third model. Two variants of ELP were 
investigated with either one (ELP-lys1) or three lysines (ELP-lys3). To these proteins a 
large excess of 1 (175 equivalents relative to the amines) was added. Using this excess
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all amines in both variants were diazotized (see Table 1), whether Cu(II) was added or 
not.
Figure 1. Mass spectra of lysozyme and CalB after diazotransfer at pH 11, which was performed 
without or in presence of Cu(II). A) Lysozyme without Cu(II), B) CalB without Cu(II), C) lysozyme 
with Cu(II), and D) CalB with Cu(II). Numbers above the peaks indicate the number of azides that 
are present in the protein.
Table 1. Detected masses after diazotransfer without or in presence of Cu(II) at pH 11.
Protein Unmodified (Da)“ Cu(II) Detected (Da)*
Lysozyme 14305.1 / 14305.2 - 14382.4, 14409.3, 14435.2, 14461.1
+ 14461.1
CalB 34269.7 / 34269.0 - 34294.9, 34320.9, 34346.2, 34371.9
+ 34372.3, 34397.9, 34423.8, 34449.0
ELP-lysl 39670.9 / 39671.7 - 39723.5
+ 39722.8
ELP-lys2 39927.2 / 39929.9 - 40032.3
+ 40031.2
a Molecular weight of the unmodified protein, calculated / detected. ‘ Molecular weight of the protein 
after diazotransfer using 1.75 equivalents (lysozyme and CalB) or 175 equivalents (ELP-lys1 and 
ELP-lys3) of diazotransfer reagent.
As stated before, Cu(II), Ni(II) or Zn(II) are known to catalyze the diazotransfer 
reaction. Even though 1 was synthesized without using any metal salts, the imidazole 
ring present in this compound might have complexed some of these metal ions. To
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verify whether this was the case, 1 was analyzed by inductively coupled plasma mass 
spectrometry (ICP-MS). The amount of Cu(II) that was detected per ^mol diazotransfer 
reagent varied between 2 and 5 pmol. The Ni(II) and Zn(II) contents were less than 2.5 
pmol and 20 pmol per ^mol diazotransfer reagent, respectively. These values 
correspond to trace amounts of 0.0002-0.002 mol% catalyst relative to amines, and 
indicate that metal ions do not play a significant role in the diazotransfer reaction and 
are well below values to affect protein activity.
5.2.2 Introduction of azides at pH 9.0 and 8.5
In addition to excluding Cu(II) from the reaction, we investigated the effect of lowering 
the pH. The diazotransfer was performed on lysozyme and CalB in diethanolamine 
buffered solutions of pH 8.5 and 9.0, using 1.75 equivalents of 1, first still in the 
presence of Cu(II). Mass analysis on the whole proteins confirmed that also under these 
conditions azide moieties were introduced. The number of amines that are converted 
into azides decreases upon lowering the pH to 9.0 and 8.5 (see Figure 2).
C Lysozym e pH  9.0
4 5
Mass I Da
D CalB p H  9.0
Mass / Da
Figure 2. Mass spectra of lysozyme and CalB after diazotransfer at pH 8.5 and pH 9.0 in presence 
of Cu(II). A) Lysozyme at pH 8.5, B) CalB at pH 8.5, C) lysozyme at pH 9.0, and D) CalB at pH 9.0. 
Numbers indicate the amount of azides that are present.
97
Chapter 5
When the diazotransfer was performed both at lower pH and in absence of Cu(II), 
the conversion efficiency was further reduced. However, increasing the amount of 1 
from 1.75 to 17.5 equivalents relative to amines had a positive effect (see Figure 3). It 
was remarkable to see that in CalB only one azide was introduced at pH 8.5 even when 
17.5 equivalents of 1 were added. Using the same conditions also in ELP-lysl and 
ELP-lys3 only one azide was introduced, whereas two or four azides were introduced at 
pH 11 and/or in presence of Cu(II).
Figure 3. Mass spectra of CalB after diazotransfer at pH 8.5 in absence of Cu(II) using 1.75 (A) 
and 17.5 (B) equivalents of diazotransfer reagent.
5.2.3 Identification of the single reactive amine
It was speculated that the selectivity was caused by differences in reactivity of the 
amines. The reactivity will depend on the pKa, which is influenced by the 
microenvironment of the amine. The pKa values of amines in a protein can vary 
significantly. For lysozyme for example, the amine with the lowest value is the a-amine 
(pKa is 7.0), while the two most basic amines have a pKa of 11.2.23 In general, the a ­
amine at the N-terminus of a protein will often have the lowest pKa. However, it is also 
the solvent accessibility of the amines that will influence their reactivity.
Mono-functionalized CalB and ELP were treated with trypsin to determine which 
amine had been converted. The digests were analysed by mass spectrometry. A peak 
was detected at 1544.8 Da instead of 1518.7 Da (see Figure 4A). So, the N-terminal 
fragment of CalB (amino acids 1-15) had shifted 26 Da in mass, indicating that the a ­
amine at the N-terminus of CalB had been converted into an azide. Additional LC- 
MS/MS analysis using trypsin, LysN24 and chymotrypsin demonstrated that all other 
lysines had remained unmodified, with the exception of a very low level of conversion
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of Lys210 (2 spectra corresponding to modified peptides versus 36 spectra matching 
peptides containing Lys210 without azide group).
In the tryptic digests of ELP-lys1 and ELP-lys3 a peak of the triply charged 
fragment was detected that corresponded to amino acids 1-16 containing an azide, i. e. 
[M+3H]3+ being 598.9 Da instead of 590.3 Da (see Figure 4B). For ELP-lys1 a small 
fraction of the unreacted fragment was detected as well. The peak corresponding to 
amino acids 17-24 containing a converted lysine at position 23 was only present when 
Cu(II), a base and/or 175 equivalents of diazotransfer reagent was added.
As shown in Figure 5, fragment 17-23 of ELP-lys3 (calculated [M+H]+ 801.4 Da) 
was detected indicating that no azide had been introduced on this lysine. The two 
additional lysines in ELP-lys3 (residue numbers 29 and 30) were not diazotized either 
as proven by the detection of tryptic fragment 30-488 (calculated [M+H]+ 36708.8 Da). 
It was therefore concluded that in both ELP variants it was the N-terminal amine as 
well that had been converted at pH 8.5 in absence of Cu(II).
Figure 4. Mass spectra of the N-terminal fragments of mono-functionalized (A) CalB, (B) ELP-lys1 
and ELP-lys3. Calculated masses are those of unmodified peptides.
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Figure 5. Mass spectrum of mono-functionalized ELP-lys3 after trypsin digestion. A) Non- 
deconvoluted spectrum in which the peak at 801.4 Da is visible. B) Spectrum derived from 
deconvolution on the multiple-charged peaks shown in A).
To confirm that selectivity is correlated to the pKa of an amine, the pH-controlled, 
copper-free diazotransfer was performed on the tripeptide Lys-Phe-Phe. While the a ­
amine at the N-terminus of the tripeptide is expected to have a pKa value of 
approximately 8.0, the e-amine in the lysine side-chain will have a pKa around 9.5.25 
The diazotransfer was performed both at pH 11 in presence of Cu(II) and at pH 8.5 
without adding Cu(II). Whereas the first reaction conditions resulted in a product 
containing two azides, only one amine was converted at pH 8.5 in absence of Cu(II). 
13C NMR proved that the N-terminal amine had been diazotized.
Lysozyme was subjected to proteolytic digestion and LC- MS/MS analysis as 
well. Even though the N-terminus has the lowest pKa of all amines present in the 
protein23, it was not modified after diazotransfer at pH 8.5. This can be explained by 
the extremely low surface accessibility of the N-terminus, as can be deduced from its 
crystal structure.26 At pH 8.5 in absence of Cu(II), only limited modification of Lys13 
and Lys116 was observed. In the presence of Cu(II), there was significant conversion 
of Lys13, Lys96 and/or Lys97 (indistinguishable by LC-MS/MS), Lys116 as well as of 
the N-terminus of the protein.
5.2.4 PEGylation and activity of azide-functionalized proteins
It was demonstrated that the azides that were introduced in CalB and lysozyme were 
available for bioconjugation (see Figure 6). Polyethyleneglycol (PEG) functionalized 
with an aza-dibenzocyclooctyne27 was added to facilitate a copper-free click reaction. 
This compound was added to the model proteins after ultrafiltration with phosphate
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buffer (pH 7) to remove the excess of diazotransfer reagent and, if present, Cu(II). 
Upon overnight incubation conjugation was visualized by gel electrophoresis. The 
degree of PEGylation correlated to the number of azides that had been introduced.
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Figure 6. SDS-PAGE gel after PEGylation of (A) CalB and (B) lysozyme, after diazotransfer using 
1.75 eq of 1 in presence of Cu(II) at pH 8.5 (lane 1), pH 9.0 (lane 2) and pH 11 (lane 3), and after 
diazotransfer without Cu(II) at pH 8.5 using 1.75 eq (lane 4) or 17.5 eq (lane 5) of 1.
The activities of both diazotized CalB and lysozyme were determined. Mono- 
functionalized CalB was nearly as active as the untreated control. The small decrease in 
activity that was observed might be caused by the fact that the sample was incubated 
overnight at room temperature and washed by ultrafiltration, whereas the control was 
kept at 4 °C all the time (see Figure 7).
100 97
i  100 i r^i 
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Figure 7. Activity of untreated CalB (1), and mono-functionalized CalB reacted with 17.5 
equivalents of 1 at pH 8.5 without addition of Cu(II) (2). Relative activities towards p-nitrophenyl 
butyrate are expressed as an average for n=3 with the error bars indicating the standard deviation.
Lysozyme was significantly less active upon incubation at pH 11, especially in 
presence of Cu(II) (see Figure 8). At pH 8.5 the presence of Cu(II) was less harmful,
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but some decrease in activity was still detected due to incubation with the metal 
catalyst. These findings underline the importance of being able to introduce azide 
moieties in proteins under milder conditions. An additional reduction of activity was 
observed upon introduction of multiple azides. This effect was particularly large when 
an increasing number of azides was introduced, suggesting that under those conditions 
lysines are converted which are crucial for catalytic activity. This result indicates that 
selective modification is desired to limit loss in activity.
Figure 8. Relative activities of lysozyme after A) incubation at pH 8.5 and 11, with or without Cu(II), 
and B) in presence of 1 as well. (1) pH 8.5, no Cu(II), (2) pH 8.5, with Cu(II), (3) pH 11, no Cu(II), 
(4) pH 11, with Cu(II). Relative activities are expressed as an average for n=3 with the error bars 
indicating the standard deviation.
5.3 -  Conclusions
We show that azides can be introduced in proteins via an aqueous diazotransfer on 
amines without adding Cu(II) or any other transition metal salt. Furthermore, it is 
shown that the reaction proceeds not only at pH 11 but also at pH 8.5. The copper-free 
reaction at pH 8.5 leads to a selective diazotransfer in which only amines with the 
lowest pKa, such as the a-amine at the N-terminus, react.
The selectivity at lower pH will especially be useful when site-specific 
functionalization is desired or when lysines play a role in maintaining structure or 
activity of the protein. It is expected that for individual proteins, the exact conditions 
for site-specific modification will depend on the surface accessibility and pKa values of 
the amines in the protein.
Longer reaction times and, if possible, a slightly increased reaction temperature 
will enable the efficient introduction of azides at even lower pH. With respect to CalB, 
for example, a single azide could already be introduced at pH 8 while using 17.5
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equivalents of 1 relative to amines. Approximately 60% conversion was obtained under 
those conditions. As for lysozyme, incubation at 30 °C and 37 °C at pH 8.5 was shown 
to improve the degree of diazotation. Extension of the reaction time to 60 hours had a 
beneficial effect on the introduction of azides as well. Furthermore, reaction times of 
only a few hours instead of overnight incubation may be applied. The most reactive 
amines will be converted in a few hours, as has been observed in our laboratory for 
several peptides as well as for ELP.
Using these non-toxic and mild conditions, the diazotransfer reaction will be an 
excellent candidate for modification of proteins, which are unstable at high pH or 
inactivated by binding of Cu(II) ions. The strategy will be useful for the site-specific 
immobilization of enzymes, for example inside microchannels or onto nanostructured 
materials such as polymeric vesicles and DNA scaffolds. So far, a small number of 
relatively stable biocatalysts, like lipases and a few oxidoreductases have been used in 
these applications.28-30 For synthetic purposes it will be desirable to expand the set of 
biocatalysts that can be exploited.
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5.5 -  Experimental section
Materials
Ampicillin and chloroamphenicol were purchased from MP Biomedicals. Imidazole (>99%), 
egg-white lysozyme (>90%), para-nitrophenyl butyrate and lyophilized Micrococcus 
lysodeikticus cells were purchased from Sigma Aldrich. Sulfuryl chloride, sodium azide, IPTG 
and diethanolamine were obtained from Acros. CuSO4-5H2O and Na2CO3 were purchased from 
Merck and Baker, respectively. Ultrapure Milli-Q water (MQ) was purified using a WaterPro PS 
polisher (Labconco, Kansas City, MO) set to 18.2 Mfl/cm.
Protein mass spectrometry
Protein samples were desalted with MQ (3 times 0.5 mL) using 10 kDa MWCO centrifugal filter 
units (Millipore) and analysed by electrospray ionization time-of-flight (ESI-TOF) on a JEOL
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AccuTOF. 5-10 ^M protein in formic acid (0.1-1 %) was injected. Deconvoluted spectra were 
obtained using MagTran 1.03b2. Isotopically averaged molecular weights were calculated using 
the “Protein Calculator v3.3” at http://www.scripps.edu/~cdputnam/protcalc.html.
Production of CalB
The pET22b-calb plasmid has been described previously (see Chapter 2) The recombinant CalB 
that is produced has the following amino acid sequence:
MGLPSGSDPAFSQPKSVLDAGLTCQGASPSSVSKPILLVPGTGTTGPQSFDSNWIPLSAQL 
GYTPCWISPPPFMLNDTQVNTEYMVNAITTLYAGSGNNKLPVLTWSQGGLVAQWGLTF 
FPSIRSKVDRLMAFAPDYKGTVLAGPLDALAVSAPSVWQQTTGSALTTALRNAGGLTQI 
VPTTNLYSATDEIVQPQVSNSPLDSSYLFNGKNVQAQAVCGPLFVIDHAGSLTSQFSYVV 
GRSALRSTTGQARSADYGITDCNPLPANDLTPEQKVAAAALLAPAAAAIVAGPKQNCEP 
DLMPYARPFAVGKRT C S GIVTPLEHHHHHH
50 mL 2xYT medium supplemented with ampicillin (100 mg/L) and chloroamphenicol (50 
mg/L) was inoculated with a single colony o f E. coli strain B834(DE3)pLysS (Novagen) 
containing pET22b-calb, and incubated overnight at 37 °C. The culture was diluted in 1 L 2x YT 
medium to an OD600 o f 0.1 and grown at 37 °C. When an OD600 o f 0.6-0.7 was reached, 
isopropyl-P-D-thiogalactopyranoside (IPTG) was added to a final concentration o f 1 mM. Protein 
production was allowed to take place for 20 hours at 25 °C. Purification was performed via N i2+ 
NTA affinity chromatography followed by size-exclusion chromatography as described before 
(see Chapter 2). Protein concentration was determined by measuring the absorbance at 280 nm 
on a NanoDrop ND-1000 spectrometer (Thermo Scientific). The yield was 3.5 mg o f purified 
protein from a 1 L bacteria culture. Purity was confirmed by SDS-PAGE. ESI-TOF: CalB 
calculated 34269.7, found 34269.0.
Production of ELP
The construction o f plasmids pET15b-ELP-lys1[V5L2G3-90] and pET15b-ELP-lys3[V5L2G3-90] 
has been described before.22 Amino acid sequences o f the produced ELPs are as follows:
ELP-lys1: MGSSHHHHHHSSGLVPRGSHMLEKREAEAGP
(VPGGGVPGVGVPGVGVPGGGVPGLGVPGVGVPGVGVPGVGVPGGGVPGLG)9
VPGGGA
ELP-lys3: MGS SHHHHHHSSGLVPRGSHMLEKREAEAKKGP
(VPGGGVPGVGVPGVGVPGGGVPGLGVPGVGVPGVGVPGVGVPGGGVPGLG)9
VPGGGA
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Both ELPs were expressed in the E. coli strain BLR(DE3)pLysS (Novagen) and purified via 
inverse transition cycling22, yielding 5 mg o f purified protein per litre culture. Protein 
concentrations were determined by BCA assay (Pierce). Purity was confirmed by SDS-PAGE. 
ESI-TOF: ELP-lys1 calculated 39670.9, found 39671.7; ELP-lys3 calculated 39927.2, found 
39929.9.
Synthesis of imidazole-1-sulfonyl azide hydrochloride
O Imidazole-1-sulfonyl azide hydrochloride was synthesized as described by
Goddard-Borger e t al.12 Sulfuryl chloride (4.0 mL, 50 mmol) was added
O dropwise to an ice-cooled suspension o f NaN3 (3.3 g, 50 mmol) in MeCN
(50 mL) and the mixture was stirred overnight, allowing it to warm up to room temperature. 
Then the mixture was recooled on ice and imidazole (6.5 g, 95 mmol) was added portion-wise. 
After the addition, the reaction mixture was stirred for 3h while the temperature was allowed to 
warm up to room temperature. Subsequently, the mixture was diluted with EtOAc (100 mL), 
washed twice with MilliQ water (2x 100 mL) and twice with saturated NaHCO3 (2x 100 mL) and 
then dried over MgSO4. Then the HCl salt was formed via dropwise addition o f 4M HCl in 
EtOAc (40 mL) to the ice-cooled mixture. The resulting precipitate was filtered and washed with 
EtOAc (3x50 mL) to obtain imidazole-1-sulfonyl azide hydrochloride in a yield o f 59%. LRMS: 
(m/z) [M-Cl]+ calculated for C3H3N 5O2S 174.0, found: 173.9. ‘H-NMR (400 MHz, D2O): S 7.57 
(s, 1H) S7.99 (s, 1H) S9.22 (s, 1H).
It should be noted that diazotransfer reagent 1  is shelf stable, but should not be kept as a 
concentrated aqueous solution for prolonged time due to risk o f decomposition.
Tryptic digest mass analysis
1 ^g trypsin (Promega, mass spectrometry grade) was added to approximately 40 ^g CalB in 30 
^L 10 mM NH4HCO3. Upon incubation overnight at 37 °C, the tryptic digestion was quenched 
by adding 0.25 % formic acid and the digest was analyzed by ESI-TOF. The sequence o f the N- 
terminal fragment with residue numbers 1-15 is MGLPSGSDPAFSQPK. In control experiments 
in which multiple azides were introduced, no cleavage was observed at diazotized lysine 15. 
When tryptic digestion resulted in the formation o f the N  terminal 15-mer and an azide was 
introduced in this fragment, the a-amine at the N-terminus o f this fragment had to be converted. 
Tryptic digest analysis o f  the ELPs, was performed by adding 0.5 ^g trypsin to 7 ^g ELP in 12 
^L 20 mM NH4HCO3. After 5 hours o f incubation at 37 °C the samples were purified using 
ZipTip-C18 (Millipore) and eluted in 20 ^L 75 % acetonitrile in 0.1 % trifluoroacetic acid / MQ. 
The lysine with residue number 23 is present in both ELP-lys1 and ELP-lys3.
Protein digestion for LC-MS/MS
Prior to mass spectrometry analysis, 5 ^g o f CalB and o f Lysozyme was reduced with 1,4- 
dithiothreitol (6mM), alkylated with iodoacetamide (12mM) and digested at with trypsin,
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chymotrypsin or Lys-N24 (each 1:50 protein/enzyme ratio) in ammonium bicarbonate 50mM at 
37 °C for 16 hours. Samples were acidified to a concentration o f 10% formic acid and analyzed 
by LC-MS/MS.
Nano LC-MS/MS
All LC-MS/MS analyses were performed on a nanoLC LTQ-Orbitrap (Thermo, San Jose, CA) 
mass spectrometer at a resolution o f 60,000 at 400 m/z. For nanoLC, an Agilent 1200 series LC 
system was equipped with a 25 mm Aqua C18 (Phenomenex, Torrance, CA) trapping column 
(packed in-house, i.d., 100 ^m; resin, 5 ^m) and 400 mm ReproSil-Pur C18-AQ (Dr. Maisch 
GmbH, Ammerbuch, Germany) analytical column (packed in-house, i.d., 50 ^m; resin, 3 ^m). 
Solvents used were 0.6% HOAc (buffer A) and 0.6% HOAc/80% acetonitrile (ACN) (buffer B). 
Trapping was performed at 5 ^L/min for 10 min, and elution was achieved with a gradient o f 13­
32% B in 30 minutes, 32-40% B in 5 minutes, 40-100% B in 2 minutes and 100%B for 2 
minutes. The flow rate was passively split from 0.6 mL/min to 100 nL/min. Nanospray was 
achieved using in-house made distally coated fused silica emitters (o.d., 375 ^m; i.d., 20 ^m) 
biased to 1.8 kV. The mass spectrometer was operated in the data dependent mode to 
automatically switch between MS and MS/MS. Survey full scan MS spectra were acquired from 
m/z 350 to m/z 1500 and the five most intense ions were fragmented in the linear ion trap using 
collisionally induced dissociation. The target ion setting was 5e5 for the Orbitrap, with a 
maximum fill time o f 250 ms. Fragment ion spectra were acquired in the LTQ with a target ion 
setting o f 1e4 and a maximum fill time o f 100 ms. Dynamic exclusion for selected precursor ions 
was set at 30 seconds.
LC-MS/MS Data Processing and Analysis
Raw MS data were converted to peak lists using Proteome Discoverer (v1.2). For protein 
identification, MS/MS data were searched against a custom database containing the CalB and 
lysozyme sequences, as well as known contaminant and background proteins, using Mascot v2.2 
(Matrix Science) with the appropriate enzyme, allowing up to 2 miss cleavages, a precursor 
tolerance o f  15 ppm, and a product ion tolerance o f 0.5 Da. Carbamidomethylation o f cysteine 
was set as a fixed modification and oxidation o f methinione, deamidation o f asparagines and 
glutamine as well as azide moieties on lysines and protein n-termini were included as variable 
modifications. Peptide identifications were accepted with a minimum Mascot score o f 25 and an 
expect value o f <0.05, corresponding to an estimated false discovery rate (FDR) o f around 1%, 
as determined by decoy database searching. All identification results are available for download 
in a Scaffold 3 file that may be downloaded from ProteomeCommons.org Tranche, 
https://proteomecommons.org/tranche/, using the following hash:
8x0MlGHIq9zIOOC3T9PTbkerc227XqNgyYDQFVHkVnaVRA/2+a2rpeHdzPrTC+6vRIqUfE
MNRpfeTjehz/8qpTJwdKkAAAAAAAADEA==
The viewer is downloadable from http://www.proteomesoftware.com.
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Synthesis of lysyl-phenylalanyl-phenylalanine (KFF)
The tripeptide lysyl-phenylalanyl-phenylalanine (KFF) was synthesized using standard Fmoc 
solid-phase peptide synthesis. Cleavage from the resin and removal o f the protecting group on 
the lysine side-chain was achieved by incubation in trifluoroacetic acid. A white powder was 
obtained upon lyophilization. Purity was confirmed by HPLC. LRMS: (m/z) [M+H]+ calcd for 
C24H32N 4O4 441.2, found: 441.6. 13C NMR (300 MHz, D2O) 6 171.3, 168.5, 136.4, 135.6,
135.7, 128.8, 128.6, 128.3, 128.1, 126.8, 126.5, 54.5, 52 .2 , 38 .5 , 36 .6 , 29.9, 25.8, 
2 0 .6 .
Diazotransfer to KFF
25 mg o f KFF (57 ^mol) was dissolved in 5 mL MQ or 30 mM diethanol amine (pH 8.5). 28.5 
mg o f diazotransfer reagent 1 (136 ^mol) was dissolved in 136 ^L 1 M NaOH. This solution was 
then added to the tripeptide. The reaction in MQ was supplemented with 1.6 mg Na2CO3 and
1.25 mg CuSO4-5H2O. The reactions were stirred overnight at room temperature and lyophilized 
afterwards. The reactions were purified upon solvation in 2 mL MQ by high-performance liquid 
chromatography (HPLC) over a C18 column using a linear gradient from 5% acetonitrile in 
MQ/0.1% trifluoroacetic acid to 0.1% trifluoroacetic acid in acetonitrile. Peak fractions were 
analyzed by mass spectrometry. LRMS (m/z) [M+H]+ calcd for C24H32N 4O4 441.2, found: 441.5; 
(m/z) [M+H]+ calcd for C24H30N 6O4 467.2, found: 467.5; (m/z) [M+H]+ calcd for C24H28N 8O4
493.2, found: 493.4. Fractions o f interest were pooled. Acetonitrile was evaporated under 
vacuum and water was removed by lyophilization. C24H30N 6O4 (product in the reaction 
performed at pH 8.5): 13C NMR (300 MHz, D2O) 6 173.8, 171.7, 136.0, 135.7, 128.8,
128.7, 128.2, 128.2, 126.6, 126.6, 62.2, 54.0, 53.5, 38 .6 , 36 .5 , 36 .3 , 30 .1 , 25.8, 20.8; 
C24H28N 8O4 (product in the reaction performed at pH 11): 13C NMR (300 MHz, CD3CN/D2O 
3:1) 6 172.6, 170.8, 169.7, 136.4, 128.9, 128.8, 128.0, 127.9, 126.4, 126.3, 62.2, 53 .5 ,
53.2, 50.3, 36 .6 , 36 .3 , 30 .3 , 27.4, 21.5.
Click reaction and SDS-page analysis
20 equivalents o f aza-dibenzocyclooctyne functionalized PEG2000 (1 mM in MQ)27 were added 
to 6 ^g o f diazotized protein. Samples were incubated overnight at room temperature while 
gently shaken. The next day sample buffer was added, samples were incubated at 95 °C for 5 
minutes and loaded on a 12% (w/v) polyacrylamide gel followed by Coomassie Brilliant Blue 
staining. The Precision Plus Dual Color Protein standard (Biorad) was used as marker.
Activity of CalB and lysozyme
The activities o f both CalB and lysozyme were determined after treatment with 1. Upon 
ultrafiltration using MQ, the CalB solution was diluted to 1 ^M by adding an aqueous solution 
containing 50 mM NaH2PO4, 150 mM NaCl (pH 7.0). Hydrolysis o f para-nitrophenyl butyrate
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was followed by measuring absorbance at 405 nm as reported elsewhere.6 The initial slope was 
taken as a measure for activity.
Lysozyme activity was determined by following lysis o f lyophilized Micrococcus lysodeikticus 
cells. A bacterial suspension was prepared containing 0.074 mg/mL cells in 66 mM phosphate 
buffer (pH 7.0), resulting in an A 405 between 0.5-0.75. 5 ^g lysozyme was added to 3 mL 
bacterial suspension and the decrease in absorption at 450 nm was followed for 3 minutes at 25 
°C using a 10 mm cuvette. The slope was taken as a measure o f activity.
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Towards the production of a hybrid catalyst
Chapter 6
Since decades both hom ogeneous and enzym atic catalysis have been applied for the 
synthesis o f  enantiopure com pounds. W hile m etal-m ediated processes are know n for 
their broad reaction scope, biocatalytic transformations are distinguished for their 
excellent selectivity and efficiency. These characteristics have inspired researchers to 
com bine the best o f  both fields.
H om ogeneous catalysts and enzym es have been added separately to the same 
reaction mixture. The major application o f  these system s is dynamic kinetic resolution  
(DK R). Traditional kinetic resolution (K R ) is the process in w hich a racem ic mixture is 
separated by selective chem ical conversion o f  one o f  the tw o enantiomers. In DKR, in 
situ  racem ization o f  the less reactive enantiomer takes p lace, allow ing for a 100% 
theoretical y ie ld  o f  the desired isomer. Several racem ization processes are known, 
among w hich  are acid/base-catalyzed racem ization, Sch iff base-m ediated racem ization, 
and racem ization v ia  sp2 interm ediates.1 A s pointed out by Stürmer, transition m etals 
can be used in D K R  as w e ll .2 C hem oenzym atic D K R , in w hich enzym atic K R  is 
com bined w ith an in s itu  m etal-based racem ization process, has been applied for a 
variety o f  com pounds among w hich are allylic acetates, allylic alcohols and secondary 
alcohols (see Schem e 1).3-5 Bäckvall and colleagues have discussed recent advances in 
several rev iew s .6-8
E nzym es and m etal catalysts have been com bined in reactions other than D K R  as 
w ell. M akkee e t  al. developed a one-pot tw o-step reaction for the conversion o f  glucose 
in m annitol.9 A n isom erase w as used for the conversion o f  glucose into fructose, w hile  
a copper catalyst w as applied for hydrogenation o f  fructose into mannitol (see Schem e 
2A ). Another exam ple is the com bination o f  a palladium -catalyzed cross-coupling with  
an asym metric, enzym atic reduction, as reported by Gröger and co lleagu es .10 Chiral 
biaryl alcohols w ere produced in aqueous m edium  w ith h igh  conversion and excellent 
enantioselectivity (see Schem e 2B). Caiazzo and coworkers describe the successful 
com bination o f  a lipase-catalyzed amidation w ith a Pd-catalyzed coupling reaction. 
Surprisingly, the b io- and chem o-catalyzed processes show ed synergistic behaviour.11
B esides o f  (sim ply) adding both a metal-catalyst and enzym e to the sam e reaction 
mixture, researchers have aimed at linking transition-metal com plexes to proteins, thus 
creating ‘artificial m etalloenzym es’.12, 13 The first exam ple o f  such a hybrid catalyst has 
been described by W hitesides e t a l .14 B iotin w as functionalized w ith a chelating  
diphosphine and com plexed w ith rhodium(I). The strong interaction o f  biotin w ith the
6.1 -  Introduction
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protein avidin enabled the creation o f  a m etalloenzym e capable o f  perform ing an 
asymmetric hydrogenation reaction in aqueous solution. The protein provided a w ell- 
defined steric environm ent around the m etal and thus induced selectivity o f  the 
reaction.
Scheme 1. Chemoenzymatic dynamic kinetic resolution of A) allylic acetates, B) allylic alcohols, 
and C) secondary alcohols. CalB is used for enantioselective transesterification using different 
metal catalysts for racemization and varying compounds as acyl acceptor or acyl donor.
Scheme 2. The combination of enzymes and metal catalysts in applications other than DKR. A) 
Synthesis of mannitol by the combined action of isomerase and a copper catalyst. B) Synthesis of 
chiral biaryl alcohols via a Pd-catalyzed cross-coupling followed by enzymatic reduction using 
alcohol dehydrogenase (ADH) and nicotinamide adenine dinucleotide (NADH) as cofactor.
Ward and others have optim ized this approach o f  supramolecular anchoring, 
w hich is based on the biotin-avidin technology. A s for the reduction o f
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acetam idoacrylic acid, an increase in enantioselectivity w as for exam ple established by 
creating a mutant o f  streptavidin and adjusting hydrogen pressure.15 A s an alternative to 
the biotin-avidin m ethodology, Harada e t  al. generated m onoclonal antibodies against 
an achiral rhodium com plex. U sing these com plexes, the catalytic hydrogenation o f  2- 
acetoam idoacrylic acid resulted in production o f  A -acetyl-L-alanine in high  
enantiomeric ex ce ss .16 A n up-to-date overview  o f  these and other artificial 
m etalloenzym es and their catalytic scope is provided by several review s such as the 
ones by Ward e t  a l } 3’ 17 and Rosati and R oelfes18.
In addition to supramolecular anchoring, artificial m etalloenzym es have been  
produced via covalent interactions. It is mainly the nucleophilic side-chain o f  cysteine  
w hich has been exploited. The protease papain contains a single free cysteine to w hich  
for exam ple a M n-salen com plex (see Schem e 3A ) or Rh-phosphine com plex w as  
coupled. Unfortunately, no high enantioselectivity w as achieved w ith these hybrid 
catalysts.19
Scheme 3. Covalent anchoring of a transition-metal complex to proteins via a maleimide-cysteine 
coupling as studied by Reetz et a/.19, 20 A) Mn-salen complex linked to papain was applied in an 
epoxidation reaction. B) A mutant of imidazole glycerol phosphate synthase tHisF was prepared to 
enable linkage of a Pd(II) complex.
In addition, R eetz e t al. developed a platform using the thermostable enzym e  
tHisF, the synthase subunit o f  im idazole glycerol phosphate synthase, as protein host. 
A  cysteine w as introduced at the “catalytic face” o f  the enzym e for conjugation o f  a 
Pd(II) com plex (see Schem e 3B ).20 A lthough bioconjugation o f  several ligands and 
ligand/m etal entities w as achieved, no results regarding the activity o f  the hybrid 
catalysts w ere presented. H ow ever, the system  w as considered to be a technological
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platform for future directed evolution studies to obtain enantioselective hybrid 
catalysts.
A n alternative strategy has been described by Van K oten e t al. A  phosphonate 
inhibitor o f  cutinase is used as anchor to im m obilize a m etal com plex in the en zym e’s 
active site (see Schem e 4A ).21 M etallopincer com plexes w ere used w hich are know n  
for their exceptionally stable m etal-carbon bond. A nchoring o f  the metal com plex  
could be fo llow ed  spectrometrically due to release o f  the para-nitrophenolate anion and 
sim ultaneously occurring enzym e inactivation. Furthermore, the cutinase hybrids were 
analysed by m ass spectrometry. A ctivity studies have not been reported so far.
A s a last exam ple, Kamer and colleagues recently reported the cysteine-m ediated  
conjugation o f  a Pd-phosphine com plex to photoactive yellow  protein (PYP, see  
Schem e 4B ).22 Coupling o f  the palladium com plex w as proven by m ass spectrometry, 
w hile it w as confirm ed by 31P N M R  that palladium  had remained coordinated to the 
phosphine ligand. N o enantioselectivity w as observed in an asym metric allylic  
amination that w as performed using the PYP-based hybrid metalloprotein. H ow ever, 
this may be due to that fact that the reaction w as perform ed in 50% DM F leading to 
denaturation o f  the protein.
A
Scheme 4. Additional examples of the production of artificial metalloenzymes by covalent linkage 
of transition-metal complexes to proteins. A) Immobilization of a metal complex in the active site of 
cutinase.21 B) Cysteine-mediated conjugation of a Pd-phosphine complex to photoactive yellow 
protein (PYP).22
In the abovem entioned studies in w hich  an enzym e w as used  as a chiral carrier, 
the endogenous biocatalytic activity w as either destroyed or not exploited. This 
limitation inspired us to investigate the linkage o f  a transition m etal ligand to azide- 
functionalized CalB. U pon com plexation o f  a m etal ion, a hybrid system  w ould be  
created containing tw o catalytic sites. By using the appropriate CalB mutant, the metal-
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chelating m oiety w ould be introduced in close proxim ity o f  the en zym e’s catalytic 
cleft. N ot only w ould w e be able to perform a m ulti-step reaction in one pot (in analogy 
to for exam ple B ackvall’s and C aiazzo’s work), the protein environm ent m ight also 
induce enantioselectivity on the m etal catalyst (as achieved by several artificial 
m etalloenzym es). This chapter describes the conjugation o f  tw o different transition 
m etal ligands to CalB, being propynyl phosphine 1 and dibenzoazacyclooctyne- 
functionalized pincer ligand 2 (see Schem e 5).
Scheme 5. Covalent linkage of a transition metal ligand near the active site of CalB using the azide 
moiety as functional handle. Aim is to retain enzyme activity while a novel metal-catalytic activity is 
introduced as well. A) Cu(I)-catalyzed coupling of a phosphine ligand. B) Coupling of an 
organometallic pincer ligand via the strain-promoted azide-alkyne cycloaddition.
6.2 -  Results and discussion
6.2.1 Linkage of propynyl phosphine via the Cu(I)-catalyzed ‘click’ 
reaction
D etz and coworkers describe the preparation o f  a series o f  P ,N  ligands using click  
chemistry. They show  that the Cu(I)-catalyzed reaction betw een propynyl phosphine  
and different azide derivatives resulted in so-called Clickphine ligands that could be 
applied in various catalytic transformations.23 Supported ligands w ere prepared by 
conjugation o f  propynyl phosphine to azide-functionalized dendrimers or polystyrene
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resin. W e envisioned that the propynyl phosphine w ould be a useful candidate for 
conjugation to azide-functionalized CalB.
A s described in Chapter 4, CalB mutants w ere produced, that contain either an 
accessible azide in the proxim ity o f  the active site or no accessib le azide at all. Two o f  
these mutants, 147CalB and M G -CalB, w ere incubated w ith 50 eq. propynyl phosphine
1 (10 m M  stock in THF, see Figure 1) in presence o f  CuSO4, sodium  ascorbate and a 
tristriazole ligand. U pon overnight incubation at room  temperature the reaction  
mixtures w ere desalted by ultrafiltration using MQ (5 tim es 0.5 mL). The desalted and 
concentrated sam ples w ere diluted in M Q/0.1%  form ic acid to a final concentration o f
10 ^M and analysed by ESI-TOF m ass spectrometry. A s can be seen in Figure 1A, the 
m ass chromatogram o f  147CalB show ed tw o peaks w ith a difference in m ass o f  238  
Da. This corresponds to the m ass o f  boronated propynyl phosphine, indicating that 
147CalB had partly reacted w ith the phosphine ligand. A s expected M G -CalB had 
remained unreacted (see Figure 1B).
Figure 1. Linkage of phosphine ligand 1 to CalB analysed by ESI-TOF MS. A) 147CalB, partially 
reacted; B) MG-CalB, unreacted.
It w as tried to im prove the conjugation o f  1 to 147CalB. A  freshly prepared so- 
called ‘c lick ’ m ix, containing Cu2SO4, ascorbate and a Cu(I) ligand, w as added after 
one day allow ing the reaction to take p lace for an additional 16 hrs. E ven though the 
signal-to-noise ratio w as rather low , tw o peaks could be distinghuised (see Figure 2A). 
The m ass difference betw een these peaks w as 274.5  Da. A s the intensity o f  the second  
peak w as higher, it seem ed that by adding extra ‘click m ix ’ the amount o f  conjugated  
product had increased.
H ow ever, longer reaction tim e had led to truncation o f  the protein as w ell. 
Furthermore, it seem ed that in addition to linkage o f  phosphine 1 som e oxidation
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and/or other m odifications had occurred. Remarkably, the signal for M G -CalB w as  
m uch better than the signal obtained from 147CalB (see Figure 2B). In addition, M G- 
CalB protein w as not truncated. A s both protein variants w ere treated in the sam e w ay, 
this result suggests that M G -CalB is more stable than 147CalB.
33000 33500 34000 34500 35000 35500 33000 33500 34000 34500 35000 35500
Mass / Da Mass / Da
Figure 2. Attempts to improve the conjugation efficiency of phosphine ligand 1 to CalB by longer 
incubation, analysed by ESI-TOF MS. A) 147AHACalB, truncated but probably functionalized; B) 
MG-CalB, unreacted.
In a single attempt to perform a Pd-catalyzed reaction using Clickphine-CalB as 
ligand, the conjugation reaction w as repeated using w ildtype CalB, w hich  contains an 
accessible azide at the N-term inus (see Chapter 3). A fter rem oval o f  excess o f  1 and 
‘click m ix ’ by ultrafiltration the phosphine ligand w as deprotected by adding D A B C O  
in degassed MQ. The reaction w as kept under Ar as much as possib le to prevent 
oxidation o f  the phosphine. D A B C O  w as rem oved by ultrafiltration and the protein was 
lyophilized. Deprotection w as not verified. Instead, the protein-phosphine conjugate 
w as im m ediately used in a test reaction, i. e. the Pd-catalyzed allylic alkylation o f  
biphenyl v iny l acetate (see Schem e 6).
Scheme 6. Allylic alkylation of diphenyl vinyl acetate to test activity of the catalyst.
Deprotected CalB-1 conjugate w as m ixed w ith [PdallylCl]2 fo llow ed  by addition  
o f  substrates. The final reaction m ix contained 0.1%  catalyst relative to diphenyl vinyl
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acetate. A s a control the reaction w as performed using 0.1% Pd-PPh3. U pon incubation  
at room  temperature for 2 days the reaction w as analysed by HPLC (Jeroen W assenaar, 
Department o f  H om ogeneous Catalysis, U niversity o f  Amsterdam ). N o conversion w as  
detected, even not in the control.
The test reaction w ith Pd-PPh3 w as repeated using 1% instead o f  0.1% catalyst 
(see Table 1). A lternatively, the reaction w as performed at a 10-fold bigger scale (5 mL 
THF). Cinnamyl acetate and diethylm ethyl m alonate w ere used as substrates. Still no  
conversion took place according to GC-M S. U sing  1% catalyst in 5 mL THF and 
heating at 40 °C did not help either. A s know n from  literature the reaction should work  
with 1% o f  catalyst. Therefore, it w ould  have been w orthw hile to study the reaction 
conditions w e had used sofar in more detail. H ow ever, it w as decided to first im prove 
the form ation o f  the hybrid catalyst.
Table 1. Reaction conditions tested in the Pd-catalyzed allylic alkylation at small scale.
E ntry  C ata lyst (% ) Su bstrate V  (m L ) T (°C ) C onversion
1 Pd-1-C alB  (<0.1) diphenyl v iny l aceatate 0.5 21 n.d
2 Pd-PPh3 (0.1) diphenyl v iny l aceatate 0.5 21 n.d
3 Pd-PPh3 (1) cinnam yl acetate 0.5 21 n.d
4 Pd-PPh3 (0.1) cinnam yl acetate 5 21 n.d
5 Pd-PPh3 (1) cinnam yl acetate 5 40 n.d
6.2.2 Linkage of a pincer ligand via the copper-free ‘click’ reaction
To m axim ize the degree o f  conjugation, w e  decided to use the d ibenzo-azacyclooctyne  
m oiety for linkage o f  the transition m etal ligand. It is know n that the strain-promoted  
click reaction requires no Cu(I)-catalyst and proceeds m uch faster and m ore efficiently  
than the Cu(I)-catalyzed reaction using the alkynyl m oiety.
The so-called pincer ligand w as chosen for this alternative approach. This kind o f  
ligand has been used before in com bination w ith biocatalysts as described by Van 
Koten e t  a ! 21 It w as decided to exploit an N C N -pincer Pd com plex, w hich is know n for 
its h igh stability. Synthesis o f  a para-substituted variant o f  this ligand w as performed 
as depicted in Schem e 7, based on literature procedures.24
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Scheme 7. Synthesis of the amine-functionalized pincer ligand 6.
The amine w as used to introduce the d ibenzoazacyclooctyne m oiety. H ow ever, 
direct linkage o f  the dibenzoazacyclooctyne 10 (see Schem e 8) to the aryl amine w as  
unsuccessful. By coupling a short spacer to the pincer ligand an aliphatic amine was 
introduced w hich  facilitated the form ation o f  the dibenzoazacyclooctyne-functionalized  
pincer ligand 2. The com pound w as obtained not entirely pure, as som e DM F and 
probably also som e triethylam ine had remained. N evertheless, it w as used for 
conjugation to azide-functionalized 147CalB.
Approxim ately 5 equivalents o f  2 in D M SO  w ere added to 147CalB in phosphate 
buffer. The reaction w as incubated overnight at room  temperature fo llow ed  by 
ultrafiltration w ith MQ. M ass analysis confirm ed that the pincer ligand had 
successfully  been linked to the enzym e (Figure 3). A  m ass shift o f  692 D a w as  
observed w hile ligand 2 has a m ass o f  657 Da. Probably, a chloride ion was 
coordinated to the ligand. N ot only proceeded the conjugation quantitatively, CalB w as  
also still active as indicated by the form ation o f  p-nitrophenol upon addition o f  p -  
nitrophenyl butyrate to the desalted enzym e fraction (data not shown).
Com plexation o f  Pd to the pincer ligand-CalB conjugate w as attempted by 
overnight incubation in toluene or M Q  fo llow ed  by addition o f  THF for one hour. 
Unfortunately, both trials did not result in Pd being coordinated to the ligand as verified  
by ESI-TOF. C om plexation o f  Pd to the ligand before linkage to CalB turned out to be 
im possible. A s observed by N M R , the m etal com plex w as reactive towards the 
dibenzoazacyclooctyne (data not shown).
120
Towards the production of a hybrid catalyst
Scheme S. Functionalization of pincer ligand S with dibenzoazacyclooctyne via the introduction of 
an aliphatic amine followed by an NHS-amine coupling.
Figure 3. Conjugation of pincer-type ligand 2 to azido-functionalized 147CalB analysed by ESI- 
TOF MS. A) no ligand, B) 5 equivalents ligand.
S.3 -  Conclusions
In conclusion, tw o different transition-metal ligands have successfully  been coupled  
near the active site o f  CalB. W hereas the Cu(I)-catalyzed conjugation o f  an alkynyl 
phosphine ligand only proceeded to moderate extent, linkage via  the
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dibenzoazacyclooctyne m oiety w as quantitative. This latter achievem ent is o f  great 
importance in the preparation o f  a biohybrid m etal-enzym e catalyst, as separation o f  
non-functionalized enzym e from  the ligand-enzym e conjugate w ill be very laborious, if  
not im possible.
Unfortunately, insertion o f  Pd(II) in the pincer ligand has not been achieved yet. It 
w as show n that the highly-activated triple bond in 2 reacted w ith the in s itu  form ed  
Pd(II) com plex, w hich  made it im possible to introduce the m etal species before  
conjugation to the enzym e. It may be w orthwhile, how ever, to study the com plexation  
o f  Pd after coupling o f  the ligand to CalB in more detail. Sofar, it has only been  
attempted in tw o test reactions.
A lternatively, a m etal catalyst may be selected w hich  is not reactive towards the 
alkyne m oiety. One could think o f  a M n-porphyrin com plex w hich can be used in 
epoxidation reactions. Changing the m etal ligand w ill be relatively straightforward as 
the amine reactive D IB A C  10 is available.
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6.5 -  Experimental section
M aterials and gen era l rem arks
Unless stated otherwise, all reactions were performed under ambient atmosphere and temperature 
and with chemicals obtained from commercial source, used without further purification. 
Purification by column chromatography was carried out using Silicycle silica gel (0.040 - 0.063 
mm, and ca. 6 nm pore diameter). Propynyl phosphine 1 was synthesized by Remko Detz 
(Department o f  Homogeneous Catalysis, University o f Amsterdam). The amino acid sequences 
o f 147CalB and MGCalB are described in Chapter 4. These CalB mutants were expressed and 
purified as described in Chapter 2. Dibenzoazacyclooctyne-functionalized pincer ligand 2 was 
synthesized by Nanda Smits and Marjoke Debets. NMR spectra were recorded on a Varian Inova 
400 (400 MHz for 'H) and a Bruker DMX 300 (75 MHz for 13C). High-resolution mass analyses
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were performed using electrospray ionization on a JEOL AccuTOF. GC-MS was conducted on a 
Thermo Finnigan PolarisQ using a capillary column (Varian FactorFour™, 30m x 0.25 mm i.d.)
C u(I)-catalyzed c lick  reaction  b etw een  CalB and  a lk yne-functionalized  p h o sp h in e  
ligand 1
A fresh stock solution o f CuSO4 (20 mM) and sodium ascorbate (25 mM) in MQ was prepared 
and premixed in a 1:1 ratio with a 40 mM stock solution o f tristriazole ligand in MeCN. This 
mixture will be referred to as ‘click mix’. A 10 mM solution o f 1 in THF was prepared as well. 
50 equivalents o f Cu(I) and 50 equivalents o f 1 were added to 45 ^g o f 147(AHA)CalB or 
MG(AHA)CalB in buffer containing 50 mM NaH2PO4, 150 mM NaCl (pH 7.0). The reaction 
mixture, containing 10% THF, was incubated overnight at room temperature while gently 
shaken. It should be noted that some white precipitate was formed upon addition o f 1 to the 
protein. A smaller amount o f precipitate appeared when 1 was added to a buffered solution 
without protein, indicating that solubility o f  the ligand was part o f the problem. ‘Click mix’ and 1 
were removed by ultrafiltration using a 10 kDa MWCO centrifugal filter unit (Millipore). The 
product was analyzed by electro-spray ionization time-of-flight (ESI-TOF) on a JEOL AccuTOF. 
10 ^M o f protein in Milli-Q/formic acid (0.1-1 %) was injected. Deconvoluted spectra were 
obtained using Magtran software. Alternatively, a fresh solution o f ‘click mix’ and 1 were added 
followed by incubation at room temperature for an additional 16 hours. When the CalB-1 
conjugate was to be tested for its ability to catalyze an allylic substitution, 340 ^g wt(AHA)CalB 
(10 nmol) was used.
D eprotection  o f  p h o sp h in e  ligand 1 con ju g a ted  to  CalB
CuSO4, ascorbate, tristriazole ligand and excess o f  1 were removed from the CalB-1 conjugate 
by ultrafiltration using degassed Milli-Q. While flushing the solution with Ar, 10 ^L o f a 10 mM 
stock solution o f 1,4-diazabicyclo[2.2.2]octane (DABCO) was added to the conjugate in 200 ^L 
degassed Milli-Q. The solution was shaken overnight at room temperature in a closed vial filled 
with Ar and lyophilized the next day.
P d-cata lyzed  ally lic su b stitu tio n  u sin g  CalB-1 or P Ph3 a s  ligand
Stock solutions in dry THF were prepared o f [PdallylCl]2, PPh3 and diphenyl vinyl acetate. To 
~10 nmol lyophilized, deprotected CalB-1 conjugate, 0.5 mL dry THF was added followed by 
addition o f 0.4 equivalents o f [PdallylCl]2 under Ar atmosphere. Alternatively, 10 or 100 nmol 
PPh3 and 4 or 40 nmol [PdallylCl]2 were added to 0.5 mL (or 5 mL) THF. The mixtures were 
shaken for 30 minutes at room temperature to allow complexation o f Pd to take place. Then, 10 
^mol diphenyl vinyl acetate (or cinnamyl acetate) was added. The sample was shaken for 5 
minutes before 30 ^mol dimethyl malonate (or diethylmethyl malonate) and 30 ^mol N,O- 
bis(trimethylsilyl) acetamide were added as well. Reaction mixtures were incubated at room 
temperature (or 40 °C) for two days and analysed by HPLC or GC-MS.
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Br Br Br 2-Bromo-1,3-bis(bromomethyl)benzene 3
According to a modified literature procedure25, 2-bromo-1,3-dimethylbenzene 
(0.56 g, 3 mmol) was dissolved in CCl4 (10 mL) together with 
azobisisobutyronitrile (25 mg, 0.15 mmol) and N-bromosuccinimide (1.07 g, 6 
mmol) and refluxed under argon atmosphere. The conversion was checked with GC and after 1 
day the mixture was filtered over Celite with CH2Cl2 and concentrated in vacuo. The crude 
product was purified using column chromatograpy («-heptane 100%), to obtain the product as a 
colorless crystalline material in 39.5% yield. *H -NMR (300 MHz, CDCl3) S: 7.41 (m, 2H), 7.29 
(m, 1H), 4.64 (s, 4H).
S ynthesis o f d ibenzoazacyclooctyne-functiona lized p incer ligand 10
■v. y  1,1'-(2-Bromo-1,3-phenylene)bis(N,N-dimethylmethanamine) 4
N Br N
Compound 3 (0.34 gram, 1mmol) was dissolved in toluene (20 mL) under 
nitrogen atmosphere. A solution o f dimethylamine (5 mL, 10 mmol) in 
toluene was then added, following literature procedure26. This mixture was 
kept at 5°C and after one hour it was stirred for 2 h at the same temperature. The reaction was 
filtered over Celite and the filtrate was concentrated in vacuo. The crude product was purified 
using column chromatograpy (EtOAc/Net3 200:1), obtaining the product as a yellow oil in 87% 
yield. 1 H-NMR (300 MHz, CDCl3) S: 7.32 (m, 2H), 7.25 (m, 1H), 3.55 (s, 4H), 2.31 (s, 12H).
\  \  /  1,1'-(2-Bromo-5-nitro-1,3-phenylene)bis(N,N-dimethylmethanamine) 5
N Br N
I I J Compound 4 (87 mg, 0.3 mmol) was added slowly to sulfuric acid (0.82 g, 8.3 
1[ mmol) at 0°C. With a temperature below 10°C, 65% nitric acid (0.12 g, 1.93
mmol) was added as described elsewhere24. This mixture was stirred at 0°C 
N° 2 for 3.5h after which it was quenched in demi-water on ice and neutralized
using NaOH. The product was extracted using CH2Cl2. The organic layer was washed with Brine 
and dried over MgSO4 and then concentrated in vacuo. The crude product was purified using 
gradient column chromatography (n-heptane/EtOAc/NEt3 199:0:1 to 199:5:1) obtaining the 
product as a yellow solid in 66.1%. *H -NMR (300 MHz, CDCl3) S: 8.25 (s, 2H), 3.61 (s, 4H), 
2.35 (s, 12H).
1,r-(5-Amino-2-bromo-1,3-phenylene)bis(NN-dimethylmethanamine) 6 
Following a literature procedure27, compound 5 (50 mg, 0.16 mmol) was 
dissolved under nitrogen atmosphere in EtOH (1.5mL). 10% Pt/C (3 mg, 1.6 
^mol) was added upon which the mixture was heated to 50°C. At this 
nh2 temperature hydrazine monohydrate (100 mg, 3.1 mmol) was added 
dropwise, after which the reaction was left to reflux for an additional 3 hours. The catalyst was 
filtered off over Celite and the filtrate was concentrated in vacuo resulting in an oil that was 
dissolved in CH2Cl2 and washed with H2O (3x) and with Brine. The organic layer was dried over 
MgSO4 and concentrated in vacuo affording a yellow solid. The product was purified using
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gradient column chromatography («-heptane/EtOAc/NEt3 4:199:1 to CH2Cl2/MeOH/NEt3 
199:20:1) to obtain the product as a brown solid in 85% yield. 1H -NMR (300 MHz, CDCl3) S: 
6.74 (s, 2H), 3.61 (m, 2H), 3.50 (s, 4H), 2.35 (s, 12H).
O O Benzyl 3-chloro-3-oxopropylcarbamate 7
Under nitrogen atmosphere 3-(benzyloxycarbonyl- 
H amino)propanoic acid (50 mg, 0.22 mmol) was dissolved in
CH2Cl2 (3 mL) and oxalyl chloride (0.28 g, 2.2 mmol) was added. 
The reaction mixture was stirred at room temperature for 4h, as described in literature28. 
Subsequently, all solvents were removed under reduced pressure obtaining the product, which 
appeared as yellow oil in 89%. The reaction was checked using mass spectrometry, showing the 
MeOH adduct and hardly any starting material.
O.
Br N'
%
NH
Benzyl 3-(4-bromo-3,5-bis((dimethylamino)methyl)phenylamino)-3-oxopro- 
pylcarbamate 8 Compound 6 (30 mg, 0.11 mmol) was dissolved in dry 
CH2Cl2. Triethylamine (21 mg, 0.21 mmol) was added upon which the 
reaction mixture was cooled to 0°C before compound 7 (38 mg, 0.16 mmol) 
was added as well. The reaction was stirred for 3h while slowly warming up 
to room temperature. The reaction was quenched with H2O and diluted in 
CH2Cl2 upon which it was washed with 2M NaOH (2x), H2O (2x) and Brine. 
The organic layer was dried over MgSO4 and concentrated in vacuo. The 
product was purified using gradient column chromatography with 0.5%NEt3 
in the eluent (CH2Cl2:MeOH:NEt3 199:6.5:1 to 199:20:1), resulting in the 
product as a yellow solid in 78%. 'H-NMR showed the product not to be 
pure. ‘H -NMR (400 MHz, CDCl3) S: 7.67 (s, 2H), 7.29-7.34 (m, 5H), 5.09 (s, 2H), 3.62 (s, 4H), 
3.55 (q, 2H), 2.64 (m, 2H), 2.36 (s, 12H). Impurity S: 3.07 (q), 1.39 (t).
H N ^ O  
,O
3-Amino-N-(4-bromo-3,5-bis((dimethylamino)methyl)phenyl)propan- 
amide 9 Compound 8 (5 mg, 10.2 ^mol) was dissolved in HBr in 
/  NHg AcOH (33wt%, 0.5 mL). This mixture was stirred for 5 minutes 
O whereupon the solvents were removed in vacuo. The crude product
appeared as a light brown crystal. 'H-NMR showed the product not to 
be pure. *H -NMR (400 MHz, D2O) S: 7.91 (m, 2H), 4.62 (m, 4H), 3.39 (m, 2H), 2.99 (m, 12H), 
2.94 (m, 2H). 13C-NMR (75 MHz, D2O) S: 170.5, 137.1, 131.4, 126.4, 122.9, 60.6, 42.4, 34.8, 
32.2.
O
O
NHS-containing dibenzoazacyclooctyne 10
Dibenzoazacyclooctyne functionalized with 5-oxopentanoic acid29 
(10 mg, 0.03mmol) was dissolved in dry THF (10 mL) and cooled
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to 0°C whereupon N-hydroxysuccinimide (7.2 mg, 0.06 mmol), DMAP (0.38 mg, 0.06 mmol) 
and EDC (12 mg, 0.12 mmol) were added. The reaction was stirred, while warming up to reach 
room temperature. The next day the reaction was diluted with CH2Cl2 and washed with 2M HCl 
(2x), 2M NaOH (2x) and Brine. The organic layer was dried over MgSO4 and concentrated in 
vacuo. The product was a yellow oil. Mass spectrometry showed the MeOH adduct and no
Dibenzoazacyclooctyne-functionalized pincer ligand 2 
Compound 9 (9 mg, 0.025 mmol) was dissolved in dry DMF 
(0.5 mL) under nitrogen atmosphere. Compound 10 (12.6 mg, 
0.03 mmol) was dissolved in dry CH2Cl2 (0.5 mL) and added to 
the reaction together with NEt3(7 ^L, 0.05 mmol). The reaction 
was stirred for 1h upon which the mixture was diluted in 
CH2Cl2 and washed with 2M NaOH (2x), H2O and brine after 
which it was dried over MgSO4 where after all solvents were 
removed under reduced pressure. The product was checked by 
mass spectrometry and 1H-NMR. 'H-NMR showed the product 
not to be pure.
*H -NMR (400 MHz, D2O) S: 8.34 (m, 1H), 7.35 (m, 11H*),
7.10 (m, 2H), 5.16 (m, 1H*), 3.65 (m, 2H), 3.53 (m, 4H), 2.30 
(m, 12H), 1.97 (m, 6H), 1.71 (m, 3H*). *These integrals should be lower, the fact that these 
integrals are higher is supposedly due to impurities. 13C-NMR (75 MHz, D2O) S: 173.8, 172.2, 
170.5, 152.3, 151.6, 138.3, 136.8, 128.1 (2C), 127.0 (2C), 123.5 (2C), 121.7, 121.5, 120.9, 119.6,
115.8, 109.2, 62.4, 48.4, 45.8, 37.0, 36.1, 34.5, 29.7, 21.5. HRMS (ESI+) m/z calcd for 
C35H40Br1N 5Na1O3 [M+Na]+ 680.2205, found 680.2212.
C oupling o f  p incer ligand 2 to  CalB
0.73 nmol 147(AHA)CalB (25 ^g) was mixed with 5 or 25 equivalents o f compound 2 (dissolved 
in DMSO, 2 or 10 mM) in a buffered solution containing 50 mM NaH2PO4, 150 mM NaCl (pH 
7.0). The final reaction volume was 25 ^L. As a negative control, 1.8 ^L DMSO instead o f 2 was 
added. Reactions were shaken overnight at room temperature and desalted against Milli-Q (five 
times 0.5 mL) using a 10 kDa MWCO centrifugal filter unit (Millipore). The product was 
analyzed by electro-spray ionization time-of-flight (ESI-TOF) on a JEOL AccuTOF. 10 ^M of 
protein in formic acid (0.1-1 %) was injected. Deconvoluted spectra were obtained using 
Magtran software.
Introduction o f  Pd in p incer ligand 2
Tris(benzylideneacetone)dipalladium (Pd2(dba)3) (0.1 mmol) was added to 2 (0.1 mmol) in 1 mL 
toluene and stirred overnight at room temperature. A few droplets o f THF were added and the
starting material. 
" 'N '  Br '"'N ''"
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reaction was stirred for an additional three hours. All volatiles were evaporated in vacuo and the 
residue was diluted in CH2Cl2 (10 mL) and filtered over Celite. The product was precipitated 
using isopropylether.
A stock solution o f Pd2(dba)3 was prepared and CalB-2 was incubated with Pd2(dba)3 as well. An 
excess o f Pd2(dba)3 relative to protein was used. Either toluene or Milli-Q were used as solvent. 
Reagents were removed by ultrafiltration with Milli-Q (five times 0.5 mL) using a 10 kDa 
MWCO centrifugal filter unit (Millipore). The product was analyzed by electro-spray ionization 
time-of-flight (ESI-TOF) on a JEOL AccuTOF as described before.
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Chapter 7
Metabolic channeling plays an important role in the biosynthesis of numerous natural 
products.1’ 2 Intermediates are transferred from one catalytic site to the other without or 
with less diffusion into the bulk phase of the cell. It has inspired researchers to mimic 
this approach by bringing enzymes together in an artificial way.3’ 4 Several studies 
involving the in vitro co-localization of enzymes have been reported, as summarized in 
Chapter 1. Different approaches have been employed, such as non-specific co­
immobilization’ non-covalent encapsulation’ scaffold-mediated co-localization and the 
construction of gene fusions.
Recently, new site-specific strategies have been developed to modify proteins in a 
controlled manner.5 For example, azides can be introduced in proteins in a specific way 
as shown in Chapters 3 and 5. They can be exploited to produce covalently linked CalB 
oligomers via selective bioconjugation (see Chapter 4). Surprisingly, this kind of 
approach has not been used yet for the controlled, direct linkage of different enzymes. 
We were therefore motivated to make use of site-specific modification strategies for the 
creation of an artificial metabolon. As a model system, the synthesis and glycosylation 
of resveratrol was chosen.
Resveratrol ( t r a n s ^ ^ ^ ’-trihydroxystilbene) is a polyphenol produced by specific 
plants. It is present in food products such as red wine, grapes, peanuts, olive oil and 
cranberries. Since twenty years, this compound has received a lot of attention for its 
potential medicinal properties, such as antioxidative and anticarcinogenic activity as 
well as protection against cardiovascular diseases.6, 7 It is derived from p-coumaric 
acid, which is attached to coenzyme A (CoA) by the action of 4-coumarate:coenzyme 
A ligase (4CL). Subsequently, three acetyl units (derived from malonyl-CoA) are added 
to coumaroyl-CoA, followed by a cyclization reaction, catalyzed by stilbene synthase 
(STS) (see Scheme 1).
As an alternative to extraction from plants or chemical synthesis, resveratrol has 
been produced in microorganisms. By co-expression of 4CL from a hybrid poplar and 
grapevine STS in Saccharomyces cerevisiae microbial resveratrol production was 
established as reported for the first time by Becker and colleagues.8 Beekwilder et al. 
used 4CL from tobacco and STS from grape to produce resveratrol in both Escherichia 
coli and S. cerevisiae in a yield of 16 mg/L and 6 mg/L, respectively.9 Similarly, Watts 
and co-workers constructed the stilbene biosynthesis pathway in E. coli using 4CL 
from Arabidopsis thaliana and STS from peanut. Recently, additional publications
7.1 -  Introduction
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describing resveratrol production in S. cerevisiae have appeared,10-12 whereas reviews 
on resveratrol bioproduction in general have been provided as well.13, 14
OH
Scheme 1. Biosynthesis of resveratrol. p-Coumaric acid is coupled to CoA by 4CL. STS adds three 
malonyl-CoA units to coumaroyl-CoA. During this chain extension step the substrate is linked to the 
enzyme's active site cysteine (Cys). The synthesis is completed by an internal cyclization reaction 
catalyzed by STS as well.
An appealing study concerning the biosynthesis of resveratrol has been reported 
by Zhang et a l 1  A fusion protein was produced in which STS from Vitis vinifera was 
attached to the C-terminal end of 4CL from A. thaliana. This fusion protein was 
expressed in S. cerevisiae. The culture was fed p-coumaric acid for 5 to 24 hours and 
resveratrol was extracted from the culture medium. The in vivo production of 
resveratrol was up to 15-fold higher compared to coexpression of 4CL and STS from 
two separate expression vectors. The 4CL:STS fusion gene was introduced into human 
HEK293 kidney cells, together with the TAL gene encoding for tyrosine ammonia lyase 
(TAL). TAL catalyzes the production of p-coumaric acid from tyrosine. This enabled 
de novo resveratrol biosynthesis in a mammalian cell line by supplying tyrosine.
Inspired by the research described by Zhang et al., we set out to produce 4CL- 
STS conjugates in vitro . However, as multi-enzyme complexes in nature often consist 
of more than two different biocatalysts, we aimed at coupling a third enzyme as well, 
being a glycosyl transferase. One of the most abundant resveratrol derivatives is piceid 
(trans-resveratrol-3-O-P-glucoside), which is formed by regioselective glycosylation by 
a UDP-glucose transferase. It has been suggested that this glycoslyated derivative 
results in better uptake in the human body.16
The aim of the research described in this chapter was to create a synthetic 
metabolon for the production of piceid, as depicted in Scheme 2. 4CL2 from Nicotiana 
tabacum (GenBank accession no. U50846), STS from Vitis vinifera (GenBank 
accession no. EU156062) and Twi, a UDP-glucosyl transferase from Solanum 
lycopersicum (GenBank accession no. CAA59450.1) were selected for this study.
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Scheme 2. An artificial metabolon consisting of 4CL, STS and Twi for in vitro biosynthesis of 
piceid.
7.2 -  Results and discussion
7.2.1 Production and purification of 4CL2, STS and Twi
4CL2, STS and glucosyl transferases related to Twi have been expressed and purified 
from E. coli before.17-26 Here, the enzymes were produced either in MTD[pREP4] E. 
coli cells (as for 4CL2 and STS), or in BLR[DE3] cells (as for Twi). The enzymes, 
containing an N-terminal histidine tag, were obtained in high purity after Ni2+ NTA 
affinity chromatography as shown in Figure 1.
Figure 1. Ni2+ NTA-mediated purification of 4CL2 (lane 1), STS (lane 2) and Twi (lane 3) analysed 
by SDS-PAGE electrophoresis. Of each enzyme an elution fraction was loaded on a 7.5% 
polyacrylamide gel. The gel was stained by Coomassie Brilliant Blue.
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Additional purification over a size-exclusion column allowed for removal of 
imidazole and exchange of buffer, as well as removal of any final impurities. With 
respect to STS, 5 mM DTT was added to the eluent as described previously.21 No DTT 
was added to 4CL2 and Twi as the reducing agent would interfere with the different 
functionalization strategies that were to be tested for these enzymes. Typically, 10-20 
mg of protein was obtained per litre bacteria culture.
The enzymes were analysed by mass spectrometry. As shown in Table 1, masses 
were detected that corresponded to the calculated values indicating that the amino acid 
sequences of the proteins were as expected and no modifications had occurred, except 
for cleavage of the N-terminal methionine of Twi.
Table 1. Analysis of 4CL2, STS and Twi by ESI-TOF mass spectrometry.
Protein  Calculated (Da) Detected (Da)
4CL2 60838.1 60838.0
STS 44239.8 44238.8
Twi 54440 .8* 54438.5
‘ Calculated mass of Twi upon removal of the N-terminal methionine.
7.2.2 Activity of the purified enzymes
The activities of the three purified enzymes were studied in vitro. First, formation of 
coumaroyl-CoA by 4CL2 was followed by UV/Vis spectroscopy. Upon addition of the 
enzyme to a solution containing p -coumaric acid and coenzyme A (CoA), an increase 
in absorbance at 333 nm was detected indicating that 4CL2 was active. In the first 30 
seconds 2.75 nmol of product was formed, corresponding to a specific activity of 23 
nkat/mg. This means that 23 nmol coumaroyl-CoA was formed in one second by 1 mg 
of enzyme.
STS activity was followed by HPLC.9 4CL2 was used to produce coumaroyl-CoA 
in situ, whereas malonyl-CoA, the second substrate for STS, was purchased from a 
commercial supplier. p -Coumaric acid and the final product resveratrol were separated 
and detected at 307 nm at retention times of 14.6 min and 21.7 min, respectively. As 
shown in Figure 2A, when no enzyme was added to the reaction mixture, only p-  
coumaric acid was detected by HPLC. Upon addition of 4CL2, the peak corresponding 
to p -coumaric acid almost entirely disappeared, indicating that coumaroyl-CoA was 
formed (see Figure 2B). Because of its hydrophilic nature, coumaroyl-CoA eluted at
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low acetonitrile concentration together with other hydrophilic compounds that were 
added to the reaction mixture (not shown in these graphs).
When STS was added to the reaction mixture as well, a new peak appeared which 
coincided with a resveratrol standard, indicating that STS was active (see Figure 2C). 
The small peak at 20.2 min is expected to be chalcone. Chalcone is synthesized by 
chalcone synthase (CHS), which uses the same substrates as STS. It is known from 
literature that CHS and STS show cross-reactivity when used in vitro, meaning that 
some chalcone is being formed by STS.22 The specific activity of STS was found to be
0.40 nkat/mg.
Figure 2. Activity of 4CL2, STS and Twi analysed by HPLC at 307 nm. The reaction mixture of 
each assay contained para-coumaric acid, ATP, CoA, malonyl-CoA and UDP-glucose. A) no 
enzyme, B) 4CL2 only, C) 4CL2 and STS, D) 4CL2, STS and Twi. Retention times: para-coumaric 
acid at 14.7 min, resveratrol at 21.7 min, monoglucosides at 16.9 and 18.1 min and diglucosides at 
14.2 and 14.6 min.
Finally, in order to detect the activity of the glucosyl transferase, the reaction 
mixture was supplemented with Twi. The chromatogram in Figure 2D shows that in 
this case hardly any resveratrol was present anymore. Instead, new peaks had appeared,
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of which one coincided with a piceid standard (18.1 min). By LC/MS it was shown that 
the additional peaks corresponded to another monoglucoside (16.9 min) and two 
diglucosides (14.2 and 14.6 min). The specific activity of Twi was shown to be 1.4 
nkat/mg.
7.2.3 Functionalization of STS by azidohomoalanine incorporation
As mentioned above, our aim was to link the three enzymes together. The strain- 
promoted cycloaddition between azides and alkynes, successfully used in the 
construction of CalB oligomers (see Chapter 4), was selected as one of the conjugation 
reactions for the production of these synthetic enzyme oligomers. Therefore, STS was 
expressed in presence of azidohomoalanine (AHA). The protein yield was lower under 
these conditions than described in Section 7.2.1, but comparable to the one obtained 
when azidohomoalanine was introduced in CalB (see Chapter 2). 0.5 to 2 mg protein 
was purified from one litre bacteria culture. The mass detected for AHA-STS showed 
that azidohomoalanine incorporation was successful. Compared to STS which 
contained methionine (Met-STS), a decrease in mass was found that corresponded to
11 methionine-azidohomoalanine replacements (see Figure 3).
A  44238.8 B 44182.8
44000 44200 44400 44600 44000 44200 44400 44600
Mass / Da Mass / Da
Figure 3. Mass spectra of (A) Met-STS and (B) AHA-STS.
The influence of azidohomoalanine incorporation on activity was determined by 
comparing the initial velocities of AHA-STS and Met-STS. 0.24 nkat/mg was found for 
AHA-STS, whereas Met-STS displayed a specific activity of 0.40 nkat/mg enzyme. So, 
replacement of methionine still yielded a functional enzyme, albeit with somewhat 
lower activity. The activity values observed were comparable to activities found in 
literature.23
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Next it was investigated whether the azides that were introduced in STS were 
accessible for conjugation. The protein was incubated with polyethylene glycol (PEG, 
Mw 2000) functionalized with a dibenzoazacyclooctyne (DIBAC) moiety27. The 
conjugation reaction was analysed by gel electrophoresis (see Figure 4). Up to four 
polymer chains were attached to the enzyme, as deduced from the additional bands that 
were visible on the polyacrylamide gel. While longer incubation times did not improve 
labeling efficiency (see Figure 4, lanes 1-4), addition of more equivalents of polymer 
did (Figure 4, lanes 7 and 8). Some STS remained unreacted, even when a large excess 
of polymer was added (see Figure 4, lane 8). This could be due to the fact that not all 
protein molecules contained azidohomoalanine. Because of so-called ‘leaky 
expression’ some STS may have been produced before the medium shift. This 
proportion of enzyme will contain methionine instead of the non-natural analogue.
kDa
1 2 3 4 5 6 7 8
► < 4
► *3
► -  50 -  .4 2
-4 1
-4 0
- 3 7  -
Figure 4. Labeling of AHA-STS with PEG2000 containing a dibenzoazacyclooctyne moiety. Lanes
1-4: Approximately 5 equivalents of PEG2000 were added relative to protein and reactions were 
incubated for 2, 4, 8 and 16 hours, respectively. Lane 5 and 6 contain negative controls to which no 
polymer was added. Lanes 7 and 8: 2 and 20 equivalents of PEG2000 were added relative to 
protein followed by incubation for 16 hours. Arrows with numbers on both sides of the gels indicate 
the amount of polymer chains attached to the protein.
7.2.4 Production of Twi-STS conjugates
It was decided to first attempt linkage of STS to Twi. In order to selectively couple 
these enzymes to each other without the chance of forming homo-oligomers, 
heterotelechelic linker 1 was designed (see Scheme 3). One of the linker’s ends was 
functionalized with a dibenzoazacyclooctyne moiety, which would allow for selective 
conjugation to AHA-STS. An activated ester moiety was introduced at the other end of 
the linker to target the amines of Twi. Unlike azidohomoalanine, the amine is a 
naturally occurring functionality, which is also present in STS. To prevent labeling of 
STS via the activated ester, Twi was first reacted with linker 1, while azide-
4
3
2
1
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functionalized STS was only added after removal of unreacted linker. So, the complex 
formation was conducted in two steps as depicted in Scheme 3. A short spacer was 
inserted in 1 to allow for some flexibility in the enzyme complexes that would be 
produced.
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Scheme 3. Schematic representation of the strategy applied to link Twi to STS. First, the activated 
ester on heterotelechelic linker 1 was allowed to react with free amines present in Twi. After 
removal of the excess of linker, AHA-STS was added to let the azides react with Twi decorated with 
dibenzoazacyclooctyne functionalities.
Labeling of Twi with 1 was studied by adding 5, 10 and 15 equivalents of 1 to the 
glycosyl transferase followed by incubation at room temperature for two hours. The 
degree of labeling was determined indirectly by adding azide-functionalized PEG2000 
to the Twi-1 conjugate. Linkage of the polymer, which could only occur if 
dibenzoazacyclooctyne groups were present on the protein, was visualized by gel 
electrophoresis. As shown in Figure 5A, a rather large amount of Twi remained 
unlabeled when only a small excess of linker had been added (see Figure 5A, lane 2). 
This is explained by the fact that the activated ester readily hydrolyzes in aqueous 
solution after which it will not react with amines anymore. By using 10-15 equivalents 
of 1, multiple polymer chains were attached to Twi indicating that more than one linker 
molecule had reacted with the enzyme (see Figure 5A, lane 3 and 4). This was as 
expected, as Twi contains 31 lysine residues.
Lysines play a role in maintaining a protein’s structure and may directly be 
involved in the catalytic function of an enzyme. Therefore, targeting amines in a 
conjugation reaction can lead to changes in enzyme activity. The effect of labeling on 
Twi activity was investigated by comparing the glycosylation velocities of different 
aliquots of Twi, which were reacted with varying amounts of 1. Figure 5B shows that 
increasing the amount of 1 leads to a decrease in Twi activity. However, after treatment 
with up to 10 equivalents of 1, approximately 85% of Twi activity was retained. Since 
it could be deduced from Figure 5A that with 10 equivalents of 1 at least 50% of the 
enzyme molecules had been labeled (Figure 5A, lane 3), it was clear that the detected 
activity did not only originate from unreacted enzyme.
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Figure 5. Functionalization of Twi with linker 1. A) The enzyme was incubated at room temperature 
for 2 hours. Increasing amounts of linker were added, being 0 (lane 1), 5 (lane 2), 10 (lane 3), and 
15 (lane 4) equivalents relative to protein. Subsequently, PEG2000-N3 (25 eq. relative to Twi) was 
allowed to react with the Twi-1 conjugate to visualize the degree of functionalization on a 10 % 
polyacrylamide gel. B) Activity of Twi after labeling with varying amounts of linker 1. Glycosylation 
of resveratrol was followed by HPLC after removal of the excess of linker by ultrafiltration.
Having confirmed that AHA-STS is active and contains azides which are 
accessible for conjugation (see Section 2.3), and Twi remains active upon targeting its 
amines, we proceeded with the enzyme oligomerization. Twi-STS conjugate formation 
was attempted as depicted in Scheme 3. Crude reaction mixtures were analysed by gel 
electrophoresis on a 10% polyacrylamide gel. Covalently linked complexes of varying 
molecular weights were formed as shown in Figure 6. As most oligomers had a mass 
higher than the Twi-STS dimer (~100 kDa), it could be concluded that multiple Twi 
and STS molecules were coupled to each other.
When Twi was labeled with more equivalents of 1, a larger amount of enzyme 
molecules was cross-linked. Not only had fewer enzyme monomers remained 
unreacted, the complexes were larger as well (Figure 6, comparing lane 2 and 3 with 
lane 4 and 5). Adding only half of the amount of STS relative to Twi had hardly any 
effect (see Figure 6, comparing lane 2 with 3 and lane 4 with 5). These results suggest 
that it is the degree of functionalization of Twi that limits the enzyme oligomerization. 
Every Twi molecule which contains only one reactive group, will terminate the 
oligomerization reaction. This will be the case when only 5 equivalents of 1 are added 
to Twi in the first step of the complex formation. The more Twi molecules contain two 
or more reactive groups, the larger the complexes can grow.
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Figure 6. Twi-STS conjugate formation analysed by gel electrophoresis (10% polyacrylamide). 
Relative to Twi, 0, 5 or 25 equivalents of 1 were added, followed by 1 or 0.5 equivalent of STS (see 
numbers under gel). As a control, STS without Twi was loaded as well (lane 6).
Twi-STS conjugates were analysed by size-exclusion chromatography using a 
Superdex200 column (GE Healthcare). This technique allowed for estimation of the 
size of the complexes by comparing the elution times to those of protein standards. The 
chromatogram shown in Figure 7A was obtained from a conjugation reaction using 20 
equivalents of 1 and one equivalent of STS relative to Twi. Unreacted Twi (54.5 kDa) 
and STS (44.2 kDa) eluted at the same time after 1.5 mL. The enzyme complexes 
eluted at volumes corresponding to 200-700 kDa.
The smallest oligomers eluted as a distinct peak corresponding to a mass of ~200 
kDa. This observed molecular weight can be explained with the formation of a complex 
containing four enzyme molecules, as depicted in Figure 7B. SDS-PAGE analysis 
showed a band close to 100 kDa (see Figure 6), which is indicative of a covalently 
bound STS-Twi dimer. From literature it is furthermore known that STS forms non- 
covalently bound dimers under native conditions.28 The four-enzyme complex therefore 
most probably consisted of two STS-Twi dimers.
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Figure 7. Twi-STS conjugate formation analysed by size-exclusion chromatography. A) Size- 
exclusion chromatogram of an oligomerization reaction using 20 equivalents of 1 and one 
equivalent of STS relative to Twi. Vertical lines indicate elution times of protein standards whose 
size (in kDa) is indicated by the number above the line. B) Schematic representation of two STS- 
Twi dimers brought together by the non-covalent interaction of the two STS units.
7.2.5 Analysis of Twi-STS conjugates by mass spectrometry
Oligomers larger than 200 kDa were expected to be less well-defined. When linear 
chains of Twi-STS would have formed, the averaged Twi:STS ratio would be equal to
1. However, branched structures could have originated as well, in which for example 
three Twi molecules were linked to one STS molecule. As demonstrated above, STS is 
known to contain at least four accessible azides (see Section 2.3). So, conjugation of 
more than two Twi units to one STS would be possible, if not restricted by steric 
hindrance. It implies that adding more Twi molecules during conjugate formation could 
result in a larger proportion of Twi in the complexes.
To investigate this possibility, Twi and STS were reacted in different ratios. Upon 
separation of the complexes by SDS-PAGE analysis, bands of oligomers larger than 
200 kDa were excised and treated with trypsin. LC-MS was performed on the tryptic 
digests. As a reference, unmodified Twi and AHA-STS were isolated from gel as well. 
Upon trypsinization and extraction, these two digests were mixed in varying ratios and 
the relative intensities of two peptides, one originating from Twi and the other from 
STS, were determined. Those peptide pairs, of which the relative intensities in the mass 
spectra were shown to correlate with the ratio in which they were mixed, were
140
A synthetic metabolon for piceid production
considered to be appropriate standards for the quantification of the relative amounts of 
Twi and STS in the complexes. Table 2 shows that a larger proportion was indeed 
present in the Twi-STS oligomers when more Twi was added during conjugate 
formation.
Table 2. Proportion of Twi and STS in the enzyme oligomers upon increasing the amount of Twi 
added to the conjugation reaction.
Twi:STS (Twi) / (STS)a (Twi) / (STS)b
1:1 1.000 1.000
2:1 1.312 1.400
5:1 2.972 4.990
a Relative intensities, as determined by mass spectrometry, of peptide 461-484 from Twi and 
peptide 294-303 from STS. b Idem, of peptide 175-193 from Twi and peptide 294-303 from STS.
7.2.6 Activity of Twi-STS conjugates
The Twi-STS conjugates were well separated from monomers as shown by analysis of 
the elution fractions by native gel electrophoresis (see Figure 8A). This allowed for 
investigation of the activity of the conjugates by HPLC, similar to the studies 
performed on the purified, unmodified enzymes (see Section 2.2). The ability of the 
complexes to synthesize and glycosylate resveratrol was compared to the activity of 
non-conjugated enzymes.
Fractions derived from size-exclusion chromatography were collected and pooled 
in three different aliquots as indicated in Figure 8B. The STS and Twi activities 
contained by these samples were determined independently by either adding 4CL2 
together with p-coumaric acid, CoA and malonyl-CoA, or resveratrol and UDP-glucose 
(see Figure 8C). The absorbance at 280 nm was used as a measure for the total amount 
of protein, being the sum of STS and Twi, in each fraction. Equal amounts of protein of 
fraction I, II and III were mixed with substrates. Production or glycosylation of 
resveratrol was allowed to take place for 90 minutes and quantified by HPLC.
While present in the oligomeric complexes, both enzymes were still active. 
Whereas the amount of resveratrol produced by STS in fraction I was equal to the 
control, 1.7 times more resveratrol was produced by the conjugates in fraction II (see 
Figure 8D). Twi activity was 0.8 and 0.7 times lower in fraction I and II, respectively. 
A difference in the ratios of STS : Twi in fraction II and the unreacted fraction III 
might be an explanation for the fact that more STS activity but less Twi activity was
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detected in fraction II. The observation that in fraction I Twi activity was slightly lower 
than in the control while STS activity was the same, suggested that a small amount of 
glycosylation activity was lost due to formation of larger conjugates. Furthermore, it 
indicated that the larger conjugates were formed by addition of Twi molecules to the 
smaller enzyme complexes in fraction II, because otherwise the STS activity would 
have further increased.
Figure 8. Catalytic activity displayed by Twi-STS conjugates. A) Silver-stained 7.5% native 
polyacrylamide gel containing elution fractions obtained from size-exclusion chromatography. The 
fractions in lanes 1-6 were collected between 1 and 1.25 mL, lane 7 is from the distinct peak 
corresponding to ~200 kDa, lane 8 is from the peak eluting after 1.5 mL. B) Size-exclusion 
chromatogram indicating in roman numbers which fractions were tested for activity. I and II were 
collected as two different conjugate fractions, whereas III, containing STS and Twi monomers, was 
taken as reference. C) Table showing which components were present in the two separate activity 
assays that were conducted. D) Relative STS and Twi activities of the conjugates I and II compared 
to the ‘free' enzymes in sample III. The amount of resveratrol synthesized by STS and the amount 
of resveratrol glycosylated by Twi were determined by HPLC.
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Aiming at the creation of an enzyme complex containing not only stilbene synthase and 
glycosylation activity but also the capability of coumaroyl-CoA formation, we explored 
the options to modify 4CL2. A way to couple 4CL2 to the Twi-STS complexes would 
be by means of linker l.This heterofunctional moiety contains an activated ester and a 
cyclooctyne group separated via a short ethylene glycol spacer. This linker could be 
employed in two different ways. First the amines present on the STS-Twi conjugates 
could be targeted with the activated ester unit. Subsequently, azide-functionalized 
4CL2 had to be added such that the reaction between the dibenzoazacyclooctyne 
moiety of 1 and azides in 4CL2 could take place (see Scheme 4A). Alternatively, linker 
1 could be coupled to the amine residues of 4CL2. In this case the STS-Twi complexes 
were to be functionalized with azides, for example via an aqueous diazotransfer 
reaction (see Scheme 4B).
For the first approach azides were introduced in 4CL2 by using the residue 
specific replacement strategy, through which the 14 methionine residues present were 
exchanged with the analogue azidohomoalanine. The same procedure was followed as 
described for STS (see Section 2.3). However, the detected mass of the protein 
obtained by Ni2+ NTA affinity chromatography and size-exclusion chromatography 
was lower than expected. It corresponded to the mass of the stress-responsive 
chaperone protein GroEL/Hsp60, which is known to be co-purified from E. coli by Ni2+ 
NTA affinity chromatography.29 Although some fractions showed to contain 4CL2 
activity, indicating that the enzyme had been expressed, the overall yield was very low.
[Twi-STS] +
B
4CL2 + £^n. 
o
Scheme 4. Two different ways of coupling 4CL2 to Twi-STS conjugates using 1 as linker.
7.2.7 Modification of 4CL2
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As an alternative, it was tested whether azides could be introduced via the mild 
and metal-free, aqueous diazotransfer as described in Chapter 5. It was observed that 
incubation at elevated pH had a detrimental effect on 4CL2 activity (data not shown). 
Hence, the diazotransfer reaction was performed at pH 7.5. However, activity was 
entirely lost upon incubation for two hours in presence of imidazole-sulfonyl azide. It 
was hypothesized that lysines were modified that were essential for enzyme activity. In 
an attempt to prohibit conversion of those lysines, the three substrates ATP, CoA and 
coumaric acid were added during the diazotransfer reaction. Unfortunately, this had no 
positive effect (data not shown).
Since the first approach was not feasible, the alternate route was explored in 
which the activated ester of linker 1 was conjugated to the available lysines on 4CL2. 
This approach was successful, but also in this case the activity of the enzyme was 
affected. Addition of 25 equivalents of 1 per protein led to a reduction in activity of 
85%. A smaller quantity of linker was added to limit its negative effect. To reach the 
desired degree of functionalization three times 2.5 equivalents of 1 were added. 
However, even though 67% activity had remained upon addition of the first aliquot of 
linker, the final activity was only 8% of the control (data not shown).
4-coumarate:CoA ligase 2 from Arabidopsis thaliana has been extensively studied 
by Stuible et al.17 With regard to this variant, at least four lysines were shown to be 
critical for catalytic activity. One lysine residue close to the C-terminus was found to be 
absolutely conserved. Substitution of three other lysines resulted in great loss of 
activity. Elucidation of the crystal structure of 4CL1 from Populus tomentosa provided 
additional insight in the ATP binding pocket.30 These findings agree with the results 
described above, i. e. modification of the lysines in 4CL2 from Nicotiana tabacum 
leads to inactivation of the enzyme.
A third strategy was therefore addressed, investigating whether any of the 
enzyme’s ten cysteines were available for conjugation. For this purpose, maleimide- 
functionalized linker 2 was synthesized (see Figure 9A). Conjugation of 2 to 4CL2 was 
studied indirectly by addition of PEG2000-N3. As shown in Figure 9B, approximately 
50% of the enzyme was labeled with one PEG chain, i. e. being mono-functionalized. 
Surprisingly, the activity of 4CL2 incubated with one or two equivalents of 2 was 
higher compared to 4CL2 to which 2 was not added (see Figure 9C). Addition of 5 or 
10 equivalents of 2 relative to protein, however, led to a decrease in activity to 56% and 
22%, respectively.
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0 1 2
Figure 9. Functionalization of 4CL2 via a cysteine-maleimide coupling. A) Structure of linker 2 
containing a maleimide moiety at one end and a dibenzocyclooctyne functionality at the other end. 
B) Labeling of 4CL2 with 2 followed by incubation with 20 equivalents of PEG2000-N3 analysed by 
gel electrophoresis (7.5 % polyacrylamide). Linker 2 was dissolved in DMSO. Only DMSO (lane 1) 
or 1 (lane 2) or 2 (lane 3) equivalents of 2 relative to 4CL2 were added. C) Activity of 4CL2 reacted 
with 0, 1 or 2 equivalents of 2 after ultrafiltration to remove DMSO and excess of 2.
7.2.8 Formation of 4CL2-STS-Twi complexes
Having found a way to modify 4CL2 without losing its activity, it was tested whether 
4CL2 could be coupled to STS. Similar to conjugation of Twi to AHA-STS (see 
Section 2.4), 1 eq. of the linker-modified enzyme (4CL2-2) was reacted with 1.1 eq. of 
azide-functionalized stilbene synthase. Covalently linked 4CL2-STS complexes were 
formed as confirmed by gel electrophoresis (see Figure 10, lane 1). However, a 
relatively large amount of both STS and 4CL2 was not coupled. Either PEG2000-N3 or 
PEG2000-DIBAC was added to the unreacted fraction. As shown in lane 4 of Figure 
10, the remaining amount of 4CL2 did not react with azide-containing PEG, meaning 
that it had not been labeled with 2. A t the other hand, STS could still be conjugated to 
PEG2000-DIBAC, which was indicated by the fact that almost all remaining STS 
disappeared after addition of this reactive polymer (see Figure 10, lane 5). Coupling of 
PEG2000-DIBAC to the STS-4CL2 conjugates took place as well (see Figure 10, lane 
2).
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Figure 10. Conjugation of 4CL2 to STS analysed by gel electrophoresis. Lane 1: non-purified 
reaction product showing covalently linked 4CL2-STS but also a large amount of unreacted 4CL2 
and STS. Lane 2: non-purified product to which PEG2000-DIBAC was added. Lane 3: unreacted 
fraction after purification, lane 4: unreacted fraction after purification incubated with PEG2000-N3, 
and lane 5: unreacted fraction after purification incubated with PEG2000-DIBAC.
This result indicated that upon conjugation of STS to 4CL2, there were still azides 
available on the stilbene synthase to which Twi could be coupled. It was decided to 
couple 4CL2 and Twi simultaneously to AHA-STS. First, 4CL2 was incubated with 2 
eq. of 2, whereas 10 eq. of 1 were added to Twi. After removal of unreacted linker 
molecules, both functionalized enzymes were added to AHA-STS (see Figure 11A). 
The reaction mix contained 3.6 nmol of AHA-STS, 1.8 nmol of Twi and 3.3 nmol of 
4CL2. More 4CL2 than Twi was added, as it was known that the degree of 
functionalization was lower for 4CL2 than for Twi (50 % of mono-functionalized 4CL2 
compared to at least 50 % of Twi containing one or more DIBAC moieties).
The conjugates were purified by size-exclusion chromatography and analysed by 
native and denaturing gel electrophoresis (see Figure 11B). Complexes in fraction II, 
eluting between 1.29 and 1.44 mL, had a mass of approximately 200 kDa as deduced 
from their elution volume. No overlap was present with the elution volume of 
unreacted fraction III. This was confirmed by native gel electrophoresis (see Figure 
11C). A single band was observed on gel. However, according to denaturing gel 
electrophoresis, fraction II was a mixture of several products with masses between 100 
and 150 kDa as well as non-conjugated STS.
This result is in agreement with previous observations concerning the STS-Twi 
conjugates (see Section 2.4). Apparently, the complexes of 200 kDa consist of smaller 
covalently linked conjugates that are brought together by dimerization of STS. In this 
case it could be two dimers (4CL2-STS and/or Twi-STS) and/or one trimer together 
with an STS monomer.
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Figure 11. Formation of enzyme oligomers consisting of 4CL2, STS and Twi. A) Schematic 
representation of the conjugate formation. B) Size-exclusion chromatogram indicating in roman 
numbers which fractions were collected and analysed. Vertical lines indicate elution times of protein 
standards whose size (in kDa) is indicated by the number above the line. C) Native (left) and 
denaturing (right) 7.5% polyacrylamide gels of fractions as derived from size-exclusion 
chromatography. The native gel shows fraction I and II as indicated. The denaturing gel contains 
fraction I in lane 1, fraction II in lane 2 and fraction III in lane 3.
The masses of complexes in fraction I, collected between 1.13 and 1.29 mL, 
varied between 230 and 500 kDa. The variation in mass is larger than in fraction II as 
confirmed by native gel electrophoresis. The denaturing gel shows a broad band of 
products, which are all larger than 200 kDa. So, these conjugates consist of at least four 
covalently linked enzyme molecules.
The activity exhibited by the complexes was studied in time and compared to the 
non-conjugated enzymes. The different fractions did not contain the same amount of 
4CL2 activity units as detected by monitoring coumaroyl-CoA formation by UV/Vis 
spectroscopy. Fraction III was shown to be most active. This is explained by the fact 
that a significant amount of 4CL2 had remained unreacted (see Figure 11B, lane 3). 
Nevertheless, in all three cases conversion was complete within 15 minutes.
STS and Twi activity in the conjugate fractions and control sample were 
determined as well. The individual activities of both STS and Twi were followed for 90
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minutes. It appeared that most Twi was incorporated into the complexes, as the 
unreacted fraction contained less glycosylation activity, when the total amount of 
enzyme added to the assay mix was the same.
To accomplish that both STS and Twi activities were equal in the control and 
conjugate enzyme mixtures, extra Twi-1 was added to fraction III. Subsequently, the 
cascade reaction conducted by the three-enzyme complex was followed in time. Figure
12  shows that by both conjugated fractions resveratrol was synthesized and 
subsequently glycosylated. The amounts of resveratrol and glucosylated resveratrol 
were comparable to the quantities produced by the non-conjugated enzymes (see Figure 
12A and 12B). In fraction I the proportion of Twi was higher than in fraction II, which 
led to faster glycosylation. Therefore, the percentage glucosides relative to total product 
(resveratrol + glucosylated resveratrol) was higher (see Figure 12C and 12D).
Figure 12. Activity of heteromeric complexes consisting of 4CL2, STS and Twi. The levels of 
resveratrol (R) and glucosylated resveratrol (G) formed by fraction I (A) and fraction II (B) were 
followed in time and compared to the activity of non-conjugated enzymes as present in fraction III. 
The amount of glucosides relative to total product (resveratrol + glucosylated resveratrol) were 
plotted as well (C and D).
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In conclusion, we produced a synthetic metabolon by the controlled linkage of three 
different enzymes. The application of multiple conjugation reactions and the use of 
heterotelechelic linkers enabled us to connect the enzymes in a well-defined manner. 
This strategy guaranteed that heteromeric complexes were formed, in which the 
enzymes with a sequential role in the metabolic route were coupled to each other.
In contrast to previous examples, the enzymes were brought together without the 
use of a solid support or protein scaffold. In this way the system is less complex 
compared to those in which for example enzymes are linked to cellulose via cellulose 
binding domains. In addition, no affinity tags need to be introduced which could 
interfere with the catalytic function of the enzyme.
Several studies are known in which enzymes are cross-linked via their lysine 
residues. However, our model system illustrates that lysines can play an essential role 
in catalytic activity. It is therefore important to explore other mild and (more) selective 
conjugation reactions as well, such as the cysteine-mediated linkage and the azide- 
alkyne cycloaddition. The latter reaction requires introduction of a non-natural 
functionality in the enzyme, which is accomplished by the introduction of a non- 
proteinogenic amino acid.
Our approach is an attractive alternative to the production of gene fusions. The 
enzymes are linked after translation and folding. Consequently, the coupling of more 
than two biocatalysts is more feasible. In addition, the presented method allows for 
variation in the multi-enzyme complex composition. For example, a larger amount of 
one of the enzymes may be incorporated in the complex, if that enzyme is rate-limiting 
in the cascade reaction. We show that this can be achieved by adding more of one 
enzyme during the coupling reaction, whereas at the same time the other biocatalyst 
contains multiple sites for conjugation.
To our knowledge, this is the first example of the creation of a synthetic 
metabolon consisting of three different enzymes that are directly coupled to each other 
in vitro. In view of the growing interest for biocatalytic synthesis of pharmaceutical and 
nutritional compounds (as an alternative to chemical synthesis), this method of enzyme 
co-localization may contribute to more efficient product formation via substrate 
channeling. We are currently investigating whether this is indeed the case for our 
model system.
7.3 -  Conclusions
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7.5 -  Experimental section
M ateria ls
Primers were purchased from Biolegio (Malden, the Netherlands) and dNTP mix from 
Invitrogen. Restriction enzymes were from N ew  England Biolabs and Promega. Natural amino 
acids, kanamycin, lysozyme, PMSF, imidazole, dithiothreitol, CoA, malonyl-CoA, resveratrol 
and UDP-glucose were obtained from Sigma Aldrich. Azidohomoalanine was prepared as 
described before.31 Ampicillin and IPTG were purchased from MP Biomedicals, and thiamine 
and glucose from Merck. ^-Coum aric acid was from Janssen Pharmaceutica and piceid from 
Extrasynthese. 2xYT medium was provided by the Nijmegen Centre for Molecular Life Sciences 
(NCMLS, the Netherlands). Solutions used for protein expression were sterilized by autoclave or 
by filtration over a 0.2 ^m membrane (Corning Life Sciences, or Whatman GmbH). Phosphate 
buffer contained 25 mM NaH2PO4 and 100 mM NaCl (pH 7.5)
Centrifugation was performed on a Biofuge Pico microcentrifuge (Heraeus Instruments), a 
Multifuge 3 S-R (Heraeus Instruments) using a Sorvall Heraeus 75006445 rotor, a RC-5 
Superspeed Refrigerated centrifuge (Sorvall, Dupont Instruments) using a GS-3 or SM-24 rotor 
and a Sepatech Minifuge RF (Heraeus Instruments) with a #3360 rotor. Cell cultures were shaken 
at 200 rpm in an Infors HT Multitron shaker. Cell densities were measured on an Ultrospec 10 
Cell density meter (Amersham Biosciences). Conjugation reactions as well as enzyme activity 
assays were shaken on an eppendorf® Thermomixer comfort.
Linker synthesis was kindly performed by M. F. Debets. Unless stated otherwise, all reactions 
were conducted under ambient atmosphere and temperature and with chemicals obtained from 
commercial source, used without further purification. Purification by column chromatography 
was carried out using Silicycle silica gel (0.040 - 0.063 mm, and ca. 6 nm pore diameter). NMR 
spectra were recorded on a Varian Inova 400 (400 MHz for 1H) and a Bruker DMX 300 (75 MHz 
for 13C), while infrared spectroscopy was performed on a Thermo Mattson Nicolet 300 FTIR.
P la sm id  c o n s t ru c t io n
The genes encoding for 4CL2 from Nicotiana tabacum  and STS from Vitis vinifera were 
amplified from pACYCDuet-4CL2/STS9 (vector from Novagen, plasmid provided by PRI, 
Wageningen) using the following primers (restriction sites in italics):
Forward BamHI-4CL2: ATAT GGATCC  ATG GAG AAA GAT ACA AAA CAG G 
Reverse HindIII-4CL2: ATAT AAG CTT  TTA ATT TGG AAG CCC AGC AGC
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Forward BamHI-STS: ATAT GGATCC  ATG GCT TCA GTC GAG GAA ATT AG 
Reverse HindIII-STS: ATAT AAG CTT  TTA ATT TGT AAC CAT AGG AAT GC
The reaction mixture (50 pl) contained 200 pmol o f  each primer, Advantage cDNA polymerase 
mix (1 pi, Clontech), dNTP mix (0.2 mM o f each), 5 pL template DNA (100 times diluted), and 
10X reaction buffer (5 pl). PCR was conducted on a PE Applied Biosystem 9700 thermal cycler 
under the following conditions: 95 °C for 2 min followed by 30 cycles o f (95 °C for 30 s, 55 °C 
for 30s, 68 °C for 90s) and finally 4 °C for 5 min.
The PCR amplified fragments were purified from an agarose gel using the Qiagen Gel Extraction 
kit. DNA fragments were treated with BamHI and HindIII and inserted in expression vector 
pQE30 (Qiagen), which contains an N-terminal histidine tag. It should be noted that the 4CL2 
gene contains a BamHI site within its coding sequence, whose presence was overlooked at the 
moment the cloning strategy was developed. Nevertheless, the cloning procedure was successful 
as the fragment o f interest could selectively be isolated from gel. Following ligation and 
transformation, plasmids pQE30-4CL2 and pQE30-STS were obtained by isolation from XL- 
Blue1 E. coli cells. They were analysed by sequencing using the primers mentioned above and 
so-called pQE30 sequencing primers CCCGAAAAGTGCCACCTG and 
GTTCTGAGGTCATTACTGG (ordered from Biolegio).
E n zy m e  p ro d u c tio n
Methionine auxotrophic E. coli MTD123 cells32, 33 were co-transformed with repressor plasmid 
pREP4 (Qiagen) and pQE30-4CL2 or pQE30-STS. 2x YT medium supplemented with ampicillin 
(100 mg/L) and kanamycin (35 mg/L) was inoculated with a single colony and incubated 
overnight at 37 °C.
For production o f 4CL2 and STS containing methionine, the culture was diluted in fresh 2x YT 
medium to an OD600 o f 0.1 and grown at 37 °C. When an OD60 0 o f 0.8 was reached, isopropyl-P- 
D-thiogalactopyranoside (IPTG) was added to a final concentration o f 1 mM. Protein production 
was allowed to take place for 20 hours at 18 °C. STS containing azidohomoalanine (AHA-STS) 
was prepared by dilution o f the overnight culture in M9 minimal medium instead o f 2x YT 
medium. The same protocol was followed as described in Chapter 2 for production o f azido- 
functionalized CalB. However, upon reaching an OD60 0 o f 0.8 a medium shift was performed 
without initial incubation in presence o f  IPTG. Upon resuspension in M9 minimal medium 
containing azidohomoalanine, proteins were expressed by incubation overnight at 18 °C.
E. coli BLR(DE3) cells (Novagen) were transformed with pAC-TC32, which contains the gene 
encoding for glucosyl transferase Twi from Solanum lycopersicm  downstream o f a histidine tag 
(provided by PRI, Wageningen). 2x YT medium supplemented with chloroamphenicol (50 mg/L) 
was inoculated with a single colony and incubated overnight at 37 °C. Production o f Twi was 
performed in a similar way as 4CL2 was produced.
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E n zy m e  p u rifica tio n
All three His6-tagged enzymes were purified by N i2+ NTA affinity chromatography under native 
conditions (Qiagen). The bacteria pellet was lysed by incubation at 4 °C for 30 minutes in lysis 
buffer (30 mL o f  50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8.0) containing PMSF 
as protease inhibitor (1 mM) and lysozyme (1 mg/mL). After sonication for at maximum 5 
minutes (40 % duty cycle, power 6) the lysate was cleared by centrifugation at 4 °C (13000 g, 30 
minutes). The proteins were allowed to bind to N i2+ NTA beads (1 mL, Qiagen) for 2 hours at 4 
°C. Beads were loaded on a column, which was washed once with lysis buffer and twice with 
wash buffer (two times 10 volumes o f 50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 
8.0). Enzymes were eluted in elution buffer (10 mL o f 50 mM NaH2PO4, 300 mM NaCl, 250 
mM imidazole, pH 8.0). As for STS, 20 mM 2-mercaptoethanol was added to lysis buffer, wash 
buffer and elution buffer.
Elution fractions containing the enzymes were concentrated by centrifugation at 4 °C using an 
Amicon® Ultra-15 Centrifugal Filter Device (10,000 NMWL). Further purification was 
performed by size exclusion chromatography using a Superdex 75 PC 10/300 column on an 
ÄKTA FPLCtm (GE Healthcare Life Sciences). Both column and fraction collector were kept at 
4 °C. Phosphate buffer (25 mM NaH2PO4 and 100 mM NaCl, pH 7.5) was used as eluent while 
applying a flow rate o f 0.5 mL/min and collecting 0.5 mL fractions. Glycerol was added to a 
final concentration o f 10 % and aliquots were snap-frozen and stored at -20 °C until use.
E n zy m e  c o n c e n tra tio n  d e te rm in a tio n
Protein concentrations were determined by measuring absorbance at 280 nm on a Nanodrop ND- 
1000 spectrometer. Extinction coefficients were used as determined by the “Protein Calculator 
v3.3” at http://www.scripps.edu/~cdputnam/protcalc.html, being 0.45, 0.90 and 1.25 (mg/mL)- 
1cm-1 for 4CL2, STS and Twi, respectively.
A m ino  a c id  s e q u e n c e s  a n d  m a s s  s p e c tro m e try
Masses o f recombinant 4CL2, STS and Twi were determined by electrospray ionization time-of- 
flight (ESI-TOF) on a JEOL AccuTOF. Protein samples were desalted with MilliQ (3 times 0.5 
mL) using 10 kDa MWCO centrifugal filter units (Millipore). 5-10 pM protein in formic acid 
(0.1%) or 1 mM NH4HCO3 was injected. As an alternative to ultrafiltration, salts were removed 
using C4 ZipTip® pipette tips (Millipore). Deconvoluted spectra were obtained using MagTran 
1.03b2. Expected molecular weights (isotopically averaged) were calculated using the “Protein 
Calculator v3.3” at http://www.scripps.edu/~cdputnam/protcalc.html.
Amino acid sequences o f the enzymes are given below. The N-terminal methionine o f Twi was 
shown to be cleaved off. No sulfur bridges are present.
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4CL2
MRGSHHHHHHGSMEKDTKQVDIIFRSKLPDIYIPNHLPLHSYCFENISEFSSRPCLINGAN
KQIYTYADVELNSRKVAAGLHKQGIQPKDTIMILLPNSPEFVFAFIGASYLGAISTMANPL
F TPAEVVKQAEASSAKIIVT QACHVNKVKDYAFENDVKIICIDSAPEGCLHFSVLT QANE
HDIPEVEIQPDDVVALPYSSGTTGLPKGVMLTHKGLVTSVAQQVDGENPNLYIHSEDVM
LCVLPLFHIYSLNSVLLCGLRVGAAILIMQKFDIVSFLELIQSYKVTIGPFVPPIVLVIAKSP
MVDDYDLSSVRTVMSGAAPLGKELEDTVRAKFPNAKLGQGYGMTEAGPVLAMCLAFA
KEPFEIKSGACGTVVRNAEMKIVDPKTGNSLPRNQSGEICIRGDQIMKGYLNDPEATART
IDKEGWLYTGDIGYIDDDDELFIVDRLKELIKYKGFQVAPAELEALLLNHPNISDAAVVP
MKDEQAGEVPVAFVVRSNGSTITEDEVKDFISKQVIFYKRIKRVFFVDAIPKSPSGKILRK
DLRAKLAAGLPN
MRGSHHHHHHGSMASVEEIRNAQRAKGPATILAIGTATPDHCVYQSDYADFYFRVTKS
EHMTALKKKFNRICDKSMIKKRYIHLTEEMLEEHPNIGAYMAPSLNIRQEIITAEVPKLG
KEAALKALKEWGQPKSKITHLVFCTTSGVEMPGADYKLANLLGLEPSVRRVMLYHQGC
YAGGTVLRTAKDLAENNAGARVLVVCSEITVVTFRGPSEDALDSLVGQALFGDGSAAVI
VGSDPDISIERPLFQLVSAAQTFIPNSAGAIAGNLREVGLTFHLWPNVPTLISENIEKCLTQ
AFDPLRISDWNSLFWIAHPGGPAILDAVEAKLNLDKKKLEATRHVLSEYGNMSSACVLFI
LDEMRKKSLKGERATTGEGLDWGVLFGFGPGLTIETVVLHSIPMVTN
MGSSHHHHHHSQDPMGQLHFFFFPMMAQGHMIPTLDMAKLVACRGVKATIITTPLNES
VFSKAIERNKHLGIEIDIRLLKFPAKENDLPEDCERLDLVPSDDKLPNFLKAAAMMKDEF
EELIGECRPDCLVSDMFLPWTTDSAAKFSIPRIVFHGTSYFALCVGDSIRRNKPFKNVSSD
TETFVVPDLPHEIRLTRTQLSPFEQSDEETGMAPMIKAVRESDAKSYGVIFNSFYELESDY
VEHYTKVVGRKNWAIGPLSLCNRDIEDKAERGRKSSIDEHACLKWLDSKKSSSIVYVCF
GSTADFTTAQMQELAMGLEASGQDFIWVIRTGNEDWLPEGFEERTKEKGLIIRGWAPQV
LILDHEAIGAFVTHCGWNSTLEGISAGVPMVTWPVFAEQFFNEKLVTEVMRSGAGVGSK
QWKRTASEGVKREAIAKAIKRVMASEETEGFRSRAKEYKEMAREAIEEGGSSYNGWAT
LIQDITSYR
S y n th e s is  o f  h e te ro te le c h e lic  linker 1
(Z)-2.5-dioxopvrrolidin-1-vl-5-(didehvdrodibenzorb.f1-azocin-5(6H)-vl)-5-oxopenta-noate (3)
DIBAC (400 mg. 1.25 mmol) was dissolved in dry CH2Cl2(15
quenched with H2O (5 mL). The water-layer was extracted with 
CH2Cl2 (2 x10 mL). The organic layers were combined and washed with 0.1 M  NaOH (2 x 15
STS
Twi
mL). Subsequently EDC (776 mg. 5 mmol). DMAP (306 mg. 2.5 
mmol) and N-hydroxysuccinimide (288 mg. 2.5 mmol) were 
added. The reaction was stirred overnight and subsequently
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mL), 2 M  HCl (3 x 20 mL), H2O (2 x 20 mL) and brine (30 mL)) and subsequently dried over 
MgSO4. The solvent was removed under reduced pressure to obtain compound 3 (370 mg, 70%) 
‘H-NMR (400 MHz, CDCl3) S: 7.69 (d, J  = 8.4 Hz, 1H), 7.43-7.26 (m, 7H), 5.16 (d, J  = 13.8 
Hz, 1H), 3.67 (d, J  = 13.8 Hz, 1H), 2.80 (br s, 4H), 2.52 (td, J  = 16.5, 7.2 Hz, 1H), 2.46-2.35 (m, 
2H), 1.98-1.78 (m, 3H). ' 13C-NMR (75 MHz, CDCl3) S(ppm): 171.9, 168.9, 168.2, 151.4, 148.0, 
132.2, 129.9, 128.5, 128.3, 128.1, 127.8, 127.1, 125.5, 122.9, 122.6, 115.0, 107.7, 55.4, 33.1,
29.9, 25.5, 20.1. FT-IR vmax film: 2915, 2854, 1745, 1523, 1454, 1260, 1204, 1053. HRMS 
(ESI+) m/zcalcd for C24H21N 2O5 [M+H]+ 417.1451, found 417.1442.
3-(2-(2-(2-aminoethoxy)ethoxy)ethoxy)propanoicacid-TFA (4) Tert-butyl 12-amino-4,7,10- 
O O OH trioxadodecanoate (50 mg, 0.18 mmol) was dissolved in
H2N^  ' ' ' O^  ' ' ' O  TFA (3 mL) and the solution was stirred for 30 minutes.
The solvent was evaporated under reduced pressure to
obtain 4 as a yellow oil (35 mg, 61%).
‘H-NMR (400 MHz, CDCl3) S: 7.57 (br s, 3H), 3.78-3.72 (m, 4H), 3.69-3.67 (m, 2H), 3.63-3.62 
(m, 6H), 3.20 (dd, J=  5.4Hz, 9.4 Hz, 2H), 2.59 (t, J  = 5.5 Hz, 2H). 13C-NMR (75 MHz, CDCl3) S: 
171.6, 70.1, 69.8 (2C), 69.7, 66.6, 66.5, 39.8, 34.8. FT-IR vmax film: 3088, 2907, 1679, 1178, 
1122, 840, 793, 716. HRMS (ESI+) m/z calcd for C9H20NO5 [M+H]+ 222.1342, found 222.1346.
(Z)-18-(didehydrodibenzo[b,f]azocin-5(6H)-yl)-14,18-dioxo-4,7,10-trioxa-13-azaocta-decan-1-
/ ^ \  oic acid (5) Compound 3 (DIBAC­
O H ^  NHS) (40 mg, 0.091 mmol) was
H O ^ ^ ^ O —'— O'—^ O ^ — di ssol ved in DMF (2 ml) and NEt3
O O (0.051 ml, 0.365 mmol) and 4 (33.7
mg, 0.100 mmol) were added. The reaction was stirred for 2 hours and subsequently quenched 
with H2O (10 mL). The water-layer was acidified to pH 1 with 2M HCl and the product was 
extracted with CH2Cl2 (2 x 15 mL). The organic layers were combined and washed with 
respectively 2M  HCl (15 mL), H2O (2 x 15 mL) and brine (20 mL), followed by drying over 
MgSO4. The solvents were removed under reduced pressure. The crude product was purified by 
gradient column chromatography (CH2Cl2: MeOH:AcOH, 9:1:0 to 17:2:1) to obtain the product 
as a colorless oil (55 mg, ~80% pure, 92%). The product still contained one undefined 
contamination. Purity was based on the integrals o f the NMR-signals.
'H-NM R (CDCl3, 400 MHz), S: 7.66 (d, J  = 7.8 Hz, 1H), 7.43-7.25 (m, 7H), 6.45 (br s, 1H), 5.15 
(d, J  = 13.8, 1H), 3.76 (t, J  = 5.9 Hz, 2H), 3.67 (d, J  = 13.8 Hz, 1H), 3.66-3.57 (m, 8 H), 3.51­
3.49 (m, 2H), 3.44-3.25 (m, 2H), 2.58 (t, J  = 6.0 Hz, 2H), 2.33-2.22 (m, 1H). 2.02-1.92 (m, 3H), 
1.76-1.69 (m, 2H).13C-NMR (75 MHz, CDCl3) S: 175.8, 173.2, 172.9, 151.5, 147.9, 132.3, 128.9,
128.5, 128.2, 128.1, 127.7, 127.1, 125.4, 123.0, 122.4, 114.8, 107.9, 70.4 (2C), 70.1, 69.8, 67.2, 
55.4, 39.1, 35.9, 35.2, 33.7, 21.5. FT-IR vmax film: 3425, 2937, 1714, 1640, 1567, 1398, 1251, 
1096, 750. HRMS (ESI+) m/z calcd for C29H35N 2O7 [M+H]+ 523.2444, found 523.2447.
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(Z)-2.5-dioxopvrrolidin-1-vl 18-(didehvdrodibenzorb.f1azocin-5(6H)-vl)-14.18-dioxo-4.7.10- 
trioxa- 13-azaoctadecan- 1-oate (1) Compound 5 (DIBAC-OEG-free acid) (50 mg. ~80% pure.
. 0.076 mmol) was dissolved in dry
y—f  O H V  CH2Cl2 (10 mL). Subsequently EDC
(59 mg. 0.38 mmol). DMAP (23 mg.Q o o
0.19 mmol) and N- 
hydroxysuccinimide (22 mg. 0.19 mmol) were added. The mixture was stirred overnight and 
quenched with H2O (5 mL). The mixture was diluted with CH2Cl2(10 mL) and the organic layer 
was washed with 0.2 M  NaOH (2 x 10 ml). 2 M  HCl (3 x 20 mL). H2O (20 mL) and brine (20 
mL) and subsequently dried over MgSO4. The solvents were removed under reduced pressure to 
obtain compound 1 as a brownish oil (15 mg. 32%).
‘H-NMR (CDCl3. 400 MHz). S: 7.69 (d. J  = 7.9. 1H). 7.42-7.25 (m. 7H). 6.00 (br s. 1H). 5.15 (d. 
J  = 13.8. 1H). 3.84 (t. J  = 6.3 Hz. 2H). 3.74-3.58 (m. 9H). 3.48 (t. J  = 5.3 Hz. 2H). 3.40-3.27 (m. 
2H). 2.89 (t. J  = 6.3 Hz. 2H. 2.81 (br s. 4H). 2.30-2.23 (m. 1H). 2.00-1.84 (m. 3H). 1.75-1.68 (m. 
2H). 13C-NHM (CDCl3. 75MHz). S: 172.8. 172.4. 169.0 (2C). 166.7. 151.7. 148.1. 132.3. 128.9.
128.5. 128.2. 128.0. 127.7 127.1. 125.4. 123.5. 123.0. 114.9. 108.0. 70.7. 70.5. 70.4. 70.2. 69.8. 
65.7. 55.3. 39.2. 35.2. 33.7. 32.1. 25.6 (2C). 21.4. FT-IR vmax film: 3321. 2928. 2881. 1731. 
1649. 1195. 1104. 1074. HRMS (ESI+) m/z calcd for C33H38N 3O9 [M+H]+ 620.2608. found 
620.2620.
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S y n th e s is  o f  h e te ro te le c h e lic  linker 2
(Z)-N-(2-(2-(2-aminoethoxv)ethoxv)ethvl)-5-(didehvdrodibenzo [b,f]azocin-5(6H)-vl)-5-oxopen-
tanamide (6) Compound 3 (DIBAC-NHS) (300
■6? \_ J j  mg. 0.72 mmol) was dissolved in dry CH2Cl2 (10
/ H
✓ N ^ ^ ^ ^ ^ N _________ O__'""'NH mL) and 1,8-diamino-3,6-dioxaoctane (842 pL,
O O 5.77 mmol) was added. The reaction was stirred
for 2 hours and the mixture was diluted with CH2Cl2 (20 mL). The organic laver was washed 
with H2O (3 x 30 mL) and brine (30 mL) and subsequent^ dried over MgSO4. The solvents were 
removed under reduced pressure and the thus obtained crude product was purified bv column 
chromatographv (CH2Cl2/MeOH/7M NH3 in MeOH, 90:9:1) to obtain the product as a vellow oil 
(180 mg, 56%). 1H-NMR (CDCl3, 400 MHz), S: 7.70 (d, J=  7.5 Hz, 1H), 7.42-7.26 (m, 7H), 6.18 
(br s, 1H), 5.15 (d, J  = 13.9 Hz, 1H), 3.67 (d, J  = 13.8 Hz, 1H), 3.62-3.58 (m, 4H), 3.53-3.48 (m, 
4H), 3.42-3.30 (m, 2H), 2.85 (t, J  = 5.7 Hz, 2H), 2.28 (td, J=  13.7, 6.6 Hz, 1H), 1.99-1.84 (m, 
3H), 1.73 (dt, J  = 14.3, 6.8 Hz, 2H). 13C-NMR (CD3OD, 75 MHz), S: 175.3, 174.8, 152.9, 149.5,
133.5, 130.4, 130.0, 129.7, 129.3, 128.9, 128.1, 126.5, 124.3, 123.7, 115.7, 108.8, 72.8, 71.3 
(2C), 70.6, 56.7, 41.9, 40.2, 36.0, 35.0, 22.8. FT-IR vmax film: 2967, 2923, 2850, 1658, 1558, 
1260, 1113, 1009, 806. HRMS (ESI+) m/z calcd for C26H32N3O4 [M+H]+ 450.2392, found 
450.2379.
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(Z)-5-(didehvdrodibenzo[b.flazocin-5(6H)-vl)-N-(2-(2-(2-(3-(2.5-dioxo-2.5-dihvdro-1H-pvrrol-
1 -vl)propanamido)ethoxv)ethoxv)ethvl)-5-oxopentanamide (2) Compound 6 (DIBAC-OEG-
NH2) (28 mg. 0.062 mol) was dissolved
mmol) and N-methvlmorpholine (14 pL. 0.13 mmol) were added and the reaction was stirred for 
3 davs at room temperature. The reaction was quenched with H2 O (10 mL) and extracted with 
CH2Cl2 (2 x 20 mL). The organic lavers were combined and subsequent^ washed with 2M HCl 
(2 x 30 mL). H2O (2 x 30 mL) and brine (30 mL) and dried over MgSO4. The solvents were 
removed under reduced pressure and the crude product was purified bv column chromatographv 
(EtOAc/ra-heptane. 2:1 followed bv CH2Cl2/MeOH. 9:1) to obtain the product as a colorless oil. 
After lvophilization the product was obtained as a white solid. 'H-NM R (CDCl3. 400 MHz). S: 
7.68 (d. J  = 7.4 Hz. 1H). 7.43-7.26 (m. 7H). 6.69 (s. 2H). 6.33 (br s. 1H). 5.95 (br s. 1H). 5.14 (d. 
J  = 14.0. 1H). 3.86-3.81 (m. 3H). 3.69-3.55 (m. 4H). 3.51-3.48 (m. 4H). 3.41-3.36 (m. 2H). 2.50 
(t. J  = 7.5 Hz. 2H). 2.30-2.19 (m. 1H). 2.02-1.87 (m. 3H). 1.75-1.68 (m. 2H). 13C-NMR (CDCl3. 
75 MHz). S: 172.9. 172.6. 170.4. 169.9. 151.5. 148.0. 134.1. 132.2. 128.9. 128.5. 128.2. 128.1.
127.9. 127.0. 125.3. 122.9. 122.3. 114.8. 107.9. 70.1. 70.1. 69.7. 69.6. 55.3. 39.1. 39.0. 35.3.
34.5. 34.3. 33.6. 33.5. 21.5. FT-IR vmax film: 3291. 2911. 1701. 1653. 1402. 616. HRMS (ESI+) 
m/z calcd for C33H37N 4O7 [M+H]+ 601.2662. found 601.2655.
C o n ju g a tio n  o f  d ib e n z o a z a c y c lo o c ty n e -fu n c t io n a liz e d  PE G 2000  to  ST S
2. 5 or 20 equivalents o f PEG2000-DIBAC (1 mM in MQ)27 were added to AHA-STS. Samples 
were incubated for 2. 4. 8 or 16 hours at room temperature while gentlv shaken.
P ro d u c tio n  a n d  p u rific a tio n  o f  T w i-STS c o n ju g a te s
Twi was reacted with linker 1 (stock in DMSO) for two hours while shaken at room temperature. 
The final concentration o f  DMSO never exceeded 10 %. Excess o f linker was removed bv 
ultrafiltration at 4 °C using phosphate buffer (3 times 450 pL) using 10 kDa MWCO centrifugal 
filter units (Millipore).
To Twi-2 AHA-STS was added. The total protein concentration in the reaction mixture varied 
between 1.4 and 2.6 mg/mL. Glvcerol was added to a final concentration o f 10 % to prevent 
formation o f inactive enzvme aggregates. Twi-STS conjugate formation was allowed to take 
place for at least 14 hours at room temperature. Subsequent^. reaction products were separated 
over a Superdex200 PC 3.2/30 column (GE Healthcare Life Sciences) on a SMART FPLC 
(Amersham Pharmacia). Phosphate buffer was used as eluent while applving a flow rate o f 25 
pL/min and collecting 25 pL fractions.
O in dry DMF (3 mL). Subsequent^. 3- 
maleimido-propionic acid (12.6 mg. 
( Ï  0.075 mmol). HATU (47.4 mg. 0.13
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Azidohomoalanine incorporation in 4CL2 was performed as described in Chapter 2. Introduction 
o f azide groups via the diazotransfer reaction was attempted according to the procedure described 
in Chapter 5, using phosphate buffer (pH 7.5) instead o f a diethanolamine solution and 17.5 
equivalents o f diazotransfer reagent relative to amines. Alternativelv, substrates o f  4CL2 were 
added. In this case the reaction mixture contained 0.41 nmol 4CL2, 62.5 nmol ATP, 25 nmol p- 
coumaric acid, 25 nmol CoA and 157 nmol o f diazotransfer reagent (2 equivalents relative to the 
total amount o f amines present in both 4CL2 and ATP) in 37.5 pL. Reactions were incubated for 
two hours at room temperature and purified bv ultrafiltration before residual activitv o f 4CL2 
was determined.
Conjugation o f linker 2 was performed bv incubation o f 4CL2 with 0, 1 or 2 equivalents o f 2. A 
stock solution o f 2 in DMSO was prepared. The final concentration o f DMSO was 8 %. After 
shaking for two hours at room temperature, unreacted linker was removed bv ultrafiltration at 4 
°C with phosphate buffer (3 times 450 pL) using 10 kDa MWCO centrifugal filter units 
(Millipore). 4CL2 functionalized with the DIBAC moietv was either allowed to react with 20 
equivalents o f PEG2000-N3 for two hours at room temperature and anafysed bv gel 
eletrophoresis, or tested for activity.
P ro d u c tio n  o f  4C L 2-ST S a n d  4C L2-STS-Tw i c o n ju g a te s
4CL2 was incubated with 2 equivalents o f 2 for two hours at room temperature. Upon removal o f 
the excess o f linker bv ultrafiltration with phosphate buffer (see above), 4CL2-2 was reacted with
1.1 equivalents o f AHA-STS while shaken overnight at room temperature. To an aliquot o f  the 
crude reaction mixture (containing 12 pg o f total protein) PEG2000-DIBAC was added. The rest 
o f the reaction mixture (~150 pg o f protein) was purified bv size-exclusion chromatographv, 
applving a flow o f 40 pL/min with phosphate buffer as eluent (see production and purification of 
Twi-STS conjugates). The unreacted enzvme fraction, eluting at 1.52 mL, was concentrated 15 
times using 50 kDa MWCO centrifugal filter units (Millipore). PEG2000-DIBAC or PEG2000- 
N 3 was added. Conjugation o f the polvmer chains was evaluated bv gel eletrophoresis after 
incubation at room temperature for two hours.
Twi-1 and 4CL2-2 were prepared as described above using 10 equivalents o f  1 and 2 equivalents 
o f 2 relative to Twi and 4CL2, respectivelv. Excess o f linker was removed bv ultrafiltration. 
Subsequent^, 200 pg o f Twi-1 and 100 pg o f 4CL2-2 were added to 160 pg AHA-STS resulting 
in a molar ratio o f 1: 1.8:2 for Twi:4CL2:STS. Glvcerol was added to a final concentration of 
10%. After incubation at room temperature for 14-16 hours, enzvme conjugates were purified bv 
size-exclusion chromatographv (see above for column and eluent). A flow o f 40 pL/min was 
applied. The total reaction mixture was injected in three separate runs to obtain optimal 
separation. Fractions eluting at the following column volumes were pooled: 1.128-1.288 mL 
(referred to as fraction I), 1.288-1.435 mL (fraction II) and 1.437-1.664 mL (fraction III). These 
were analvsed bv gel electrophoresis and tested for enzvmatic activitv.
Modification of 4CL2
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G el e le c tro p h o r e s is
Purified enzvmes and conjugated protein samples were analvsed bv electrophoresis on 7.5% or 
10% (w/v) polvacrvlamide gels followed bv Coomassie BB R-250 or silver staining. Where 
indicated, electrophoresis was performed under native conditions bv omitting SDS in the gels. In 
this case, native sample buffer was used which did not contain SDS or P-mercaptoethanol, and 
samples were not boiled at 95 °C before loading.
P ro te in  d ig e s tio n  a n d  e x tra c tio n  from  p o ly a c ry la m id e  ge l
Twi-STS conjugates were separated on a 15% (w/v) polvacrvlamide SDS-PAGE gel with a 5% 
(w/v) stacking gel using the Mini-Protean II gel svstem (Bio-Rad). Broad Range Molecular Mass 
markers (Bio-Rad) were used to determine relative molecular masses. After staining with 
Coomassie BB R-250, the protein bands o f interest were cut out o f the SDS-PAGE gel and sliced 
into 1 mm3 -pieces. Proteins were reduced with DTT and alkvlated with iodoacetamide. Gel 
pieces were dried under vacuum, and swollen in 0.1 M  NaHCO3 containing sequence-grade 
porcine trypsin (10 ng/pl, Promega). After digestion at 37 °C overnight, peptides were extracted 
from the gel with 50% (v/v) acetonitrile, 5% (v/v) formic acid and dried under vacuum.
2-D LC-MS c o n f ig u ra tio n
LC-MS experiments were carried out using the 2-D nanoAcquitv UPLC svstem online coupled to 
a Svnapt HDMS Q-TOF MS instrument (Waters, Milford, MA, USA). Reversed phase UPLC 
(pre)columns, used in this studv were obtained from Waters (Milford, MA, USA). In the first 
dimension a 300 pm x 50 mm X bridge C18 (5 pm) trap column was used and the sample was 
eluted with a discontinuous step gradient at 2 pl/min, using 13, 45 and 65 % ACN in 20 mM 
ammonium formate (pH=10). In the 2nd dimension a 180 pm x 20 mm Svmmetrv C18 (5 pm) 
trap column was used. To maximize sample recoverv on the 2nd dimension trap column, an 
online dilution o f peptides eluting from the first dimension trap with 0.1 % formic acid in water 
at a flow rate o f 20 pl/min was used (10:1). Peptides were separated on a 75 pm x 250 mm BEH 
130 C18 (1.7 pm) analvtical column at 0.2 pl/min using 0.1 % formic acid in water as eluent A 
and 0.1 % formic acid in ACN as eluent B. The separation was carried out using 5 % B for 1 
min, 10 % B for 2 min, 10-40 % B over 62 min and 40-85 % B over 9 min. After 6 min o f rinsing 
with 85 % B and a linear gradient back to 5% B over 2 min the column was re-equilibrated at 
initial conditions. The analvtical column temperature was maintained at 35° bv a built-in column 
heater.
MS analvses were performed in positive mode using ESI with a NanoLockSprav source. As lock 
mass, [Glu']fibrinopeptide B (1 pmol/pl) (Sigma) was delivered from a svringe pump (Harvard 
Apparatus, USA) to the reference spraver o f the NanoLockSprav source at a flow rate o f 0.2 
pl/min. The lock mass channel was sampled everv 30 s. Accurate LC-MS data were collected 
with the Svnapt operating in either MSE mode for data-independent acquisition or in MS/MS
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mode for data-dependent acquisition (DDA). W hen operating in the LC-MSE alternate scanning 
mode, low and elevated energv spectra were acquired every 0.6 s over the m/z range 140 to 1900. 
The Svnapt was programmed to step between normal (6 eV) and elevated (ramp from 15 to 35 
eV) collision energies applied to the gas cell.
DDA was performed in such a wav that the three most intensive multiplv charged ions eluting 
from the column were selected for peptide fragmentation. The eluting peptide ions were detected 
in the MS survev scan (0.6 s) from m/z o f 300 to 1400. A dvnamic exclusion window was set at 
60 s. The collision energv was autom atical^ set based on the observed precursor m/z and charge 
state.
All data was processed with ProteinLvnx Global Server (PLGS 2.4)
E n zy m e  ac tiv ity  a s s a y s
All enzvme activity assavs were carried out in a buffered solution containing 25 mM NaH2PO4 
and 100 mM NaCl (pH 7.5). Stock solutions o f  Coenzvme A and UDP-glucose (each 10 mM in 
MQ) were stored in aliquots at -20 °C and thawed upon use. Stock solutions containing 10 mM 
para-coum aric acid in EtOH, 0.5 or 2.5 mM malonvl-CoA in 50 % DMSO and 4.4 mM 
resveratrol in DMSO were stored at -20 °C as well. Time samples o f STS and Twi activity assavs 
were anatysed bv high-performance liquid chromatographv (HPLC) on a Shimadzu anatytical 
HPLC over a C18 column. 20 pL was injected. A linear gradient was applied from 5 % 
acetonitrile in MQ/0.1 % trifluoroacetic acid to 50 % acetonitrile in MQ/0.1% trifluoroacetic acid 
in 30 minutes. Compounds were detected bv measuring absorbance at 307 nm.
4CL2 activitv
4CL2 activitv was followed in time at 30 °C bv measuring absorbance at 333 nm on a Varian 
Cary-50 UV/Vis spectrophotometer. The reaction mixture consisted o f 0.5 mM CoA, 0.5 mM 
para-coum aric acid, 3.125 mM ATP, 3.125 mM MgCl2, and 1.25 mM DTT in 200 pL. 10 pg 
4CL2 was added to start the reaction. The slope o f the curve obtained during the first minute was 
taken as a measure o f  activitv.
STS activitv
The specific activitv o f STS was determined at high substrate concentrations, i.e. 0.5 mM 
malonvl-CoA and 0.1 mM coumarovl-CoA. Coumarovl-CoA was prepared as described above. 
An aliquot o f the 4CL2 assav reaction mixture, which was incubated in presence o f 4CL2 at 30 
°C for 10 minutes or longer, was mixed with malonvl-CoA. The amount o f resveratrol formed at 
30 °C bv 2 pg Met-STS or AHA-STS in 100 pL was measured. After quenching a 25 pL aliquot 
with 12.5 pL 50 % HOAc, the product was extracted using 150 pL EtOAc. The organic phase 
was collected and the solvent was removed bv speedvac after which the product was redissolved 
in 50 pL 50 % MeOH in MQ/5 % formic acid and anatysed bv HPLC.
STS activitv exhibited bv the conjugates was determined using an assav mix which contained 25 
pM CoA, 25 pM para-coum aric acid, 156.25 pM ATP, 156.25 pM MgCl2, and 62.5 pM DTT
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together with 0.1 mM malonyl-CoA. As for the STS-Twi coupling reactions, 1 pg 4CL2 was 
added. Reactions were incubated at 30 °C. Samples were quenched by addition o f 10 % formic 
acid in MeOH (25 pL was added to a 25 pL aliquot o f  the reaction) and analysed by HPLC.
Twi activity
The specific activity o f Twi was determined in presence o f 500 pM resveratrol, 2.5 mM UDP- 
glucose in a buffered solution containing 2.5 mM MgCl2. The amount o f glycosylated resveratrol 
formed at 30 °C in 15 minutes by 1 or 2 pg Twi in 100 pL was determined.
Twi activity displayed by the conjugates was measured in a reaction mixture containing 40 pM 
resveratrol and 0.4 mM UDP-glucose. All time samples were quenched by addition o f 10 % 
formic acid in MeOH (25 pL was added to a 25 pL aliquot o f the reaction) and analysed by 
HPLC.
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Summary
In living cells enzymes catalyze a wide variety of metabolic processes consisting of 
multiple reaction steps. Efficient transfer of the intermediates from one catalytic site to 
the other is achieved by the formation of macromolecular enzyme complexes. So-called 
metabolic channeling takes place, which prevents diffusion of the intermediate into the 
bulk phase of the cell. Well-known examples of this kind of assemblies are the 
tryptophane synthase complex and the co-localization of the enzymes of the citric acid 
cycle. They have inspired researchers to mimic this approach by bringing biocatalysts 
together in an artificial way. As described in Chapter 1, various strategies have been 
exploited, which differ in their degree of control over the assembly process. 
Surprisingly, so far, site-specific modification methods have hardly been applied. It 
encouraged us to explore this approach in more detail, that is, to construct well-defined 
enzyme architectures via selective bioconjugation methods without the use of a solid 
support or protein scaffold.
Chapter 2 describes the incorporation of the non-natural amino acid 
azidohomoalanine in the model enzyme Candida antarctica lipase B (CalB). 
Expression of CalB in Escherichia coli is reported as well as its purification. 
Methionine was efficiently replaced by the non-proteinogenic azide analogue as proven 
by mass spectrometry. Adaptations in the protein expression protocol did not result in 
higher protein yields. However, purity of the final product was improved by preventing 
the production of a native E. coli stress protein.
Use of the introduced azide moiety as a functional handle for bioconjugation is 
presented in Chapter 3. It was demonstrated that residue-specific incorporation of 
azidohomoalanine enabled modification of CalB at a single position via the Cu(I) 
catalyzed azide-alkyne cycloaddition. Out of the five introduced azide groups, only one 
moiety appeared to be reactive under native conditions. The other residues were buried 
inside the protein. As reported elsewhere, the strategy was successfully applied in the 
site-specific immobilization of CalB to different polymer-like materials, being 
polymersomes, elastin-like polypeptide and DNA oligonucleotides. In all cases it was 
shown that the enzyme remained active while the function of the polymer-like 
materials was retained as well.
As a next step, we investigated whether the introduced azide moiety could be used 
for the controlled and direct linkage of multiple CalB molecules to each other. In 
Chapter 4, four different strategies are highlighted. The oligomers that were prepared
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were separated from unreacted monomers by size-exclusion chromatography. The 
activity of CalB dimers was studied in more detail, showing that they were as active as 
the monomers.
In order to be able to introduce azide moieties in enzymes without the use of 
molecular biology techniques, an alternative strategy was explored, which is described 
in Chapter 5. A mild, metal-free and pH-controlled diazotransfer reaction was 
developed, which allowed for selective conversion of amines into azides in a post- 
translational manner. This straightforward modification method was tested on CalB, 
lysozyme and two elastin-like polypeptides (ELPs). By mass spectrometry it was 
shown that the diazotransfer was selective towards the most reactive amines, being the 
a-amine at the N-terminus of both CalB and ELPs. Activity studies on lysozyme 
showed the beneficial effect of using non-toxic and mild conditions in order to retain 
enzyme activity.
In addition to linking multiple enzymatic functionalities, we set out to produce a 
biohybrid system, in which an enzyme and metal catalyst were covalently bound. As 
described in Chapter 6, two different transition-metal ligands were coupled near CalB’s 
active site. The strain-promoted cycloaddition between a dibenzoazacyclooctyne 
functionalized pincer ligand and CalB containing azidohomoalanine proceeded 
quantitatively, as verified by mass spectrometry. Insertion of a metal ion to obtain the 
active enzyme -  metal biohybrid catalyst remains to be achieved.
Our final goal of creating a multi-enzymatic complex through direct linkage of a 
number of different enzymes was reached as presented in Chapter 7. A synthetic 
metabolon was produced containing three enzymes involved in the biosynthesis of 
piceid. Heterotelechelic linkers were used to control complex formation. It was 
demonstrated that the enzyme conjugates successfully catalyzed the production of the 
metabolite of interest.
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Enzymen versnellen in de natuur een groot aantal stofwisselingsprocessen die uit 
meerdere reactiestappen bestaan. De efficiënte overdracht van tussenproducten van het 
ene naar het andere katalytische centrum wordt mogelijk gemaakt door de vorming van 
macromoleculaire enzymcomplexen. In deze complexen vindt een proces plaats dat 
‘metabolic channeling’ genoemd wordt. Het zorgt ervoor dat de tussenproducten niet 
verloren raken door diffusie naar andere delen van de cel. Bekende voorbeelden van dit 
soort assemblages zijn het tryptofaansynthasecomplex en de clustering van de enzymen 
van de citroenzuurcyclus. Deze complexen zijn voor onderzoekers aanleiding geweest 
om enzymen ook op synthetische wijze bij elkaar te brengen. In hoofdstuk 1 worden 
verschillende strategieën beschreven. Ze verschillen in de mate waarmee controle kan 
worden uitgeoefend over de complexvorming. Tot nu toe heeft men nauwelijks gebruik 
gemaakt van site-specifieke modificatiemethodes. Dit motiveerde ons om deze 
benadering in meer detail te bestuderen. Het doel van het hier beschreven onderzoek 
was om op gedefinieerde wijze enzymen te koppelen zonder gebruik te maken van een 
vaste drager of een eiwitstructuur als basis.
Hoofdstuk 2 beschrijft de introductie van het niet-natuurlijke aminozuur 
“azidohomoalanine” in ons model-enzym Candida antarctica lipase B (CalB). De 
productie van CalB in de bacterie Escherichia coli en de opzuivering worden 
beschreven. Uit massaspectrometrie-resultaten bleek dat het aminozuur methionine 
efficient was vervangen door de niet-natuurlijke azide analoog. Aanpassingen in het 
protocol van eiwitproductie resulteerden niet in een grotere opbrengst. Echter, de 
zuiverheid van het gemodificeerde CalB kon wel verbeterd worden door te voorkomen 
dat E. coli een stress-eiwit produceerde.
Het gebruik van de geïntroduceerde azide-groep als een aangrijpingspunt voor 
bioconjugatie wordt beschreven in hoofdstuk 3. Als bioconjugatie-reactie werd gebruik 
gemaakt van de Cu(I)-gekatalyseerde cycloadditie tussen een azide en een alkyn. Er 
wordt aangetoond, dat het mogelijk is om CalB op één enkele positie te modificeren 
door op residue-specifieke wijze azidohomoalanine te introduceren. Van de vijf azide- 
groepen die in CalB geïntroduceerd werden, was er maar één toegankelijk. De andere 
residuen zaten verborgen in het eiwit. Collega’s hebben beschreven hoe deze strategie 
op succesvolle wijze gebruikt kon worden om CalB te immobilizeren op drie 
verschillende polymeren: polymersomen, eiwitmoleculen lijkend op elastine en DNA
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oligonucleotides. In alledrie de gevallen werd aangetoond dat zowel het enzym als de 
polymeer hun functie behielden.
Vervolgens hebben we onderzocht of de azide-groep ook gebruikt kon worden om 
op gecontroleerde manier meerdere CalB-moleculen aan elkaar te koppelen. In 
hoofdstuk 4 worden vier verschillende methodes gepresenteerd. De gemaakte 
oligomeren konden door middel van size-exclusion chromatografie worden gescheiden 
van monomeren die niet gereageerd hadden. De activiteit van de CalB-dimeren werd in 
meer detail bestudeerd. Deze studie toonde aan dat ze even actief waren als de 
monomeren.
In hoofdstuk 5 staat beschreven hoe azides in enzymen kunnen worden 
geïntroduceerd zonder gebruik te maken van moleculaire biologietechnieken. Een 
milde, metaal-vrije en pH-gecontroleerde ‘diazotransfer’ reactie werd ontwikkeld, 
waarbij selectief amines in azides werden omgezet. De reactie vond post-translationeel 
plaats, dat wil zeggen nadat het enzym geproduceerd was. Deze eenvoudige 
modificatiemethode werd getest op zowel CalB, als lysozym en twee polypeptides die 
op elastine lijken (ELP’s genoemd). Door middel van massaspectrometrie werd 
bevestigd dat de ‘diazotransfer’ reactie selectief was voor de meest reactieve amines. 
Voor zowel CalB als de ELP’s was dit enkel de a-amine aan de N-terminus. Eveneens 
toonden we aan dat het gebruik van deze niet-toxische en milde reactiecondities 
essentieel was om de activiteit van lysozym te behouden.
Naast de aaneenkoppeling van meerdere enzymen, hebben we geprobeerd om een 
biohybride systeem te produceren door een enzym en metaalkatalysator met elkaar te 
verbinden. In hoofdstuk 6 staat beschreven hoe twee verschillende liganden voor 
overgangsmetalen vlakbij het actieve centrum van CalB werden gekoppeld. De ‘strain- 
promoted’ cycloadditie vond plaats tussen een dibenzocyclooctyn, gekoppeld aan een 
‘pincer’ ligand, en het azidohomoalanine bevattend CalB. Door middel van 
massaspectrometrie werd aangetoond dat deze reactie quantitatief verliep. Een 
volgende stap zal zijn om een metaalion te introduceren zodat een actief enzym-metaal 
biohybride katalysator zal worden verkregen.
In hoofdstuk 7 beschrijven we hoe ons uiteindelijk doel werd bereikt. Een 
synthetisch metabolon werd geproduceerd door het koppelen van drie enzymen, die 
betrokken zijn bij de biosynthese van piceid. Verbindingsmoleculen met twee 
verschillende functionele uiteindes werden gebruikt om de complexvorming 
gecontroleerd te laten verlopen. Er werd aangetoond dat de enzymconjugaten op een 
efficiënte manier de productie van piceid katalyseerden.
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